{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Using TensorFlow backend.\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorflow/python/framework/dtypes.py:516: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_qint8 = np.dtype([(\"qint8\", np.int8, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorflow/python/framework/dtypes.py:517: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_quint8 = np.dtype([(\"quint8\", np.uint8, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorflow/python/framework/dtypes.py:518: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_qint16 = np.dtype([(\"qint16\", np.int16, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorflow/python/framework/dtypes.py:519: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_quint16 = np.dtype([(\"quint16\", np.uint16, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorflow/python/framework/dtypes.py:520: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_qint32 = np.dtype([(\"qint32\", np.int32, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorflow/python/framework/dtypes.py:525: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  np_resource = np.dtype([(\"resource\", np.ubyte, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorboard/compat/tensorflow_stub/dtypes.py:541: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_qint8 = np.dtype([(\"qint8\", np.int8, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorboard/compat/tensorflow_stub/dtypes.py:542: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_quint8 = np.dtype([(\"quint8\", np.uint8, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorboard/compat/tensorflow_stub/dtypes.py:543: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_qint16 = np.dtype([(\"qint16\", np.int16, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorboard/compat/tensorflow_stub/dtypes.py:544: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_quint16 = np.dtype([(\"quint16\", np.uint16, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorboard/compat/tensorflow_stub/dtypes.py:545: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  _np_qint32 = np.dtype([(\"qint32\", np.int32, 1)])\n",
      "/Users/nastul/Documents/anaconda3/envs/ner/lib/python3.7/site-packages/tensorboard/compat/tensorflow_stub/dtypes.py:550: FutureWarning: Passing (type, 1) or '1type' as a synonym of type is deprecated; in a future version of numpy, it will be understood as (type, (1,)) / '(1,)type'.\n",
      "  np_resource = np.dtype([(\"resource\", np.ubyte, 1)])\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "from sklearn.model_selection import ShuffleSplit\n",
    "from data_utils import ENTITIES, Documents, Dataset, SentenceExtractor, make_predictions\n",
    "from data_utils import Evaluator\n",
    "from models import build_lstm_crf_model\n",
    "from gensim.models import Word2Vec"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_dir = 'brat/'\n",
    "ent2idx = dict(zip(ENTITIES, range(1, len(ENTITIES) + 1)))\n",
    "idx2ent = dict([(v, k) for k, v in ent2idx.items()])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "#载入文件\n",
    "docs = Documents(data_dir=data_dir)\n",
    "#分配训练集和测试集\n",
    "#自动迭代，返回id\n",
    "rs = ShuffleSplit(n_splits=1, test_size=20, random_state=2018)\n",
    "train_doc_ids, test_doc_ids = next(rs.split(docs))\n",
    "train_docs, test_docs = docs[train_doc_ids], docs[test_doc_ids]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['11319941', '11532192', '11597317', '11604102', '11897010',\n",
       "       '12079497', '12546709', '12585968', '12925238', '14609438',\n",
       "       '14611657', '14624252', '14675480', '14691534', '14723793',\n",
       "       '14737183', '15005800', '15018652', '15040800', '15061865',\n",
       "       '15070402', '15207008', '15238161', '15314655', '15314659',\n",
       "       '15320950', '15328533', '15328538', '15345036', '15492776',\n",
       "       '15550985', '15560850', '15588329', '15615595', '15619330',\n",
       "       '15630473', '15676071', '15760270', '15784609', '15819996',\n",
       "       '15836427', '15850489', '15876356', '15882093', '15917436',\n",
       "       '15921521', '15938754', '16026622', '16027110', '16098226',\n",
       "       '16103912', '16109169', '16110338', '16121255', '16121256',\n",
       "       '16216087', '16221973', '16255782', '16279840', '16362077',\n",
       "       '16410827', '16433929', '16462940', '16504143', '16504174',\n",
       "       '16507151', '16517939', '16539743', '16579849', '16611361',\n",
       "       '16628246', '16670015', '16700629', '16787536', '16800892',\n",
       "       '16870721', '16968134', '17002498', '17020410', '17022820',\n",
       "       '17029558', '17069463', '17078885', '17083276', '17194222',\n",
       "       '17201918', '17206865', '17244351', '17425782', '17447844',\n",
       "       '17465682', '17503968', '17565376', '17590087', '17608565',\n",
       "       '17677002', '17696610'], dtype='<U8')"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "docs.doc_ids"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'11319941'"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "docs[0].doc_id"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(array([93, 23, 11, 65, 67, 18, 32, 30, 74, 14, 48, 57, 80, 15, 27,  8, 24,\n",
       "        46, 55, 39, 61, 89, 86, 54, 50, 12,  1, 19,  4, 16,  3, 34, 10, 72,\n",
       "        35, 82, 36, 58, 76, 49, 64, 68, 44, 63, 13, 70, 45, 78, 81, 83, 69,\n",
       "        84, 29, 79, 71, 40, 53, 38, 26,  0, 42, 92, 22, 31, 60, 90, 88, 47,\n",
       "        75, 87, 91, 25,  6, 20, 28, 21,  9]),\n",
       " array([59,  7, 85, 41, 94, 33, 17, 56, 52,  2, 77, 37,  5, 62, 73, 95, 51,\n",
       "        96, 66, 43]))"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "next(rs.split(docs))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<data_utils.data_utils.Documents at 0x23f1bb10400>"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([59,  7, 85, 41, 94, 33, 17, 56, 52,  2, 77, 37,  5, 62, 73, 95, 51,\n",
       "       96, 66, 43])"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_doc_ids"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([93, 23, 11, 65, 67, 18, 32, 30, 74, 14, 48, 57, 80, 15, 27,  8, 24,\n",
       "       46, 55, 39, 61, 89, 86, 54, 50, 12,  1, 19,  4, 16,  3, 34, 10, 72,\n",
       "       35, 82, 36, 58, 76, 49, 64, 68, 44, 63, 13, 70, 45, 78, 81, 83, 69,\n",
       "       84, 29, 79, 71, 40, 53, 38, 26,  0, 42, 92, 22, 31, 60, 90, 88, 47,\n",
       "       75, 87, 91, 25,  6, 20, 28, 21,  9])"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_doc_ids"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'GO_UBERON_EXT': 1,\n",
       " 'CHEBI_GO_SO_EXT': 2,\n",
       " 'SO': 3,\n",
       " 'CHEBI_GO_EXT': 4,\n",
       " 'PR_EXT': 5,\n",
       " 'CHEBI_EXT': 6,\n",
       " 'PATO_SO_EXT': 7,\n",
       " 'CHEBI_CHMO_EXT': 8,\n",
       " 'CL_EXT': 9,\n",
       " 'GO_PATO_UBERON_EXT': 10,\n",
       " 'MOP': 11,\n",
       " 'GO_PATO_EXT': 12,\n",
       " 'GO_RO_EXT': 13,\n",
       " 'OBI_SO_EXT': 14,\n",
       " 'GO_EXT': 15,\n",
       " 'CHEBI_PR_EXT': 16,\n",
       " 'CHEBI_SO_EXT': 17,\n",
       " 'CHEBI_MOP_EXT': 18,\n",
       " 'CL_UBERON_EXT': 19,\n",
       " 'PATO_UBERON_EXT': 20,\n",
       " 'NCBITaxon_EXT': 21,\n",
       " 'CHEBI_UBERON_EXT': 22,\n",
       " 'UBERON': 23,\n",
       " 'CHMO_UBERON_EXT': 24,\n",
       " 'GO_SO_EXT': 25,\n",
       " 'NCBITaxon': 26,\n",
       " 'SO_EXT': 27,\n",
       " 'GO_PR_EXT': 28,\n",
       " 'PR': 29,\n",
       " 'CL_GO_EXT': 30,\n",
       " 'UBERON_EXT': 31,\n",
       " 'GO_PATO_RO_EXT': 32,\n",
       " 'CL': 33,\n",
       " 'CHEBI_GO_PR_EXT': 34,\n",
       " 'CHEBI': 35,\n",
       " 'CHEMINF_GO_EXT': 36,\n",
       " 'NCBITaxon_UBERON_EXT': 37,\n",
       " 'GO_MOP_EXT': 38,\n",
       " 'GO': 39}"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ent2idx"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "#实体个数\n",
    "num_cates = max(ent2idx.values()) + 1\n",
    "#句子长度\n",
    "sent_len = 64\n",
    "vocab_size = 3000\n",
    "#向量长度\n",
    "emb_size = 100\n",
    "#两头padding长度\n",
    "sent_pad = 10\n",
    "#抽取句子\n",
    "sent_extrator = SentenceExtractor(window_size=sent_len, pad_size=sent_pad)\n",
    "train_sents = sent_extrator(train_docs)\n",
    "test_sents = sent_extrator(test_docs)\n",
    "train_data = Dataset(train_sents, cate2idx=ent2idx)\n",
    "train_data.build_vocab_dict(vocab_size=vocab_size)\n",
    "test_data = Dataset(test_sents, word2idx=train_data.word2idx, cate2idx=ent2idx)\n",
    "vocab_size = len(train_data.word2idx)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<data_utils.data_utils.Dataset at 0x23f233ed0f0>"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "w2v_train_sents = []\n",
    "for doc in docs:\n",
    "    w2v_train_sents.append(list(doc.text))\n",
    "    \n",
    "    \n",
    "w2v_model = Word2Vec(w2v_train_sents, size=emb_size)\n",
    "w2v_embeddings = np.zeros((vocab_size, emb_size))\n",
    "for char, char_idx in train_data.word2idx.items():\n",
    "    if char in w2v_model.wv:\n",
    "        w2v_embeddings[char_idx] = w2v_model.wv[char]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "33532"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(w2v_train_sents[0]) #第一个文章中所有的字符\n",
    "#字符级的词嵌入"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<gensim.models.keyedvectors.Word2VecKeyedVectors at 0x23f2289d470>"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "w2v_model.wv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_items([('<unk>', 0), (' ', 1), ('e', 2), ('t', 3), ('i', 4), ('n', 5), ('a', 6), ('o', 7), ('s', 8), ('r', 9), ('l', 10), ('d', 11), ('c', 12), ('h', 13), ('m', 14), ('u', 15), ('p', 16), ('f', 17), ('g', 18), ('y', 19), ('b', 20), ('w', 21), ('.', 22), (',', 23), ('v', 24), ('A', 25), ('-', 26), ('1', 27), ('\\n', 28), ('T', 29), ('C', 30), (')', 31), ('(', 32), ('x', 33), ('2', 34), ('P', 35), ('0', 36), ('k', 37), ('S', 38), ('F', 39), ('B', 40), ('5', 41), ('D', 42), ('M', 43), ('G', 44), ('3', 45), ('/', 46), ('I', 47), ('R', 48), ('E', 49), ('4', 50), ('N', 51), ('H', 52), ('6', 53), ('7', 54), ('z', 55), ('L', 56), ('9', 57), (']', 58), ('[', 59), ('O', 60), ('8', 61), ('K', 62), ('W', 63), ('q', 64), (';', 65), ('X', 66), ('+', 67), ('J', 68), ('U', 69), (':', 70), ('%', 71), ('–', 72), ('V', 73), ('j', 74), ('−', 75), ('Q', 76), (\"'\", 77), ('β', 78), ('=', 79), ('μ', 80), ('Y', 81), ('Z', 82), ('α', 83), ('′', 84), ('Δ', 85), ('<', 86), ('×', 87), ('°', 88), ('±', 89), ('*', 90), ('~', 91), ('γ', 92), ('\"', 93), ('†', 94), ('”', 95), ('“', 96), ('>', 97), ('#', 98), ('δ', 99), ('_', 100), ('&', 101), ('ö', 102), ('?', 103), ('—', 104), ('ω', 105), ('’', 106), ('‘', 107), ('∼', 108), ('\\u200a', 109), ('é', 110), ('χ', 111), ('ü', 112), ('≥', 113), ('¤', 114), ('™', 115), ('κ', 116), ('|', 117), ('®', 118), ('ï', 119), ('Å', 120), ('▪', 121), ('≤', 122), ('\\u2009', 123), ('□', 124), ('Ö', 125), ('ç', 126), ('Χ', 127), ('µ', 128), ('ä', 129), ('‡', 130), ('→', 131), ('•', 132), ('σ', 133), ('↔', 134), ('^', 135), ('ñ', 136), ('{', 137), ('}', 138), ('Φ', 139), ('Ω', 140), ('⋅', 141), ('\\xa0', 142), ('ó', 143), ('§', 144), ('ı', 145), ('λ', 146), ('!', 147), ('à', 148), ('⇔', 149), ('è', 150)])"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_data.word2idx.items()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "G:\\Coding\\Anaconda3\\envs\\ner\\lib\\site-packages\\keras_contrib-2.0.8-py3.6.egg\\keras_contrib\\layers\\crf.py:346: UserWarning: CRF.loss_function is deprecated and it might be removed in the future. Please use losses.crf_loss instead.\n",
      "G:\\Coding\\Anaconda3\\envs\\ner\\lib\\site-packages\\keras_contrib-2.0.8-py3.6.egg\\keras_contrib\\layers\\crf.py:353: UserWarning: CRF.accuracy is deprecated and it might be removed in the future. Please use metrics.crf_accuracy\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "WARNING:tensorflow:From G:\\Coding\\Anaconda3\\envs\\ner\\lib\\site-packages\\tensorflow\\python\\ops\\math_ops.py:2403: add_dispatch_support.<locals>.wrapper (from tensorflow.python.ops.array_ops) is deprecated and will be removed in a future version.\n",
      "Instructions for updating:\n",
      "Use tf.where in 2.0, which has the same broadcast rule as np.where\n",
      "Model: \"model_1\"\n",
      "_________________________________________________________________\n",
      "Layer (type)                 Output Shape              Param #   \n",
      "=================================================================\n",
      "input_1 (InputLayer)         (None, 84)                0         \n",
      "_________________________________________________________________\n",
      "embedding_1 (Embedding)      (None, 84, 100)           15100     \n",
      "_________________________________________________________________\n",
      "bidirectional_1 (Bidirection (None, 84, 512)           731136    \n",
      "_________________________________________________________________\n",
      "crf_1 (CRF)                  (None, 84, 40)            22200     \n",
      "=================================================================\n",
      "Total params: 768,436\n",
      "Trainable params: 753,336\n",
      "Non-trainable params: 15,100\n",
      "_________________________________________________________________\n"
     ]
    }
   ],
   "source": [
    "#句子的长度前后都padding\n",
    "seq_len = sent_len + 2 * sent_pad\n",
    "model = build_lstm_crf_model(num_cates, seq_len=seq_len, vocab_size=vocab_size, \n",
    "                             model_opts={'emb_matrix': w2v_embeddings, 'emb_size': 100, 'emb_trainable': False})\n",
    "model.summary()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "train_X.shape (50146, 84)\n",
      "train_y.shape (50146, 84, 1)\n"
     ]
    }
   ],
   "source": [
    "train_X, train_y = train_data[:]\n",
    "print('train_X.shape', train_X.shape)\n",
    "print('train_y.shape', train_y.shape)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "type(train_X)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([ 1,  1,  1,  1,  1,  1,  1,  1,  1,  1, 42,  2, 10,  2,  3,  4,  7,\n",
       "        5,  1,  6,  3,  1, 47, 29, 35, 48, 27,  1, 69,  5, 11,  2,  9, 10,\n",
       "        4,  2,  8,  1, 25,  3,  6, 33,  4,  6,  1,  4,  5,  1, 43,  4, 12,\n",
       "        2,  1,  6,  5, 11,  1, 38, 16,  4,  5,  7, 12,  2,  9,  2, 20,  2,\n",
       "       10, 10,  6,  9,  1, 25,  3,  6, 33,  4,  6,  1, 27, 41,  1,  4])"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_X[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "WARNING:tensorflow:From G:\\Coding\\Anaconda3\\envs\\ner\\lib\\site-packages\\keras\\backend\\tensorflow_backend.py:422: The name tf.global_variables is deprecated. Please use tf.compat.v1.global_variables instead.\n",
      "\n",
      "Epoch 1/10\n",
      "50146/50146 [==============================] - 334s 7ms/step - loss: 0.6775 - crf_viterbi_accuracy: 0.7987\n",
      "Epoch 2/10\n",
      "50146/50146 [==============================] - 338s 7ms/step - loss: 0.2435 - crf_viterbi_accuracy: 0.8867\n",
      "Epoch 3/10\n",
      "50146/50146 [==============================] - 330s 7ms/step - loss: 0.1326 - crf_viterbi_accuracy: 0.9243\n",
      "Epoch 4/10\n",
      "50146/50146 [==============================] - 333s 7ms/step - loss: 0.0892 - crf_viterbi_accuracy: 0.9416\n",
      "Epoch 5/10\n",
      "50146/50146 [==============================] - 330s 7ms/step - loss: 0.0658 - crf_viterbi_accuracy: 0.9516\n",
      "Epoch 6/10\n",
      "50146/50146 [==============================] - 327s 7ms/step - loss: 0.0503 - crf_viterbi_accuracy: 0.9590\n",
      "Epoch 7/10\n",
      "50146/50146 [==============================] - 330s 7ms/step - loss: 0.0386 - crf_viterbi_accuracy: 0.9643\n",
      "Epoch 8/10\n",
      "50146/50146 [==============================] - 338s 7ms/step - loss: 0.0284 - crf_viterbi_accuracy: 0.9689\n",
      "Epoch 9/10\n",
      "50146/50146 [==============================] - 327s 7ms/step - loss: 0.0190 - crf_viterbi_accuracy: 0.9726\n",
      "Epoch 10/10\n",
      "50146/50146 [==============================] - 328s 7ms/step - loss: 0.0100 - crf_viterbi_accuracy: 0.9757\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<keras.callbacks.callbacks.History at 0x23f296dea20>"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "model.fit(train_X,train_y, batch_size=64, epochs=10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<keras.engine.training.Model at 0x23f233e1898>"
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "G:\\Coding\\Anaconda3\\envs\\ner\\lib\\site-packages\\keras_contrib-2.0.8-py3.6.egg\\keras_contrib\\layers\\crf.py:346: UserWarning: CRF.loss_function is deprecated and it might be removed in the future. Please use losses.crf_loss instead.\n",
      "G:\\Coding\\Anaconda3\\envs\\ner\\lib\\site-packages\\keras_contrib-2.0.8-py3.6.egg\\keras_contrib\\layers\\crf.py:353: UserWarning: CRF.accuracy is deprecated and it might be removed in the future. Please use metrics.crf_accuracy\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model: \"model_2\"\n",
      "_________________________________________________________________\n",
      "Layer (type)                 Output Shape              Param #   \n",
      "=================================================================\n",
      "input_2 (InputLayer)         (None, 84)                0         \n",
      "_________________________________________________________________\n",
      "embedding_2 (Embedding)      (None, 84, 100)           15100     \n",
      "_________________________________________________________________\n",
      "bidirectional_2 (Bidirection (None, 84, 512)           731136    \n",
      "_________________________________________________________________\n",
      "crf_2 (CRF)                  (None, 84, 40)            22200     \n",
      "=================================================================\n",
      "Total params: 768,436\n",
      "Trainable params: 753,336\n",
      "Non-trainable params: 15,100\n",
      "_________________________________________________________________\n"
     ]
    }
   ],
   "source": [
    "#句子的长度前后都padding\n",
    "seq_len = sent_len + 2 * sent_pad\n",
    "model1 = build_lstm_crf_model(num_cates, seq_len=seq_len, vocab_size=vocab_size, \n",
    "                             model_opts={'emb_matrix': w2v_embeddings, 'emb_size': 100, 'emb_trainable': False})\n",
    "model1.summary()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "from keras.models import load_model\n",
    "model2 = load_model(\"model\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "13837/13837 [==============================] - 31s 2ms/step\n"
     ]
    }
   ],
   "source": [
    "test_X, _ = test_data[:]\n",
    "preds = model.predict(test_X, batch_size=64, verbose=True)\n",
    "pred_docs = make_predictions(preds, test_data, sent_pad, docs, idx2ent)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<data_utils.data_utils.Dataset at 0x23f233ed160>"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[ 1,  1,  1, ..., 11,  1, 40],\n",
       "       [ 2,  1, 17, ..., 17,  1, 53],\n",
       "       [ 6,  3,  2, ...,  8, 13,  7],\n",
       "       ...,\n",
       "       [23,  1, 69, ...,  2,  3,  1],\n",
       "       [ 1, 52, 23, ...,  1,  3, 13],\n",
       "       [20,  3, 19, ...,  1,  1,  1]])"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_X"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "f_score:  0.8030347063952155\n",
      "precision:  0.8727889346987632\n",
      "recall:  0.74360499702558\n"
     ]
    }
   ],
   "source": [
    "f_score, precision, recall = Evaluator.f1_score(test_docs, pred_docs)\n",
    "print('f_score: ', f_score)\n",
    "print('precision: ', precision)\n",
    "print('recall: ', recall)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">Ablation of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> Protects <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> from Age-Related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> Loss</br></br>Abstract</br></br>The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src substrate associated in mitosis of 68 kDa<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mitosis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of 68 kDa (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>) is a KH-type <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> that has been shown to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> several aspects of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA metabolism<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>; however, its <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">physiologic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> role has remained elusive. Herein we report the generation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">null<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> by homologous <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">recombination<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">recombination<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_SO_EXT</span></mark>. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> preserved their <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass, in sharp contrast with 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> littermates in which <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass was decreased up to approximately 75%. In fact, the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> volume of the 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> was virtually indistinguishable from that of 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> or <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> had a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> advantage for the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> pathway. Moreover, the knockdown of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> using <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">short hairpin RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic mesenchymal multipotential progenitor C3H10T1/2 cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal multipotential progenitor C3H10T1/2 cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> resulted in more pronounced <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of the mature <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marker<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marker<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteocalcin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> when <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> was induced with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone morphogenetic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone morphogenetic protein-2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark>-2. Cultures of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryo<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fibroblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> generated from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> littermates were induced to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> into <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> with culture medium containing <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pioglitazone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> and the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryo<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fibroblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> shown to have impaired <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>. Furthermore, in vivo it was shown that sections of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> from 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> had few <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> compared with their age-matched <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> littermate controls, which exhibited <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fatty<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fatty<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>. Our findings identify endogenous <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> as a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">positive regulator<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> and a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">negative regulator<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>, which is consistent with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> being a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">modulator<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow mesenchymal cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>, and hence <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">metabolism<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>, in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>.</br></br>Synopsis</br></br>Osteoporosis is a debilitating <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> disease that is characterized by reduced <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass and microarchitectural damage, which result in increased <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> fragility and susceptibility to fracture. Peak <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass, which is achieved by the age of 30 in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">humans<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>, has been identified as a major determinant of resistance or susceptibility to osteoporosis. The authors generated <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> deficient for the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark>, a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> of unknown <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">physiologic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> function. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> develop normally and are protected against <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss during <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. Age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss has long been associated with an increase in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>, which are derived from the same <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> lineage as <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>. The authors showed that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulates<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> of this <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> lineage, such that in its absence, <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> continued to be generated in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark>, leading to preservation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass. This study identifies a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">physiologic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> role for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> as a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">modulator<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> of the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stem cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">stem cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> niche and hence of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">metabolism<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. The data identify <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> as a potential therapeutic target for the prevention and treatment of age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss.</br></br>Introduction</br></br>During <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal development<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>, the anabolic activity of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> [1] is favored over the catabolic activity of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> [2], which results in a net gain in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass. At <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> maturity, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass is maintained through the balanced activity of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> during the remodeling cycle. During <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>, there is a shift in the balance that favors <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> over <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> activity, which results in net <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss [3]. The amount and rate at which <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> is gained during development and lost during <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> are determined in large part by <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genetics<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">OBI_SO_EXT</span></mark> [4–6] but also by physical activity and by alterations in the availability and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">response of bone cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> to circulating <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hormones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hormones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_GO_EXT</span></mark> [7–9] and locally derived <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">growth<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">growth factors<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> [10,11]. Whereas <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genetic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>-based studies have provided novel insights into the pathways that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone development<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> [12–14], relatively little is known about the etiology of age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss. Increased <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone resorption<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> in elderly men and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">women<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_UBERON_EXT</span></mark> is associated with a reduction in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass and an increase in circulating levels of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">biomarkers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">biomarkers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> [15]. These changes have been attributed primarily to nutritional deficits resulting in alterations in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">parathyroid<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">parathyroid hormone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">parathyroid hormone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hormone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_GO_EXT</span></mark>–<mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">vitamin D<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> axis [16], to <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gonadal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hormone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hormone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_GO_EXT</span></mark> deficiency [17], to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> levels and the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sympathetic nervous system<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> [8,18–20], and to alterations in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell apoptosis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> [21]. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss in the elderly has also been attributed to alterations in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">response of bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> to their microenvironment that favors <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> down the <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> lineage rather than the <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> lineage [22].</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> has long been associated with an increase in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark>, where the generation of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> is favored over <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> [23]. <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> are derived from a common <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> precursor <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> present in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, and the factors that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">control<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> this age-induced switch toward <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> is not well understood [24]. While several <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">transcriptional<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulatory<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> have been associated with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell fate determination<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow mesenchymal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark>, including <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peroxisome<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peroxisome proliferator–activated receptor γ<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">receptor<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> γ (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">PPARγ<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>) and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">KLF5<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> [25–30], the role of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> in this process remains unknown. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> of the KH type are known <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulators<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cellular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cellular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cellular differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. For example, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> defects in the KH <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">domain<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">NOVA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">FMRP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> are known to cause paraneoplastic <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">neurologic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> disorders [31] and the fragile <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">X<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> syndrome, respectively, in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">humans<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> [32]. The phenotype of the quaking viable <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> suggests a role for the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">QUAKING<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">oligodendrocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">myelination<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> [33]. Indeed, the ectopic <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">QKI<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>-6/7 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">isoforms<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> in vivo led to the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">formation of glial cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">formation of glial cells rather than neurons<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">glial cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> rather than <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">neurons<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">neural<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> progenitor, demonstrating its role in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell fate determination<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> [34]. The loss of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GLD-1<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Caenorhabditis elegans<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> prevents the appearance of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">stem cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> [35], and the absence of the KH <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">domain<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">HOW<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Drosophila<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> prevents <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">muscle<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> and results in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">flies<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> with held-out-<mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wings<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> [36,37]. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src substrate associated in mitosis of 68 kDa<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mitosis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of 68 kDa (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>) is also a member of the family of KH <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">domain<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proteins<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> [38]; however, its <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">physiologic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> role has remained undefined.</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> was identified as an SH3 and SH2 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">domain<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> interacting <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src family kinases<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">kinases<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> and is also a known substrate of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src kinases<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">kinases<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> [39–42] and of the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">breast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">breast tumor kinase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">kinase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> [43]. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> has been shown to facilitate the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">export<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> of un<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">spliced<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">HIV<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> [44] and to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pre-mRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">processing<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> [45]. In the present paper, we report the generation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and analysis of their <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> phenotype. Our data indicate that the absence of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> confers resistance to age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> such that old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> have a higher <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass than their <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> littermates. We provide evidence that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulates<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation of bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> by showing that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> isolated from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animals<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> had enhanced <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> activity and decreased <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> activity than those harvested from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> littermates. Furthermore, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryo<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fibroblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (MEFs) were impaired in their capacity to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> into <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>, consistent with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> being a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulator<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow mesenchymal cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. These results also characterize a new <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> model to study <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone metabolism, regeneration<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">metabolism<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>, regeneration, and repair during <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>.</br></br>Results</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> Is <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Expressed<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> in the Developing <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Skeleton<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> is known to be widely <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expressed<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> [38], whereas its pattern of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> in vivo remains to be defined. Sections of paraffin-embedded <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> E14.5 and E16.5 <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were immunostained with the well-characterized AD1 anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>, raised in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">rabbits<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> against an immunizing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> that corresponds to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">amino acids<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">amino acids<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> 330 to 348 of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> [46]. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> immunoreactivity was observed in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeleton<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and soft <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissues<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of developing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> at E14.5 and E16.5 (Figure 1). Intense staining was seen in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">nucleus of cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> in the developing <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">brain<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">heart<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">small intestine<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (Figure 1B), as well as in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">chondrocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">nasal septum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">glandular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissue<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> adjacent to the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">nasal cartilage<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (Figure 1C, panels A–D), in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">vertebra<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">intervertebral discs<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (panels E–H) and in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">epiphysis (panels I–K) and metaphysis (panel L) of long bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">metaphysis (panel L) of long bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Nuclear<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> staining was observed in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">proliferating<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">chondrocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hypertrophic chondrocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (Figure 1C, panel H), in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (panel L; Dataset S1), and in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (Dataset S1). No staining was observed with preimmune <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> or when the anti<mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> was preadsorbed with the immunizing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (Figure 1C, panels B, F, and J). Taken together, these data demonstrate that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> is selectively <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expressed<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> in the developing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryo<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, with particularly elevated <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cartilage<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark>.</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> is Not Essential for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> Development</br></br>To define the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">physiologic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> role of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, we generated <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>-deficient <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> by targeted disruption of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">exons<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 4 and 5 of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gene<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>, which <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">encode<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> the functional region of the KH-type <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">domain<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (Figure 2A). The integrity of the targeted <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">allele<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> was verified by Southern blot analysis (Figure 2B) and by PCR of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genomic DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (unpublished data). <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">transcripts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">encoded<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> by <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">exons<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 1 to 5 were absent as evidenced by <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-PCR (Dataset S2), and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were devoid of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark>, as visualized by immunoblotting with anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> AD1 and SC-333 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibodies<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> or control normal <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">rabbit<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> or anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> AD1 preabsorbed with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (Figure 2C). SC-333 is a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">rabbit<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> that was raised against the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C-terminal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C-terminal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> 20 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">amino acids<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">amino acids<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> [47]. These data confirmed the generation of a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> deficient in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genotypes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> of offspring from heterozygote intercrosses exhibited a Mendelian segregation at E18.5 (Table 1). Despite the lack of visible deformity, many of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pups<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pups<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">died<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> at <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">birth<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of unknown causes. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">-<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were phenotypically normal and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pups<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pups<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_UBERON_EXT</span></mark> that survived the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">perinatal period<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">natal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> period invariably lived to old age. Despite evidence that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> is widely <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expressed<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">phosphorylated<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mitosis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> [41,42], the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> did not develop tumors and showed no immunologic or other major illnesses. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> did, however, have difficulty <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">breeding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> due to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">male<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> infertility and the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">females<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> rarely provided adequate care to their young.</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> Deficiency Protects <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> from Age-Related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> Loss</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">null<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animals<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> are known to have <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">metabolism<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> defects [48], and since <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> is a substrate of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, we decided to analyze the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> for <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> abnormalities. Cohorts of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were euthanized at 4 and 12 months of age for <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> phenotyping. To minimize differences in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> phenotype that might arise secondary to gender or weight differences, we selected age-matched <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">female<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> for these analyses. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">female<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> demonstrated similar increases in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">body<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> weight, although 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> weighed less than <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>, and similar changes in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> lengths in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">axial and appendicular skeleton<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">appendicular skeleton<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> between 4 and 12 months of age (Table 2). Faxitron radiography (Faxitron X-ray Corporation, Wheeling, Illinois, United States) (Figure 3A) and micro–computed tomography (CT) (Figure 3B) revealed significant <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cortical<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> thinning (arrow) and a reduction in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">metaphyseal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> (asterisk) in the distal <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femora<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> compared with 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> of either <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genotype<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. Similar reductions in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">trabecular bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> were shown by Faxitron and micro-CT in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fifth lumbar vertebrae<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of the 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> but not in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (unpublished data). Total <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">body<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mineral<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> content (BMC), quantified with a Lunar PIXImus <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> densitometer (GE-Lunar, Madison, Wisconsin, United States), increased in both <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> between 4 months and 12 months of age, but only reached significance in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (Table 2). Similarly, a greater increase in BMC was seen in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femur<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">vertebra<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mineral<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> density (BMD) remained constant or decreased in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> but increased significantly in the total <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">body<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> and in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femoral<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">vertebral<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> regions of interest in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (Table 2). These data showed that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> continued to thrive and accrue <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">axial and appendicular skeleton<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">appendicular skeleton<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> for longer than 12 months. This was in contrast to the situation in age-matched, littermate controls in which a significant amount of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> was lost over the same timeframe.</br></br>Three-Dimensional Architecture of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> Is Preserved in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss and compromised architecture are characteristic features of the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletons<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> C57BL/6 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and resemble the clinical features of age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">humans<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> that can predispose an <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">individual<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> to fracture. Quantification of the micro-CT data shown in Figure 3B confirmed the reduction in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> volume compared with <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissue<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> volume (BV/TV; Figure 4A, left) in the 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (hatched bars) compared with 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> of both <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genotypes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (solid bars) and 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (stippled bars). This was associated with a significant increase (p &lt; 0.01; denoted by the asterisks) in the structure model index, which measures the ratio of plate-like to rod-like structures (Figure 4A, right). A quantifiable increase in the mean <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">trabecular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> separation (Tb.Sp) (unpublished data) in 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> was due to an increase in the percentage of spaces falling in the range of 350 to 700 μm (Figure 4B, red hatched line). <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Trabecular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> thickness remained constant among the different groups of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (unpublished data). In effect, this meant that there were fewer <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">trabeculae<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, rather than equivalent numbers of thin <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">trabeculae<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, in the 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> compared with any of the other groups of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>.</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone Remodeling<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> Is Preserved in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>To further define the mechanisms involved in the preservation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>, we prepared sections from plastic-embedded <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femora<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tibia<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> to evaluate <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> activity (Figure 5). In situ <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">enzyme<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_GO_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">enzyme<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_GO_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">enzyme<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_GO_SO_EXT</span></mark> histochemical staining for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">alkaline phosphatase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">alkaline phosphatase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark>; brown stain) activity was used as a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">biomarker<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">biomarker<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> for <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tartrate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tartrate-resistant ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tartrate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tartrate-resistant acid phosphatase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">acid<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">acid phosphatase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> [<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">TRAP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>]; red stain) activity as a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marker<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marker<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> for <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>. Little difference was seen between <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (Figure 5A and 5B) and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (Figure 5C and 5D) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> at 4 months of age. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark>- and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">TRAP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>-positive <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> were reduced in the 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (Figure 5E and 5F) and remained unchanged in 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (Figure 5G and 5H). The reduction in both <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> activity in the 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> argued against <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> being lost primarily due to a relative increase in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> over <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> activity, as seen in high turnover disease [49].</br></br>Histomorphometric analyses [50] of the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">long bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (Table 3) corroborated the radiologic evidence of age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> volume (BV/TV), newly formed <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoid<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (OV/TV), and <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mineral<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> apposition rate (MAR) were all significantly reduced in 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> compared with 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. These reductions were associated with a significant increase in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark> (FV/TV) and decreased numbers of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (nOB/TV) and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (nOC/TV) per <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissue<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> volume (Table 3). These results were in contrast to those of the 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> in which all histomorphometric parameters, including <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark>, resembled those of young <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> of either <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genotype<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (Table 3). When <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> were expressed as a function of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> perimeter (nOB/BP, nOC/BP), there were no statistical differences and the ratio of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> to <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> was similar in all groups of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (Table 3).</br></br>Circulating levels of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark>-telopeptide (sCTX; Roche Diagnostics, Mannheim, Germany) and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> showed little difference among the groups, except for a small decrease in 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and (Dataset S3). <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">estrogen<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> was significantly decreased in all 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> regardless of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genotype<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> with a reciprocal increase in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">interleukin-6<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> levels (Dataset S3). Given the involvement of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulating<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">body<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass, <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> was measured in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. Twelve-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> had significantly lower levels than young and old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and young <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (Dataset S3). Taken together, these observations suggested that preservation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> was not due primarily to altered <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">estrogen<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> status but could have been influenced by differences in circulating <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> levels.</br></br><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>, but Not <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>, Activity Is Altered in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> Ex Vivo</br></br>Maintenance of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass during the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adult<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> remodeling cycle is dependent on the coupling of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> to <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> activity, such that there is no net gain or loss of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> [49]. To further explore the age-related advantage of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> with respect to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> preservation, we examined the functional activity of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> ex vivo (Figure 6A and 6B). Cultures of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> harvested from 4-week-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and maintained for 18 days in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> medium demonstrated more intense staining for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> at 6 days (unpublished data) and 18 days (Figure 6A), and more mineralized nodules at 18 days, than the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>, even though similar amounts of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fibroblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> colony-forming units (CFU-<mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">F<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>) were observed (Figure 6A and unpublished data). <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-PCR analysis of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">molecular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">markers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">markers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> (Dataset S2) revealed similar increases over time in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>, although <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">type I collagen<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">collagen<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> appeared to be <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">up-regulated<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> at both timepoints in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. Short-term cultures of mature <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">released<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> from the crushed <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">long bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> stained equally well for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">TRAP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> and excavated approximately equal numbers of pits of equal size in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">dentin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> slices, as visualized by scanning <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">electron<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> microscopy (Figure 6B). These findings suggest that the <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> may not be the primary defect in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>, as they are in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">null<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> [48].</br></br>The Absence of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> Prevents <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> and Promotes <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark></br></br>It is well recognized that <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> give rise to both <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and that age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss is accompanied by an increase in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> down the <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> lineage [22]. Therefore, the loss of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> could influence the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> along the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> versus the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> pathway. Alternatively, the loss of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> could indirectly <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass as a general disturbance of neuroendocrine <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">control<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> as was shown when <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> and the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sympathetic nervous system<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> axis were shown to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">negatively regulate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass [8]. To confirm a role for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulation of adipocyte differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> differentiation, we isolated primary MEFs from 14.5-day-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryos<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>. The primary <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> MEFs were <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiated<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_RO_EXT</span></mark> into <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> in vitro in culture medium containing 5 μM <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pioglitazone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> to induce <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenesis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> at days 0, 4, 6, and 12 were stained with Oil red O to monitor <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenesis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Adipogenesis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> was more pronounced in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> MEFs cultures than in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> MEFs, consistent with the positive role of endogenous <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> (Figure 7). The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of key <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">transcription<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">transcription factors<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> including the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">PPARγ<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">KLF5<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> was impaired in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiated<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_RO_EXT</span></mark> MEFs compared with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> MEFs, consistent with impaired <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenesis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> in the absence of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (Figure 7). These data, together with data confirming a lean phenotype in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (N. Torabi and S. Richard, unpublished data), support the hypothesis that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">modulates<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation of mesenchymal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark>.</br></br>To further examine this phenotype in a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> autonomous system, we chose the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic mesenchymal multipotential progenitor cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal multipotential progenitor cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> C3H10T1/2. The addition of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">BMP-2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> induced <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>, as evidenced by an approximately 400-fold increase in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteocalcin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">OCN<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gene<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> [51]. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Populations of C3H10T1/2 cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> stably <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">transfected<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> with either pSuper-retro (control) and pSuper-retro harboring a short <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hairpin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> against <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (Sam68sh) were selected with <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">puromycin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> was reduced by approximately 80% as evidenced by immunoblot analyses using <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">β-actin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> as a loading control (Figure 8A). <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> was induced in cultures <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expressing<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> pSuper-retro or pSuper-retro Sam68sh by addition of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">BMP-2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> to the culture medium. . The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">OCN<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">β-actin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mRNAs<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mRNAs<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> was examined by semiquantitative <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-PCR and the Sam68sh-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expressing<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> displayed a more pronounced <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> phenotype compared with control <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark>, as assessed by the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">OCN<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (Figure 8B).</br></br>Given the apparent enhancement of mineralized nodule formation by <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> ex vivo and the phenotype observed with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">short hairpin RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">shRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>)-treated C3H10T1/2, we stained sections of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> from 4- and 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> for evidence of changes in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> adiposity. Figure 9 shows sections of undecalcified <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> from 4- and 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> stained with von Kossa and toluidine blue to show mineralized <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissue<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (Figure 9A, black) and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (Figure 9B, white) and left unstained to show <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fluorochrome<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">labeling<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">labeling<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> of the mineralization fronts (Figure 9C). Twelve-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> showed a noticeable decrease in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">trabecular bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (Figure 9A), which was associated with a significant increase in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> adiposity (Figure 9B) and with the two <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fluorochrome<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">labels<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">labels<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> superimposed upon one another (Figure 9C). In contrast, the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> appeared similar to those of the 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> of either <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genotype<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>. These data demonstrate that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulates<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation of bone marrow mesenchymal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow mesenchymal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> to promote <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> and inhibit <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark>.</br></br>Discussion</br></br>The present study provides evidence that a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">physiologic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> role of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> is to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">modulate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow mesenchymal stem cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> stem <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark>. Young <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> developed normally and contained similar <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass compared with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> littermates. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> (12 months) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> displayed a high <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass phenotype compared with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> littermates. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> littermates underwent age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss that occurs naturally in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mammals<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>, while the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animals<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> preserved their <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation of bone marrow stem cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stem cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">stem cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> isolated from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic mesenchymal multipotential progenitor cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal multipotential progenitor cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> C3H10T1/2 treated with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">shRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> resulted in a more pronounced <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>. These findings demonstrate that the loss of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> enhances <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>. The converse was also true, as MEFs isolated from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animals<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were impaired in their ability to undergo <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> compared with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> MEFs. These findings suggest that a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">physiologic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> role for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> is to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> the balance between <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> of the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>.</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> was observed throughout the developing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryo<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, in keeping with previous reports that identified the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> to be widely <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expressed<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> [38]. We observe <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> staining in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">brain<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">heart<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">intestine<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (see Figure 1) as well as <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">liver<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark>, and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">kidney<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (unpublished data) of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">late-stage embryos<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>. This <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> pattern is consistent with previous work that has observed <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">neurons<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> [52] and as a substrate of the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">intestinal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">intestinal SIK<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>/<mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">breast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">breast tumor kinase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">kinase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> [43]. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> was not altered in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> or in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">senescencing<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> WI-38 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> (unpublished data). The presence of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">chondrocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>, <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> in developing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cartilage<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> predicted a pivotal role for the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal development<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>.</br></br>The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were generated using a traditional targeting approach where the functional KH <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">domain<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> was <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">deleted<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and approximately one third of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> survived to <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adulthood<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> with no apparent defects. One explanation for this phenomenon is that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> function is sub-served by one or more of its family members during development such as <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">SLM-1<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">SLM-2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> [47]. Alternatively, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> is not required during <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic development<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. However, two thirds of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>, but not the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">-<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pups<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pups<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_UBERON_EXT</span></mark>, were <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">killed<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> by their <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">-<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> mothers. These findings suggest that the mothers are able to detect a subtle defect/difference that we cannot. <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Adult<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> live a normal <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">life span<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of approximately two years. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">males<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> were sterile and the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">females<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> provided inadequate care to their young, but the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pups<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pups<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon_UBERON_EXT</span></mark> were not scattered and neglected as observed with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">FosB<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> [53]. <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> levels of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">estrogen<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> decreased in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">females<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> as expected; however, the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> levels decreased in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">females<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark>. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">females<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> were not obese and actually weighed less than the littermate controls (see Table 2). Moreover, their appetite was not altered with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> (N. Torabi and S. Richard, unpublished data), suggesting that the observed <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> reduction was not recreating ob/ob-like phenotypes related to weight, appetite and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">female<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> sterility [54].</br></br>The <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">skeletal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> phenotyping of cohorts of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> showed that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass was preserved in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. Traditional histology and histomorphometry suggested that the mechanism involved preservation of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> activity. The documented role of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulatory<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark>, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, in osteopetrosis led us to investigate the morphology and activity of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> ex vivo. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tyrosine<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tyrosine<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tyrosine kinase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> was shown to play a role in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone remodeling<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> when <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">died<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> at 6 months of age with an osteopetrotic phenotype [48] and the defect was attributed to defective <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> function [55−59]. We therefore cultured mature <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> harvested from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> ex vivo on <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">dentin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> slices to quantify their resorptive capacity. The fact that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> looked and acted like <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> ex vivo and in vivo made it unlikely that this was the primary source of the difference in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">metabolism<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> in 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. The fact that the CTX levels were lower in young and old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> suggested that there is reduced <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone resorption<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> compared with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> littermate controls. However, this reduction in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone resorption<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> occurred with normal <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> activity, as assessed by in vitro culturing. These observations are consistent with the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> having a youth-like <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> phenotype. However, it is still possible, that a mild impairment in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> function may manifest itself later in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">life<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> in overall accumulation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> and this will require further detailed studies.</br></br>Ex vivo <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation of primary bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">primary bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark>, harvested from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>, down the <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> lineage revealed an <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> advantage in the cultures of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> derived from the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. It will be important to demonstrate that a similar effect is observed using <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">primary bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. Similar findings were observed when <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic mesenchymal multipotential progenitor cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal multipotential progenitor cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> C3H10T1/2 treated with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">shRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>, were <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiated<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_RO_EXT</span></mark> into <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">BMP2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>. Our findings that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> do not develop <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fatty<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fatty<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and that MEFs derived from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> have impaired <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>, indicate that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulates<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> both <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>. These findings identify <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> as the first <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> and the challenge will be to identify the specific <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> targets that it <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulates<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> during this process. The fact that <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> function is altered in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> [60,61] raises the possibility that preservation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> could be linked with and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulated<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> by <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Src<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>.</br></br>The pathway by which <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulates<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone resorption<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> was identified to involve the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sympathetic nervous system<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> relaying to the <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> via the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">β-adrenergic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">β-adrenergic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> pathway leading to the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">release<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">growth<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">growth factors<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> including <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RANKL<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> that causes the <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> to thrive [8,18–20]. The lowering of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> levels in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> is consistent with these <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> having a high <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> mass compared with their <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aged<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> littermates. These data would suggest that the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark>-sympathetic pathway is unaltered in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and that the lowering of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> may explain the lower levels of CTX in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. These findings suggest that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> may be <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">regulating<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">metabolism<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> at two different levels: (1) the absence of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> results in lower <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> levels that may reduce <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone resorption<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> via the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sympathetic nervous system<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and (2) the absence of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> favors <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>, rather than <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>.</br></br>In conclusion, our data define a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">physiologic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> role for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">metabolism<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone marrow mesenchymal stem cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mesenchymal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> stem <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> phenotype observed in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> imply that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">inhibitors<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> could prevent age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss. Furthermore, the results also suggest that <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> levels, hypomorphism, and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mutations<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">humans<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> may influence susceptibility to <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> accumulation and osteoporosis. Our findings also identify a new <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> model to study <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">aging<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss.</br></br>Materials and Methods</br></br>Histologic, immunohistochemical, and histomorphometric analyses.</br></br>All analyses were performed essentially as described previously [62,63]. Briefly, <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were removed from timed <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pregnant<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> dams at E14.5 and E16.5 and fixed intact for 36 h in 4% <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">paraformaldehyde<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark>, rinsed thoroughly in PBS, and processed for paraffin embedding. Serial 4-μm sections were cut on a modified Leica RM 2155 rotary microtome (Leica Microsystems, Richmond Hill, Ontario, Canada), stained with a 1:600 dilution of the AD1 anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> [46] and counterstained with either methyl green or <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hematoxylin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>.</br></br><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Adult<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were given an intra<mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peritoneal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> injection of 30 mg/kg <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">calcein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> at 7 days and 30 mg/kg <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tetracycline<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> at 2 days prior to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sacrifice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">label<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">label<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> actively mineralizing surfaces. After overnight fixation in 4% <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">paraformaldehyde<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> and rinsing in PBS, the left <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femur<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tibia<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> were embedded in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">polymethylmethacrylate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> (<mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">MMA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>) or a <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mixture<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> of 50% <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">MMA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> and 50% <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">glycolmethacrylate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> (<mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GMA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>). Serial 4- to 6-μm sections of <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">MMA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>-embedded <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissues<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> were left unstained or stained with von Kossa and toluidine blue or with toluidine blue alone, while 4-μm <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">MMA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>-<mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GMA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> sections were stained for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">TRAP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> activity. Images were captured using a Leica DMR microscope (Leica Microsystems) equipped with a Retiga 1300 camera (Qimaging, Burnaby, British Columbia, Canada) and the primary histomorphometric data obtained using Bioquant Nova Prime image analysis software (Bioquant Image Analysis Corp, Nashville, Tennessee, United States). Nomenclature and abbreviations conform to those recommended by the American Society for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> and <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mineral<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> Research [50].</br></br>Generation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> with targeted disruption of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gene<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>.</br></br>A λ bacteriophage <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">clone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> encompassing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">exons<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 3 to 9 was isolated from a 129/SvJ <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genomic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> library using full-length <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cDNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> as a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">probe<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">probe<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark>. XbaI-digested <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genomic DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragments of 4 k<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (encompassing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">exon<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 4 and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">part of exon<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 5) and 3kb (spanning <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">part of exon<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 5 and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">exon<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 6) were subcloned in Bluescript SK resulting in pBS4 and pBS3, respectively. A <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragment was amplified from pBS4 with the following <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">oligonucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">oligonucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (5′-AAT GTC TAG AAA CAA CTC ATA TAC AGA C-3′) and the universal <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">primer<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>. The XbaI-digested 1-k<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragment was subcloned in the XbaI site of pPNT (a gift from Andrew Karaplis, McGill University, Montréal, Quebec, Canada). The 3-k<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragment from pBS3 was amplified by PCR with (5′-GGG ATG CGG CCG CTC TAG AAT TGT CCT ACT TGA ACG G-3') and (5′-CGG TGG CGG CCG CTG TCG ACC TGA GTA ACA TTT CTT A-3′) and subcloned in the NotI site of pPNT. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">targeting vector<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> pPNT-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">replaces<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">exon<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 4 and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">part of exon<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 5 with a <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">neomycin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>-resistant <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gene cassette<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>. An SalI site was introduced at the 3′ end of the 3-k<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragment and was used to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">linearize<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">plasmid<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> for electroporation into <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic stem (ES) cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ES) cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark>. Approximately 1,000 <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ES<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> colonies were screened and two <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">clones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> were identified that contained the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mutant<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">allele<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>, as determined by Southern blotting. Targeted <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ES cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> were injected into 3.5-day-old BALB/c <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">blastocysts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and were <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">transferred<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> into CD-1 foster mothers, and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animals<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> classified as chimeras by <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">coat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> color were <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mated<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> with BALB/c <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. Germ line transmission was achieved and the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were maintained in C57BL/6 background. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> used for this study represent <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> that were backcrossed in C57BL/6 between three and eight generations; in addition, we maintained the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> in the 129/SvJ strain and observed a similar phenotype.</br></br>Genotyping and immunoblot analyses.</br></br>All <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> procedures were performed in accordance with McGill University guidelines, which are set by the Canadian Council on <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Animal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> Care. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Genomic DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> was isolated from <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tail<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> biopsies and analyzed by Southern blotting and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genomic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> PCR analysis. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragment utilized as the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">probe<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">probe<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> for the Southern blotting analysis was amplified with the following two <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">oligonucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">oligonucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (5′-AAG CCT TTA CTG GTT GTG T-3′) and (5′-CTT GAA ACG CAC CGT AGG CT-3′). The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">allele<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> was identified by <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genomic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> PCR using the following <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">oligonucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">oligonucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> 5′-AAA TCC TAA CCC TCC TCA GTC AG-3′ and 5′-GAT ATG ATG GAT GAT ATC TGT CAG-3′. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>-targeted <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">allele<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> was identified by <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genomic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> PCR using the following <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">oligonucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">oligonucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> 5′-CTT GGG TGG AGA GGC TAT TCG-3′ and 5′-GTC GGG CAT GCG CGC CTT GAG C-3′.</br></br>Radiology and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> biochemistry on <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>.</br></br>Radiography, BMD, and micro-CT were performed essentially as described previously [63]. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were administered a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">lethal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> dose of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">anesthetic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> at the indicated times, exsanguinated, and imaged using a Faxitron MX20 equipped with an FPX-2 Imaging system (Dalsa Medoptics, Waterloo, Ontario, Canada). <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Body<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark>, BMC, and BMD were evaluated using a Lunar PixiMUS 1.46 (GE-Lunar, Madison, Wisconsin, United States). Morphometric parameters were determined on <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">anesthetized<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> at the time of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sacrifice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> by direct measurement or from the Faxitron radiograph.</br></br>Micro-CT was performed on the left <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femur<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fourth lumbar vertebra<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> after removal of soft <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissues<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and overnight fixation in 4% <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">paraformaldehyde<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark>. The <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">distal metaphysis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> was scanned with a Skyscan 1072 micro-CT instrument (Skyscan, Antwerp, Belgium). Image acquisition was performed at 100 kV and 98 μA, with a 0.9° rotation between frames. The two-dimensional images were used to generate three-dimensional reconstructions to obtain quantitative data with the 3D Creator software supplied with the instrument.</br></br><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> biochemistry (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark>, Ca, PO4, Mg) was determined at the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Rodent<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> Diagnostics Lab (McGill University, Montréal, Quebec, Canada) using routine automated techniques. Commercial assays were used to determine <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> levels of CTX (RatLaps ELISA, Nordic Bioscience), <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">17β estradiol<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> (IBL Immuno-Biological, Hamburg, Germany), <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">leptin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> (R &amp; D Systems, Minneapolis, Minnesota, United States), and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">interleukin-6<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (R &amp; D Systems).</br></br>Ex vivo assessment of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> activity.</br></br><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> was flushed from the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tibia<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femora<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">juvenile<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> 4-week-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> to obtain <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> that were maintained in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> medium for 6 or 18 days as described [63]. Cultures were stained in situ for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> activity and with von Kossa stain to detect mineralized nodules. Total <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> was harvested from parallel cultures for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-PCR analysis of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gene<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gene expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> over time as described previously [63].</br></br><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> were isolated from the crushed <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">long bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">juvenile<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and used for quantitative studies as described [64]. Briefly, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> were plated on glass coverslips or on <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">dentin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> slices in 24-well cluster plates for assessment of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> number and pit number, respectively. Cover slips were immersed in 4% <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">paraformaldehyde<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> and stained for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">TRAP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> activity after 2 h. <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Dentin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> slices were left for 28 h before removing the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> with 1 M <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ammonium hydroxide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> and air drying before coating with sputter <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Au<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark>-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Pd<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> and examination with scanning <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">electron<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> microscopy (McGill <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Electron<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> Microscopy Centre). Light microscope images were captured using a Leica DMR microscope equipped with a Retiga 1300 camera. Quantitative analyses were performed using Adobe Photoshop and the data presented as the mean ± SD of two or three independent experiments. Statistical comparisons were made using the Student's t test.</br></br>Preparation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fibroblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and induction of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>.</br></br>MEFs were prepared from 14.5-day-old <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryos<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>. Only early-passage MEFs were used for the experimental studies, and induction of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> was carried out according to the methods previously described [30]. <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Cultured cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> were stained with Oil Red O as described [29].</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> preparation and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-PCR to assess <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenesis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> MEFs.</br></br>Total <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cellular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cellular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> was prepared by TRIzol <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">reagent<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> according to the manufacturer's protocol (Invitrogen, Carlsbad, California, United States). Total <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (1 μg) was <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">reverse-transcribed<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>, and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cDNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> samples were subjected to PCR. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-PCR was normalized by the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">transcriptional<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> level of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GAPDH<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GAPDH<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark>. The following 5′ and 3′ <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">primers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> were used to evaluate <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>: <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">KLF5<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>: 5'-AGA CAA GCT GAG ATG CTG C-3′, 5′-GGC AAA CCT CCA GTC GC-3′; <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">PPARγ<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>: 5′-GTG CGA TCA AAG TAG AAC CTG C-3′, 5′-CCT ATC ATA AAT AAG CTT CAA TCG-3′; <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">β-Actin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>: 5′-TAG GCG GAC TGT TAC TGA GC-3′, 5′-AGC CTT CAT ACA TCA AGT TGG-3′; and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>: 5′- GTG GAG ACC CCA AAT ATG CCC A-3′ and 5′-AAA CTG CTC CTG ACA GAT ATC A-3′.</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">down-regulation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> using Sam68sh.</br></br>To generate an <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">shRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>, 64-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">base<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">base<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">duplex DNA nucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">duplex DNA nucleotides<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> were purchased from Invitrogen. This fragment comprised 19 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">base<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">base<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">residues<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> specific to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (GATCCCC AAGATGACGAGGAGAATTATTCAAGAGA TAATTCTCCTCGTCATCTT TTTTTGGAAA). This fragment was <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cloned<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> into pSUPER retro (OligoEngine, Seattle, Washington, United States). <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Transfections<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> were performed using LipofectAMINE Plus (Invitrogen) with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cloned<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragment or empty <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">vector<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>. At 48 h after <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">transfection<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>, populations were selected for 2.5 μg/ml <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">puromycin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> and the knockdown observed by immunoblotting with anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (AD1) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>.</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> analysis of C3HT101/2 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark>.</br></br>For <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>, C3HT101/2 (ATCC) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> were incubated in 48-well <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissue<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> culture plates at 1.25 × 104 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark>/cm2 . After 24-h incubation, the culture media were changed to fresh media containing 300 ng/ml <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">BMP-2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (Sigma, St. Louis, Missouri, United States). Total <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cellular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cellular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> was prepared as described above, and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteocalcin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">β-actin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GAPDH<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GAPDH<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gene<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gene expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> at indicated times after <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">BMP-2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> treatment was quantified by <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-PCR.</br></br>Supporting Information</br></br>Dataset S1</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Localization<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> in Primary <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark></br></br>(124 KB PPT)</br></br>Click here for additional data file.</br></br>Dataset S2</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Gene<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Gene Expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> Profile of <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Cultured Stromal Cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Stromal Cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> at Days 6 and 18 of Culture Isolated from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>(204 KB PPT)</br></br>Click here for additional data file.</br></br>Dataset S3</br></br><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> Biochemistry and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Biomarkers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Biomarkers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> in 4- and 12-Month-Old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>(46 KB DOC)</br></br>Click here for additional data file.</br></br>Acknowledgements</br></br>We acknowledge Jean-Sebastien Binette (Centre for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Periodontal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> Research) and Jacinthe Sirois (Québec <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Transgenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> Research Network) for excellent technical assistance. We are grateful to Erique Lukong, Daniel Larocque, and Mark Bedford for helpful discussions. This work was supported by grant MT13377 to SR and grant MOP-13419 to JEH from the Canadian Institutes of Health Research (CIHR). SR holds an Investigator Award from the CIHR and JEH is a Chercheur Boursier, Senior of the FRSQ.</br></br>Abbreviations</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> - <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">alkaline phosphatase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">alkaline phosphatase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark></br></br>BMC - <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mineral<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> content</br></br>BMD - <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mineral<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> density</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">BMP-2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> - <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone morphogenetic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone morphogenetic protein-2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark>-2</br></br>CT - computed tomography</br></br>CTX - <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark>-telopeptide</br></br>MEF - <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryo<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fibroblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark></br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">PPARγ<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> - <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peroxisome<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peroxisome proliferator–activated receptor γ<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">receptor<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> γ</br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">shRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> - <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">short hairpin RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark></br></br><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">TRAP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> - <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tartrate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tartrate-resistant acid phosphatase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">acid<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">acid phosphatase<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark></br></br>Figures and Tables</br></br>Figure 1</br></br>Immunohistochemical Localization of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>(A) <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were removed from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pregnant<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> dams at E14.5 and E16.5, fixed in 4% <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">paraformaldehyde<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark>, and embedded in paraffin. The entire <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryo<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> was immunostained with the AD1 anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> and counterstained with methyl green, and the image was captured at ×1.2 magnification.</br></br>(B) <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> soft <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissues<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> from the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">brain<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">heart<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">gut<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> were stained with <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hematoxylin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> (left) and immunostained with anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> (right), and images were captured at ×20 magnification.</br></br>(C) Intense anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> immunoreactivity was seen in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">chondrocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">nasal septum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (panels A–D), in developing <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">vertebra<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (panels E–H), and in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femoral epiphysis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (panels I–K), as well as in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">diaphyseal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (panel L). Adjacent sections were stained with <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">hematoxylin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">eosin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> (panels A, E, and I) or with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> preadsorbed with the immunizing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (panels B, F, and J). <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> was <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">localized<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PATO_EXT</span></mark> primarily in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">nucleus of cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> in a variety of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissues<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> but was also found occasionally in the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cytoplasm<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. Magnification at source ×20, except for panels D, H, and L, which were ×40. Staining patterns are representative of three to five <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryos<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>.</br></br>Figure 2</br></br>Generation of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>-Deficient <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>(A) The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genomic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> organizations of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and targeted <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">alleles<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> after homologous <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">recombination<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">recombination<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_SO_EXT</span></mark> are depicted. The location of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragment used as a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">probe<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">probe<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> for the Southern blot analysis is shown, as well as the sizes of the two BglII fragments detected for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and targeted <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">alleles<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>. The targeted <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">allele<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">replaces<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">exon<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 4 and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">part of exon<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> 5 of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> with a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">PGK<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">neomycin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cassette<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>.</br></br>(B) Southern-blot analysis of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">genomic DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>), heterozygous (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>), and homozygous (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragments corresponding to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (4.5 k<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark>) and the targeted (5.5 k<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">b<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark>) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">alleles<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> are illustrated.</br></br>(C) Western blot analysis of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> extracts from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">wild-type<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>, heterozygous, and homozygous <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> subjected to immunoblot analyses using normal <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">rabbit<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">serum<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark>, anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> AD1 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark>, the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> AD1 preabsorbed with the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">immunogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">peptide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> corresponding to <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">amino acids<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">amino acids<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> 330–348 of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> Sc333 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> that recognizes the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C-terminal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C-terminal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> 20 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">amino acids<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">amino acids<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, and anti-actin <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibodies<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> as loading control. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">migration<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">molecular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> mass <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">markers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">markers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> is known on the left in kDa.</br></br>Figure 3</br></br>Radiologic Assessment of the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Femur<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of Young and Old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>(A) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> were given a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">lethal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark> dose of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">anesthetic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> at the indicated times, and contact radiographs of the distal <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femora<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> were obtained on a Faxitron MX20 equipped with an FPX-2 Imaging system. Representative radiographs of the distal <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femur<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>) and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> revealed comparable radiopacity at 4 months (left). At 12 months (right), <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cortical<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> thinning (arrow) and radiolucency (asterisk) were apparent in the distal <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femur<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> but not <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>.</br></br>(B) <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> were dissected free of soft <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissue<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and fixed overnight in 4% <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">paraformaldehyde<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> before scanning on a Skyscan 1072 static instrument equipped with 3D Creator analytical software. Representative three-dimensional re-constructions and two-dimensional cross-sectional scans demonstrated similar architecture in the distal <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femur<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>) and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. In keeping with the results from Faxitron x-ray, <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">trabecular bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (asterisk) and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cortical<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> thickness (arrow) were reduced in the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femur<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> compared with all other groups. The images are representative of those from five to seven <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animals<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> in each group.</br></br>Figure 4</br></br>Quantitative Micro-CT of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Trabecular Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> Composition and Architecture</br></br>(A) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> volume/<mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissue<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> volume (BV/TV) and structure model index (SMI) were calculated on the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">femur<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> and <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fourth lumbar vertebra<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of six or seven <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> in each group using 3D Creator software supplied with the Skyscan instrument. Results expressed as the mean ± SD showed significant differences (p &lt; 0.01) between 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (solid black) and 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (hatched black) but not between 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (solid white) and 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (stippled white).</br></br>(B) The distance between <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">trabeculae<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> was reflected in a shift to the right of the distribution curves for 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>. Solid black = 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>; hatched black = 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>; solid red = 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>; stippled red = 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>. The asterisks denote p &lt; 0.01.</br></br>Figure 5</br></br>Histologic Analysis of Undecalcified <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>Sections of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tibia<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> fixed in 4% <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">paraformaldehyde<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> and embedded in plastic were stained for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> (A–C, E–G) activity to identify <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> or for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">TRAP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (B–D, F–H) activity to identify <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark>. Staining patterns were similar in 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (A and B), 4-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (C and D), and 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (G and H) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> compared with 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> (E and F). Magnification at source, left panels ×10 and right panels ×40. Micrographs are representative of those taken from five to seven sections in each group of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animals<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>.</br></br>Figure 6</br></br>Ex Vivo Activity of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark></br></br><mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Marrow stromal<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Marrow stromal cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> were isolated from the <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">long bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">juvenile<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and maintained under conditions that promote <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark>.</br></br>(A) Cultures were fixed in 4% <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">paraformaldehyde<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> after 6 or 18 days and stained in situ for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> activity and with <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">silver nitrate<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> (von Kossa) to detect mineralized nodules. <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> cultures stained more intensely for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ALP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> at early and late time points and produced significantly more mineralized nodules after 18 days. Asterisks represent p &lt; 0.01.</br></br>(B) Primary <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> were isolated from the crushed <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">long bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> of the same <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> and plated on glass coverslips or on <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">dentin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> slices to quantify numbers and activity, respectively. <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteoclasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> were identified as <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells with three or more nuclei<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">nuclei<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> that stained positive for <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">TRAP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> activity (upper) and excavated pits in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">dentin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> slices, as demonstrated by SEM (lower, bar = 20 μm). No statistical differences were observed either in the number of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">TRAP<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>-positive <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> or in their resorptive activity.</br></br>Figure 7</br></br>Ex Vivo <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Adipogenesis<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> Analysis of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Fibroblasts<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark></br></br>MEFs were isolated from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mouse<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryos<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> at <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> day 14.5. Equal number of MEFs from <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> was plated on glass cover slips in 24 well-plates. <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Adipocyte<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> was carried out at indicated times by the addition of complete media containing the <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">pioglitazone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>.</br></br>(A) Cultures were fixed in 4% <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">paraformaldehyde<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> and stained with Oil Red O to detect the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fat<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark> droplets stored in <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> and photographed (top). The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> images were magnified ×10 and ×20 as indicated.</br></br>(B) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-PCR was carried out on total <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cellular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cellular<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> isolated after <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> of the MEFs for day 0, 2, 4, 6, and 12. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragments were visualized on <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">agarose<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> gels stained with <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ethidium bromide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">markers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">markers<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C/EBPβ<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">C/EBPδ<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">PPARα<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">KLF5<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> was examined as well as the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of controls including <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">β-actin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>, and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GAPDH<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GAPDH<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark>.</br></br>Figure 8</br></br>Enhanced <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> of the C3HT101/2 <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Embryonic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark><mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Embryonic Cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Cell<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> Line Depleted of Endogenous <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark></br></br>(A) C3HT101/2 <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">transfected<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> with an empty <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">vector<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (pSuper-retro) or a <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">vector<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> containing an <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">shRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">shRNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>) were selected with <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">puromycin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>, and knockdown populations depleted of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> were identified. The reduction in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> was analyzed by immunoblotting with anti-<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (AD1) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibody<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> and anti–<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">β-actin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">antibodies<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> as loading controls.</br></br>(B) <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> was carried out with conditioned medium containing <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">BMP-2<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> for the indicated times. To assess the level of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteogenic<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">differentiation<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_RO_EXT</span></mark> in these <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">cells<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL_GO_EXT</span></mark>, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">expression<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark> of late <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteoblast<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marker<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marker<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark>, <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">osteocalcin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> (<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">OCN<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark>), was analyzed by <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RT<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark>-PCR and compared with <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">β-actin<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GAPDH<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">GAPDH<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_PR_EXT</span></mark> controls. The <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">DNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> fragments were visualized by <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">agarose<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> gel stained with <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">ethidium bromide<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark>.</br></br>Figure 9</br></br>Old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">−<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> Are Protected from the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Development of Fatty Bone Marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Fatty<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Fatty<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone Marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark></br></br>Sections of undecalcified <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> were stained with von Kossa and toluidine blue and images captured at original magnifications of ×2 (A), ×40 (B and C) to evaluate mineralized <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">tissue<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> (A, black), <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (B, white), and the mineralization fronts (C, yellow and green). The 12-month-old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark>/<mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">+<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> demonstrated a significant reduction in <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> (A) and increase in <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">marrow<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> <mark class=\"entity\" style=\"background: #ffa500; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">adipocytes<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CL</span></mark> (B) and a decrease in the distance between two consecutive <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">fluorochrome<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">labels<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">labels<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> (C). Magnification at source was ×40. Micrographs are representative of four to six screened in each group of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">animals<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>.</br></br>Table 1</br></br>Progeny of <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> Heterozygote <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Breeding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GO_EXT</span></mark></br></br>Table 2</br></br>Morphology and <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #32cd32; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mineral<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI</span></mark> Density in 4- and 12-Month-Old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Female<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PATO_UBERON_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>Table 3</br></br>Histomorphometric Analysis of <mark class=\"entity\" style=\"background: #5f9ea0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Long Bones<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON</span></mark> from 4- and 12-Month-Old <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark></br></br>Footnotes</br></br>Competing interests. The authors have declared that no competing interests exist.</br></br>Author contributions. SR and JEH conceived and designed the experiments. SR, NT, GVF, GAT, TC, GV, MM, PC, AFR, SK, WL, AL, and YJG performed the experiments. SR and JEH analyzed the data. MLT generated the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark>. SR and JEH wrote the paper.</br></br>A previous version of this article appeared as an Early Online Release on November 11, 2005 (DOI: 10.1371/journal.pgen.0010074.eor).</br></br>Citation: Richard S, Torabi N, Franco GV, Tremblay GA, Chen T, et al. (2005) Ablation of the <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">Sam68<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PR_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">RNA<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_SO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">binding<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEMINF_GO_EXT</span></mark> <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark><mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">protein<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CHEBI_PR_EXT</span></mark> protects <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">mice<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NCBITaxon</span></mark> from age-related <mark class=\"entity\" style=\"background: #47e542; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;\">bone<span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">UBERON_EXT</span></mark> loss. PLoS Genet 1(6): e74.</div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "<data_utils.data_utils.Document at 0x23f7bcf8748>"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sample_doc_id = list(pred_docs.keys())[0]\n",
    "test_docs[sample_doc_id]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'16362077'"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sample_doc_id"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(T1, PR_EXT, (16, 21), Sam68)\n",
      "(T2, CHEBI_SO_EXT, (22, 25), RNA)\n",
      "(T3, CHEMINF_GO_EXT, (26, 33), Binding)\n",
      "(T4, CHEBI_PR_EXT, (34, 41), Protein)\n",
      "(T5, NCBITaxon, (51, 55), Mice)\n",
      "(T6, PR_EXT, (98, 101), Src)\n",
      "(T7, GO, (126, 133), mimitos)\n",
      "(T8, PR_EXT, (145, 150), Sam68)\n",
      "(T9, PR_EXT, (157, 159), KH)\n",
      "(T10, SO_EXT, (159, 164), -type)\n",
      "(T11, CHEBI_SO_EXT, (165, 168), RNA)\n",
      "(T12, CHEMINF_GO_EXT, (169, 176), binding)\n",
      "(T13, CHEBI_PR_EXT, (177, 184), protein)\n",
      "(T14, GO, (208, 216), regulate)\n",
      "(T15, GO, (236, 250), RNA metabolism)\n",
      "(T16, GO_PATO_EXT, (265, 276), physiologic)\n",
      "(T17, PR_EXT, (339, 344), Sam68)\n",
      "(T18, SO_EXT, (345, 349), null)\n",
      "(T19, NCBITaxon, (350, 354), mice)\n",
      "(T20, GO_SO_EXT, (369, 382), recombination)\n",
      "(T21, PR_EXT, (389, 394), Sam68)\n",
      "(T22, SO_EXT, (394, 395), −)\n",
      "(T23, SO_EXT, (396, 397), −)\n",
      "(T24, NCBITaxon, (398, 402), mice)\n",
      "(T25, UBERON_EXT, (419, 423), bone)\n",
      "(T26, SO_EXT, (466, 475), wild-type)\n",
      "(T27, UBERON_EXT, (497, 501), bone)\n",
      "(T28, UBERON_EXT, (559, 563), bone)\n",
      "(T29, PR_EXT, (591, 596), Sam68)\n",
      "(T30, SO_EXT, (596, 597), −)\n",
      "(T31, SO_EXT, (598, 599), −)\n",
      "(T32, NCBITaxon, (600, 604), mice)\n",
      "(T33, SO_EXT, (662, 671), wild-type)\n",
      "(T34, PR_EXT, (675, 680), Sam68)\n",
      "(T35, SO_EXT, (680, 681), −)\n",
      "(T36, SO_EXT, (682, 683), −)\n",
      "(T37, NCBITaxon, (684, 688), mice)\n",
      "(T38, PR_EXT, (690, 695), Sam68)\n",
      "(T39, SO_EXT, (695, 696), −)\n",
      "(T40, SO_EXT, (697, 698), −)\n",
      "(T41, UBERON_EXT, (699, 703), bone)\n",
      "(T42, UBERON, (704, 710), bone m)\n",
      "(T43, CL, (711, 719), stromal )\n",
      "(T44, CL_GO_EXT, (719, 724), cells)\n",
      "(T45, GO, (731, 746), differentiation)\n",
      "(T46, GO, (765, 783), ostosteogenic path)\n",
      "(T47, PR_EXT, (812, 817), Sam68)\n",
      "(T48, GO, (830, 841), hahairpin R)\n",
      "(T49, UBERON, (849, 858), embryonic)\n",
      "(T50, UBERON, (859, 870), mesenchymal)\n",
      "(T51, GO, (871, 885), multipotential)\n",
      "(T52, CL_GO_EXT, (907, 912), cells)\n",
      "(T53, GO, (941, 951), expression)\n",
      "(T54, CL, (966, 976), osteoblast)\n",
      "(T55, CHEBI_SO_EXT, (977, 983), marker)\n",
      "(T56, CHEBI, (984, 995), osteocalcin)\n",
      "(T57, GO, (1001, 1016), differentiation)\n",
      "(T58, PR_EXT, (1034, 1053), bone morphogenetic )\n",
      "(T59, CHEBI_PR_EXT, (1053, 1060), protein)\n",
      "(T60, PR_EXT, (1060, 1062), -2)\n",
      "(T61, NCBITaxon, (1076, 1081), mouse)\n",
      "(T62, UBERON, (1082, 1088), embryo)\n",
      "(T63, CL, (1089, 1100), fibroblasts)\n",
      "(T64, PR_EXT, (1116, 1121), Sam68)\n",
      "(T65, SO_EXT, (1121, 1122), +)\n",
      "(T66, SO_EXT, (1123, 1124), +)\n",
      "(T67, PR_EXT, (1129, 1134), Sam68)\n",
      "(T68, SO_EXT, (1134, 1135), −)\n",
      "(T69, SO_EXT, (1136, 1137), −)\n",
      "(T70, CL, (1185, 1195), adipocytes)\n",
      "(T71, PR_EXT, (1248, 1253), Sam68)\n",
      "(T72, SO_EXT, (1253, 1254), −)\n",
      "(T73, SO_EXT, (1255, 1256), −)\n",
      "(T74, NCBITaxon, (1257, 1262), mouse)\n",
      "(T75, UBERON, (1263, 1269), embryo)\n",
      "(T76, CL, (1270, 1281), fibroblastf)\n",
      "(T77, CL, (1305, 1314), adipocyte)\n",
      "(T78, GO, (1315, 1330), differentiation)\n",
      "(T79, UBERON_EXT, (1383, 1387), bone)\n",
      "(T80, PR_EXT, (1406, 1411), SaSam)\n",
      "(T81, SO_EXT, (1411, 1412), −)\n",
      "(T82, SO_EXT, (1413, 1414), −)\n",
      "(T83, NCBITaxon, (1415, 1419), mice)\n",
      "(T84, CL, (1435, 1445), adipocytes)\n",
      "(T85, SO_EXT, (1478, 1487), wild-type)\n",
      "(T86, UBERON, (1531, 1536), bone )\n",
      "(T87, PR_EXT, (1577, 1582), Sam68)\n",
      "(T88, GO_EXT, (1597, 1606), regregula)\n",
      "(T89, CL, (1610, 1619), adipocyte)\n",
      "(T90, GO, (1620, 1647), differentiation and a negat)\n",
      "(T91, GO_EXT, (1651, 1660), regulator)\n",
      "(T92, CL, (1664, 1674), osteoblast)\n",
      "(T93, GO, (1675, 1690), differentiation)\n",
      "(T94, PR_EXT, (1717, 1722), Sam68)\n",
      "(T95, GO, (1731, 1755), modulator of bone marrow)\n",
      "(T96, CL, (1756, 1768), mesenchymal )\n",
      "(T97, GO, (1768, 1788), cell differentiation)\n",
      "(T98, UBERON_EXT, (1800, 1804), bone)\n",
      "(T99, GO, (1805, 1815), metabolism)\n",
      "(T100, GO_PATO_EXT, (1820, 1824), aged)\n",
      "(T101, NCBITaxon, (1825, 1829), mice)\n",
      "(T102, GO, (1842, 1854), Osteoporosis)\n",
      "(T103, UBERON_EXT, (1873, 1877), bone)\n",
      "(T104, UBERON_EXT, (1919, 1923), bbon)\n",
      "(T105, UBERON_EXT, (1986, 1990), bone)\n",
      "(T106, SO_EXT, (2038, 2042), bone)\n",
      "(T107, NCBITaxon, (2087, 2093), humans)\n",
      "(T108, GO, (2175, 2185), tosteoporo)\n",
      "(T109, NCBITaxon, (2209, 2213), mice)\n",
      "(T110, PR_EXT, (2232, 2237), Sam68)\n",
      "(T111, CHEBI_SO_EXT, (2238, 2241), RNR)\n",
      "(T112, CHEMINF_GO_EXT, (2242, 2249), binding)\n",
      "(T113, CHEBI_PR_EXT, (2250, 2257), protein)\n",
      "(T114, CHEBI_PR_EXT, (2261, 2268), protein)\n",
      "(T115, GO_PATO_EXT, (2280, 2291), physiologic)\n",
      "(T116, NCBITaxon, (2306, 2310), mice)\n",
      "(T117, UBERON_EXT, (2354, 2358), bone)\n",
      "(T118, GO, (2371, 2376), aging)\n",
      "(T119, UBERON_EXT, (2390, 2394), bone)\n",
      "(T120, CL, (2452, 2462), adipocytes)\n",
      "(T121, UBERON, (2496, 2507), mesenchymal)\n",
      "(T122, CL, (2519, 2530), osteoblasts)\n",
      "(T123, UBERON, (2534, 2545), bone marrow)\n",
      "(T124, PR_EXT, (2571, 2576), Sam68)\n",
      "(T125, GO, (2577, 2586), regulates)\n",
      "(T126, GO, (2591, 2615), differentiation of this )\n",
      "(T127, UBERON, (2615, 2626), mesenchymme)\n",
      "(T128, CL, (2662, 2673), osteoblasts)\n",
      "(T129, GO, (2703, 2713), aging bone)\n",
      "(T130, UBERON_EXT, (2742, 2746), bone)\n",
      "(T131, GO_PATO_EXT, (2777, 2788), physiologic)\n",
      "(T132, PR_EXT, (2798, 2803), Sam68)\n",
      "(T133, GO_EXT, (2809, 2818), modulatmo)\n",
      "(T134, UBERON, (2826, 2837), bone marrow)\n",
      "(T135, CL, (2838, 2843), stem )\n",
      "(T136, CL_GO_EXT, (2843, 2847), cell)\n",
      "(T137, UBERON_EXT, (2867, 2871), bone)\n",
      "(T138, GO, (2872, 2882), metabolime)\n",
      "(T139, PR_EXT, (2902, 2907), Sam68)\n",
      "(T140, UBERON_EXT, (2990, 2994), bone)\n",
      "(T141, GO, (3023, 3043), skeletal development)\n",
      "(T142, GO, (3049, 3057), anabolic)\n",
      "(T143, CL, (3070, 3081), ososteoblas)\n",
      "(T144, GO, (3106, 3115), catabolic)\n",
      "(T145, CL, (3128, 3139), osteoclaost)\n",
      "(T146, UBERON_EXT, (3176, 3180), bone)\n",
      "(T147, UBERON_EXT, (3190, 3198), skeletal)\n",
      "(T148, UBERON_EXT, (3209, 3213), bone)\n",
      "(T149, CL, (3266, 3277), osteoblasts)\n",
      "(T150, CL, (3282, 3293), osteoclasts)\n",
      "(T151, GO, (3305, 3321), remodeling cycle)\n",
      "(T152, GO, (3330, 3344), skeletal aging)\n",
      "(T153, GO, (3392, 3400), teoclast)\n",
      "(T154, CL, (3406, 3416), osteoblast)\n",
      "(T155, UBERON, (3444, 3452), net bone)\n",
      "(T156, UBERON_EXT, (3492, 3496), bone)\n",
      "(T157, GO, (3514, 3520), develo)\n",
      "(T158, GO, (3542, 3547), aging)\n",
      "(T159, OBI_SO_EXT, (3580, 3588), genegene)\n",
      "(T160, GO, (3668, 3680), response of )\n",
      "(T161, CL, (3680, 3685), bone )\n",
      "(T162, CL_GO_EXT, (3685, 3690), cells)\n",
      "(T163, GO, (3694, 3705), circulating)\n",
      "(T164, CHEBI_GO_EXT, (3706, 3714), hormonho)\n",
      "(T165, GO_EXT, (3741, 3755), growth factors)\n",
      "(T166, SO_EXT, (3773, 3780), gengene)\n",
      "(T167, GO, (3847, 3855), regulate)\n",
      "(T168, GO, (3856, 3872), bone development)\n",
      "(T169, UBERON_EXT, (3943, 3947), bone)\n",
      "(T170, GO, (3964, 3979), bonebone resorp)\n",
      "(T171, NCBITaxon_UBERON_EXT, (3999, 4004), women)\n",
      "(T172, UBERON_EXT, (4039, 4043), bone)\n",
      "(T173, CHEBI_SO_EXT, (4095, 4105), bbiomarker)\n",
      "(T174, CHEBI_PR_EXT, (4213, 4224), parathyroid)\n",
      "(T175, CHEBI_EXT, (4224, 4225), a)\n",
      "(T176, CHEBI_GO_EXT, (4225, 4232), hormone)\n",
      "(T177, UBERON, (4257, 4264), gonadal)\n",
      "(T178, CHEBI_GO_EXT, (4265, 4272), hormone)\n",
      "(T179, CHEBI_PR_EXT, (4293, 4299), leptin)\n",
      "(T180, UBERON, (4327, 4341), nervous system)\n",
      "(T181, GO, (4375, 4394), bone cell apoptosis)\n",
      "(T182, UBERON_EXT, (4401, 4405), Bone)\n",
      "(T183, GO_EXT, (4473, 4481), responsr)\n",
      "(T184, UBERON, (4485, 4496), bone marrow)\n",
      "(T185, CL, (4497, 4505), stromal )\n",
      "(T186, CL_GO_EXT, (4505, 4510), cells)\n",
      "(T187, GO, (4549, 4570), differentiation down )\n",
      "(T188, CL, (4574, 4583), adipocyte)\n",
      "(T189, CL, (4608, 4618), osteoblast)\n",
      "(T190, GO, (4634, 4639), Aging)\n",
      "(T191, CHEBI_UBERON_EXT, (4692, 4695), fat)\n",
      "(T192, CL, (4721, 4731), adipocytes)\n",
      "(T193, CL, (4748, 4759), osteoblasts)\n",
      "(T194, CL, (4766, 4777), Osteoblasts)\n",
      "(T195, CL, (4782, 4792), adipocytes)\n",
      "(T196, UBERON, (4819, 4830), mesenchymal)\n",
      "(T197, CL_GO_EXT, (4841, 4845), cell)\n",
      "(T198, UBERON, (4857, 4868), bone mabone)\n",
      "(T199, GO, (4891, 4898), control)\n",
      "(T200, GO, (4930, 4956), adipogenic differentiation)\n",
      "(T201, GO_EXT, (5000, 5015), transcriptional)\n",
      "(T202, GO, (5016, 5026), regulatory)\n",
      "(T203, CHEBI_PR_EXT, (5027, 5035), proteins)\n",
      "(T204, GO, (5062, 5089), cell fate determination of )\n",
      "(T205, UBERON, (5089, 5100), bone marrow)\n",
      "(T206, CL, (5101, 5113), mesenchymal )\n",
      "(T207, CL_GO_EXT, (5113, 5118), cells)\n",
      "(T208, PR_EXT, (5130, 5164), peroxisome proliferator–activated )\n",
      "(T209, GO_EXT, (5164, 5172), receptor)\n",
      "(T210, PR_EXT, (5172, 5174),  γ)\n",
      "(T211, PR_EXT, (5176, 5181), PPARγ)\n",
      "(T212, PR_EXT, (5187, 5191), KLF5)\n",
      "(T213, CHEBI_SO_EXT, (5213, 5216), RNA)\n",
      "(T214, CHEMINF_GO_EXT, (5217, 5224), binding)\n",
      "(T215, CHEBI_PR_EXT, (5225, 5233), proteins)\n",
      "(T216, CHEBI_SO_EXT, (5267, 5270), RNA)\n",
      "(T217, CHEMINF_GO_EXT, (5271, 5278), binding)\n",
      "(T218, CHEBI_PR_EXT, (5279, 5287), proteins)\n",
      "(T219, SO_EXT, (5298, 5302), type)\n",
      "(T220, GO_EXT, (5313, 5323), regulators)\n",
      "(T221, GO, (5327, 5351), cellular differentiation)\n",
      "(T222, GO, (5366, 5376), expression)\n",
      "(T223, SO_EXT, (5395, 5401), domain)\n",
      "(T224, CHEBI_PR_EXT, (5402, 5410), proteins)\n",
      "(T225, PR_EXT, (5420, 5424), FMRP)\n",
      "(T226, UBERON, (5459, 5469), neurologic)\n",
      "(T227, NCBITaxon, (5530, 5536), humans)\n",
      "(T228, NCBITaxon, (5579, 5583), mice)\n",
      "(T229, CHEBI_SO_EXT, (5616, 5619), RNA)\n",
      "(T230, CHEMINF_GO_EXT, (5620, 5627), binding)\n",
      "(T231, CHEBI_PR_EXT, (5628, 5635), protpro)\n",
      "(T232, GO, (5639, 5655), oligodendrocytes)\n",
      "(T233, GO_EXT, (5660, 5671), myelination)\n",
      "(T234, GO, (5698, 5708), expression)\n",
      "(T235, PR_EXT, (5716, 5723), QKI-6/7)\n",
      "(T236, SO_EXT, (5724, 5732), isoforms)\n",
      "(T237, GO, (5752, 5765), formatioe for)\n",
      "(T238, CL, (5765, 5771), glial )\n",
      "(T239, CL_GO_EXT, (5771, 5776), cells)\n",
      "(T240, CL, (5789, 5796), neurons)\n",
      "(T241, UBERON_EXT, (5802, 5808), neural)\n",
      "(T242, GO, (5847, 5870), cell fate determination)\n",
      "(T243, PR_EXT, (5889, 5894), GLD-1)\n",
      "(T244, CHEBI_PR_EXT, (5895, 5902), protein)\n",
      "(T245, NCBITaxon, (5906, 5928), Caenorhabditis elegans)\n",
      "(T246, CL, (5956, 5961), stem )\n",
      "(T247, CL_GO_EXT, (5961, 5966), cells)\n",
      "(T248, SO_EXT, (5999, 6005), domain)\n",
      "(T249, CHEBI_PR_EXT, (6006, 6013), protein)\n",
      "(T250, PR_EXT, (6014, 6017), HOH)\n",
      "(T251, NCBITaxon, (6021, 6031), Drosophila)\n",
      "(T252, UBERON_EXT, (6041, 6047), muscle)\n",
      "(T253, GO, (6048, 6063), differentiation)\n",
      "(T254, CHEBI_EXT, (6090, 6094), held)\n",
      "(T255, UBERON, (6099, 6104), wings)\n",
      "(T256, PR_EXT, (6118, 6121), Src)\n",
      "(T257, GO, (6146, 6153), mitosis)\n",
      "(T258, PR_EXT, (6165, 6170), Sam68)\n",
      "(T259, SO_EXT, (6209, 6215), domain)\n",
      "(T260, CHEBI_SO_EXT, (6216, 6219), RNA)\n",
      "(T261, CHEMINF_GO_EXT, (6220, 6227), binding)\n",
      "(T262, CHEBI_PR_EXT, (6228, 6236), proteins)\n",
      "(T263, GO_PATO_EXT, (6256, 6267), physiologic)\n",
      "(T264, PR_EXT, (6298, 6303), Sam68)\n",
      "(T265, SO_EXT, (6337, 6343), domain)\n",
      "(T266, CHEBI_PR_EXT, (6356, 6363), protein)\n",
      "(T267, PR_EXT, (6368, 6379), Src family )\n",
      "(T268, GO_EXT, (6379, 6386), kinases)\n",
      "(T269, PR_EXT, (6420, 6424), Src )\n",
      "(T270, GO_EXT, (6424, 6431), kinases)\n",
      "(T271, NCBITaxon, (6451, 6457), breast)\n",
      "(T272, PR_EXT, (6458, 6464), tumor )\n",
      "(T273, GO_EXT, (6464, 6470), tumor )\n",
      "(T274, PR_EXT, (6477, 6482), Sam68)\n",
      "(T275, GO, (6526, 6535), ununsplic)\n",
      "(T276, PR_EXT, (6536, 6539), HIV)\n",
      "(T277, CHEBI_SO_EXT, (6540, 6543), RNA)\n",
      "(T278, GO, (6556, 6564), regulate)\n",
      "(T279, SO_EXT, (6565, 6569), pre-)\n",
      "(T280, CHEBI_SO_EXT, (6569, 6573), mRNA)\n",
      "(T281, SO_EXT, (6574, 6584), processing)\n",
      "(T282, PR_EXT, (6641, 6646), Sam68)\n",
      "(T283, SO_EXT, (6646, 6647), −)\n",
      "(T284, SO_EXT, (6648, 6649), −)\n",
      "(T285, NCBITaxon, (6650, 6654), mice)\n",
      "(T286, UBERON, (6677, 6685), skeletal)\n",
      "(T287, PR_EXT, (6735, 6740), Sam68)\n",
      "(T288, SO_EXT, (6775, 6779), bone)\n",
      "(T289, NCBITaxon, (6788, 6792), mice)\n",
      "(T290, PR_EXT, (6807, 6812), Sam68)\n",
      "(T291, UBERON_EXT, (6827, 6831), bone)\n",
      "(T292, SO_EXT, (6848, 6857), wild-type)\n",
      "(T293, PR_EXT, (6896, 6901), Sam68)\n",
      "(T294, GO, (6902, 6911), regulates)\n",
      "(T295, GO, (6916, 6935), differentiation of )\n",
      "(T296, UBERON, (6935, 6946), bone marrow)\n",
      "(T297, CL, (6947, 6955), stromal )\n",
      "(T298, CL_GO_EXT, (6955, 6960), cells)\n",
      "(T299, CL_GO_EXT, (6977, 6982), cells)\n",
      "(T300, PR_EXT, (6997, 7002), Sam68)\n",
      "(T301, SO_EXT, (7002, 7003), −)\n",
      "(T302, SO_EXT, (7004, 7005), −)\n",
      "(T303, NCBITaxon, (7006, 7013), animals)\n",
      "(T304, GO, (7027, 7037), osteogenic)\n",
      "(T305, GO, (7061, 7071), adipogenic)\n",
      "(T306, SO_EXT, (7107, 7116), wild-type)\n",
      "(T307, PR_EXT, (7143, 7148), Sam68)\n",
      "(T308, SO_EXT, (7148, 7149), −)\n",
      "(T309, SO_EXT, (7150, 7151), −)\n",
      "(T310, NCBITaxon, (7152, 7157), mouse)\n",
      "(T311, UBERON, (7158, 7164), embryo)\n",
      "(T312, CL, (7165, 7176), fibfibrobla)\n",
      "(T313, GO_RO_EXT, (7219, 7232), differentiate)\n",
      "(T314, CL, (7238, 7248), adipocytes)\n",
      "(T315, PR_EXT, (7266, 7271), Sam68)\n",
      "(T316, GO_EXT, (7280, 7289), regulator)\n",
      "(T317, GO, (7293, 7304), bontor of b)\n",
      "(T318, UBERON, (7305, 7316), mesenchymal)\n",
      "(T319, GO, (7317, 7337), cell differentiation)\n",
      "(T320, NCBITaxon, (7377, 7383), animal)\n",
      "(T321, GO, (7404, 7414), metabolism)\n",
      "(T322, GO, (7416, 7428), regenerarege)\n",
      "(T323, GO, (7434, 7440), repair)\n",
      "(T324, GO, (7448, 7453), aging)\n",
      "(T325, PR_EXT, (7465, 7470), Sam68)\n",
      "(T326, GO, (7474, 7483), Expressed)\n",
      "(T327, UBERON, (7502, 7523), Skeleton of Embryonic)\n",
      "(T328, NCBITaxon, (7524, 7528), Mice)\n",
      "(T329, PR_EXT, (7534, 7539), Sam68)\n",
      "(T330, CHEBI_SO_EXT, (7540, 7544), mRNA)\n",
      "(T331, GO, (7567, 7576), expressed)\n",
      "(T332, CHEBI_PR_EXT, (7606, 7613), protein)\n",
      "(T333, GO, (7614, 7624), exexpressi)\n",
      "(T334, SO_EXT, (7686, 7695), wild-type)\n",
      "(T335, UBERON, (7712, 7721), embryonic)\n",
      "(T336, NCBITaxon, (7722, 7726), mice)\n",
      "(T337, PR_EXT, (7774, 7777), AD1)\n",
      "(T338, PR_EXT, (7783, 7788), Sam68)\n",
      "(T339, GO, (7789, 7797), antibody)\n",
      "(T340, NCBITaxon, (7809, 7816), rabbits)\n",
      "(T341, CHEBI_SO_EXT, (7839, 7846), peptide)\n",
      "(T342, CHEBI_SO_EXT, (7867, 7878), aminoamino )\n",
      "(T343, NCBITaxon, (7897, 7902), mouse)\n",
      "(T344, PR_EXT, (7903, 7908), Sam68)\n",
      "(T345, CHEBI_PR_EXT, (7909, 7916), protein)\n",
      "(T346, PR_EXT, (7923, 7928), Sam68)\n",
      "(T347, UBERON, (7966, 7974), skeleton)\n",
      "(T348, UBERON, (7984, 7991), tissues)\n",
      "(T349, SO_EXT, (8006, 8015), wild-type)\n",
      "(T350, NCBITaxon, (8016, 8020), mice)\n",
      "(T351, GO, (8085, 8096), nucleus of )\n",
      "(T352, CL_GO_EXT, (8096, 8101), cells)\n",
      "(T353, UBERON, (8109, 8125), developing brain)\n",
      "(T354, UBERON, (8127, 8132), hhear)\n",
      "(T355, UBERON, (8138, 8153), small intestine)\n",
      "(T356, CL, (8181, 8193), chondrocyteh)\n",
      "(T357, UBERON, (8201, 8213), nasal septum)\n",
      "(T358, UBERON, (8222, 8231), glandular)\n",
      "(T359, UBERON, (8232, 8238), tissue)\n",
      "(T360, UBERON, (8255, 8260), nnasa)\n",
      "(T361, UBERON_EXT, (8261, 8270), cartilage)\n",
      "(T362, UBERON, (8303, 8311), vertebra)\n",
      "(T363, UBERON, (8316, 8336), inteintervertebral d)\n",
      "(T364, UBERON, (8361, 8370), epiphysis)\n",
      "(T365, UBERON, (8388, 8398), metaphysis)\n",
      "(T366, UBERON, (8417, 8422), bones)\n",
      "(T367, GO, (8424, 8431), Nuclear)\n",
      "(T368, GO, (8457, 8470), proliferating)\n",
      "(T369, CL, (8471, 8483), chondrocytes)\n",
      "(T370, CL, (8488, 8513), hypertrophic chondrocyteh)\n",
      "(T371, CL, (8539, 8550), osteoblasts)\n",
      "(T372, CL, (8581, 8592), osteoclasts)\n",
      "(T373, UBERON, (8647, 8652), serum)\n",
      "(T374, UBERON, (8665, 8674), antiserum)\n",
      "(T375, CHEBI_SO_EXT, (8711, 8718), peptide)\n",
      "(T376, PR_EXT, (8796, 8801), Sam68)\n",
      "(T377, CHEBI_PR_EXT, (8802, 8809), protein)\n",
      "(T378, GO, (8825, 8834), expressex)\n",
      "(T379, NCBITaxon, (8853, 8858), mouse)\n",
      "(T380, UBERON, (8859, 8865), embryo)\n",
      "(T381, GO, (8894, 8904), exexpressi)\n",
      "(T382, UBERON_EXT, (8908, 8917), cartilage)\n",
      "(T383, UBERON_EXT, (8922, 8926), bone)\n",
      "(T384, NCBITaxon, (8956, 8961), MousM)\n",
      "(T385, GO_PATO_EXT, (8989, 9000), physiologic)\n",
      "(T386, PR_EXT, (9009, 9014), Sam68)\n",
      "(T387, PR_EXT, (9029, 9034), Sam68)\n",
      "(T388, NCBITaxon, (9045, 9049), mice)\n",
      "(T389, SO_EXT, (9076, 9081), exons)\n",
      "(T390, PR_EXT, (9097, 9102), sam68)\n",
      "(T391, SO_EXT, (9103, 9107), gene)\n",
      "(T392, SO_EXT, (9115, 9121), encode)\n",
      "(T393, CHEBI_SO_EXT, (9159, 9162), RNA)\n",
      "(T394, CHEMINF_GO_EXT, (9163, 9170), binding)\n",
      "(T395, SO_EXT, (9171, 9177), domain)\n",
      "(T396, SO_EXT, (9221, 9227), allele)\n",
      "(T397, SO_EXT, (9293, 9301), genomic )\n",
      "(T398, CHEBI_SO_EXT, (9301, 9304), DNA)\n",
      "(T399, SO_EXT, (9331, 9342), transcripts)\n",
      "(T400, SO_EXT, (9343, 9350), eencode)\n",
      "(T401, SO_EXT, (9354, 9359), exons)\n",
      "(T402, GO_EXT, (9395, 9397), RT)\n",
      "(T403, PR_EXT, (9420, 9425), Sam68)\n",
      "(T404, SO_EXT, (9425, 9426), −)\n",
      "(T405, SO_EXT, (9427, 9428), −)\n",
      "(T406, NCBITaxon, (9429, 9433), mice)\n",
      "(T407, PR_EXT, (9449, 9454), Sam68)\n",
      "(T408, CHEBI_PR_EXT, (9455, 9462), protein)\n",
      "(T409, PR_EXT, (9506, 9515), Sam68 AD1)\n",
      "(T410, PR_EXT, (9520, 9526), SC-333)\n",
      "(T411, GO, (9527, 9537), antibodiea)\n",
      "(T412, GO, (9541, 9548), control)\n",
      "(T413, NCBITaxon, (9556, 9562), rabbit)\n",
      "(T414, UBERON, (9563, 9568), serum)\n",
      "(T415, PR_EXT, (9577, 9586), Sam68 AD1)\n",
      "(T416, CHEBI_SO_EXT, (9604, 9611), peptide)\n",
      "(T417, NCBITaxon, (9637, 9643), rabbit)\n",
      "(T418, PR_EXT, (9649, 9654), Sam68)\n",
      "(T419, GO, (9655, 9663), antibody)\n",
      "(T420, CHEBI_SO_EXT, (9692, 9702), C-terminal)\n",
      "(T421, CHEBI_SO_EXT, (9706, 9717), amino acids)\n",
      "(T422, PR_EXT, (9721, 9726), Sam68)\n",
      "(T423, NCBITaxon, (9774, 9779), mouse)\n",
      "(T424, PR_EXT, (9793, 9798), Sam68)\n",
      "(T425, SO_EXT, (9804, 9813), genotypes)\n",
      "(T426, PR_EXT, (9963, 9968), Sam68)\n",
      "(T427, SO_EXT, (9968, 9969), −)\n",
      "(T428, SO_EXT, (9970, 9971), −)\n",
      "(T429, NCBITaxon_UBERON_EXT, (9972, 9976), pups)\n",
      "(T430, GO, (9977, 9981), died)\n",
      "(T431, GO, (9985, 9990), birth)\n",
      "(T432, PR_EXT, (10010, 10015), Sam68)\n",
      "(T433, SO_EXT, (10015, 10016), +)\n",
      "(T434, SO_EXT, (10017, 10018), -)\n",
      "(T435, NCBITaxon, (10019, 10023), mice)\n",
      "(T436, PR_EXT, (10055, 10060), Sam68)\n",
      "(T437, SO_EXT, (10060, 10061), −)\n",
      "(T438, SO_EXT, (10062, 10063), −)\n",
      "(T439, NCBITaxon_UBERON_EXT, (10064, 10068), pups)\n",
      "(T440, GO, (10091, 10096), natal)\n",
      "(T441, PR_EXT, (10155, 10160), Sam68)\n",
      "(T442, CHEBI_SO_EXT, (10161, 10165), mRNA)\n",
      "(T443, GO, (10176, 10185), expressed)\n",
      "(T444, GO_PATO_EXT, (10190, 10204), phosphorylated)\n",
      "(T445, GO, (10208, 10215), mitosis)\n",
      "(T446, PR_EXT, (10229, 10234), Sam68)\n",
      "(T447, SO_EXT, (10234, 10235), −)\n",
      "(T448, SO_EXT, (10236, 10237), −)\n",
      "(T449, NCBITaxon, (10238, 10242), mimi)\n",
      "(T450, UBERON, (10307, 10316), illnesses)\n",
      "(T451, PR_EXT, (10318, 10323), Sam68)\n",
      "(T452, SO_EXT, (10323, 10324), −)\n",
      "(T453, SO_EXT, (10325, 10326), −)\n",
      "(T454, NCBITaxon, (10327, 10331), mice)\n",
      "(T455, GO_EXT, (10362, 10370), breedibr)\n",
      "(T456, PATO_UBERON_EXT, (10378, 10382), male)\n",
      "(T457, PATO_UBERON_EXT, (10403, 10410), females)\n",
      "(T458, PR_EXT, (10458, 10463), Sam68)\n",
      "(T459, NCBITaxon, (10484, 10488), Mice)\n",
      "(T460, CHEBI_SO_EXT, (10496, 10497), A)\n",
      "(T461, PR_EXT, (10517, 10520), Src)\n",
      "(T462, SO_EXT, (10521, 10525), null)\n",
      "(T463, NCBITaxon, (10526, 10533), animals)\n",
      "(T464, GO, (10557, 10567), metmetabol)\n",
      "(T465, PR_EXT, (10592, 10597), Sam68)\n",
      "(T466, PR_EXT, (10616, 10619), Src)\n",
      "(T467, PR_EXT, (10647, 10652), Sam68)\n",
      "(T468, NCBITaxon, (10653, 10657), mice)\n",
      "(T469, UBERON, (10662, 10670), skeletal)\n",
      "(T470, PR_EXT, (10697, 10702), Sam68)\n",
      "(T471, SO_EXT, (10702, 10703), +)\n",
      "(T472, SO_EXT, (10704, 10705), +)\n",
      "(T473, PR_EXT, (10710, 10715), Sam68)\n",
      "(T474, SO_EXT, (10715, 10716), −)\n",
      "(T475, SO_EXT, (10717, 10718), −)\n",
      "(T476, NCBITaxon, (10719, 10723), mice)\n",
      "(T477, UBERON, (10770, 10778), skeletal)\n",
      "(T478, UBERON_EXT, (10823, 10827), bone)\n",
      "(T479, PATO_UBERON_EXT, (10922, 10928), female)\n",
      "(T480, NCBITaxon, (10929, 10933), mice)\n",
      "(T481, PATO_UBERON_EXT, (10958, 10964), female)\n",
      "(T482, NCBITaxon, (10965, 10969), mice)\n",
      "(T483, UBERON_EXT, (11004, 11008), body)\n",
      "(T484, PR_EXT, (11038, 11043), Sam68)\n",
      "(T485, SO_EXT, (11043, 11044), −)\n",
      "(T486, SO_EXT, (11045, 11046), −)\n",
      "(T487, NCBITaxon, (11047, 11051), mice)\n",
      "(T488, PR_EXT, (11070, 11075), SaSam)\n",
      "(T489, SO_EXT, (11075, 11076), +)\n",
      "(T490, SO_EXT, (11077, 11078), +)\n",
      "(T491, NCBITaxon, (11079, 11083), mice)\n",
      "(T492, UBERON_EXT, (11108, 11112), bone)\n",
      "(T493, GO, (11128, 11136), axial an)\n",
      "(T494, UBERON, (11138, 11159), appendicular skeleton)\n",
      "(T495, GO, (11202, 11210), Faxitron)\n",
      "(T496, GO, (11233, 11250), X-ray Corporation)\n",
      "(T497, GO, (11367, 11375), cortical)\n",
      "(T498, UBERON, (11412, 11428), metaphyseal bone)\n",
      "(T499, UBERON, (11454, 11460), fefemo)\n",
      "(T500, PR_EXT, (11477, 11482), Sam68)\n",
      "(T501, SO_EXT, (11482, 11483), +)\n",
      "(T502, SO_EXT, (11484, 11485), +)\n",
      "(T503, NCBITaxon, (11486, 11490), mice)\n",
      "(T504, NCBITaxon, (11517, 11521), micm)\n",
      "(T505, SO_EXT, (11532, 11540), genotype)\n",
      "(T506, PR_EXT, (11558, 11563), Sam68)\n",
      "(T507, SO_EXT, (11563, 11564), −)\n",
      "(T508, SO_EXT, (11565, 11566), −)\n",
      "(T509, NCBITaxon, (11567, 11571), mice)\n",
      "(T510, UBERON, (11595, 11610), trabecular bone)\n",
      "(T511, UBERON, (11667, 11676), vertebrae)\n",
      "(T512, PR_EXT, (11697, 11702), Sam68)\n",
      "(T513, SO_EXT, (11702, 11703), +)\n",
      "(T514, SO_EXT, (11704, 11705), +)\n",
      "(T515, NCBITaxon, (11706, 11710), mice)\n",
      "(T516, PR_EXT, (11726, 11731), Sam68)\n",
      "(T517, SO_EXT, (11731, 11732), −)\n",
      "(T518, SO_EXT, (11733, 11734), −)\n",
      "(T519, NCBITaxon, (11735, 11739), mice)\n",
      "(T520, UBERON_EXT, (11766, 11770), body)\n",
      "(T521, CHEBI, (11776, 11783), mineral)\n",
      "(T522, NCBITaxon, (11831, 11836), mouse)\n",
      "(T523, PR_EXT, (11915, 11920), Sam68)\n",
      "(T524, SO_EXT, (11920, 11921), +)\n",
      "(T525, SO_EXT, (11922, 11923), +)\n",
      "(T526, PR_EXT, (11928, 11933), Sam68)\n",
      "(T527, SO_EXT, (11933, 11934), −)\n",
      "(T528, SO_EXT, (11935, 11936), −)\n",
      "(T529, NCBITaxon, (11937, 11941), mice)\n",
      "(T530, PR_EXT, (12018, 12023), Sam68)\n",
      "(T531, SO_EXT, (12023, 12024), −)\n",
      "(T532, SO_EXT, (12025, 12026), −)\n",
      "(T533, NCBITaxon, (12027, 12031), mice)\n",
      "(T534, GO, (12076, 12079), BMC)\n",
      "(T535, UBERON, (12096, 12101), femur)\n",
      "(T536, UBERON, (12106, 12114), vertebra)\n",
      "(T537, PR_EXT, (12122, 12127), Sam68)\n",
      "(T538, SO_EXT, (12127, 12128), −)\n",
      "(T539, SO_EXT, (12129, 12130), −)\n",
      "(T540, NCBITaxon, (12131, 12135), mice)\n",
      "(T541, SO_EXT, (12202, 12211), wild type)\n",
      "(T542, NCBITaxon, (12212, 12216), mice)\n",
      "(T543, UBERON_EXT, (12258, 12262), body)\n",
      "(T544, UBERON, (12274, 12281), femoral)\n",
      "(T545, UBERON, (12286, 12295), vevertebr)\n",
      "(T546, PR_EXT, (12323, 12328), Sam68)\n",
      "(T547, SO_EXT, (12328, 12329), −)\n",
      "(T548, SO_EXT, (12330, 12331), −)\n",
      "(T549, PR_EXT, (12366, 12371), Sam68)\n",
      "(T550, SO_EXT, (12371, 12372), −)\n",
      "(T551, SO_EXT, (12373, 12374), −)\n",
      "(T552, NCBITaxon, (12375, 12379), mice)\n",
      "(T553, UBERON, (12433, 12454), appendicular skeleton)\n",
      "(T554, UBERON_EXT, (12589, 12593), bone)\n",
      "(T555, UBERON_EXT, (12663, 12667), Bone)\n",
      "(T556, PR_EXT, (12689, 12694), Sam68)\n",
      "(T557, SO_EXT, (12694, 12695), −)\n",
      "(T558, SO_EXT, (12696, 12697), −)\n",
      "(T559, NCBITaxon, (12698, 12702), Mice)\n",
      "(T560, CHEBI, (12704, 12708), Bone)\n",
      "(T561, UBERON, (12778, 12787), skeletons)\n",
      "(T562, GO_PATO_EXT, (12791, 12795), aged)\n",
      "(T563, NCBITaxon, (12804, 12808), mice)\n",
      "(T564, UBERON_EXT, (12859, 12863), bone)\n",
      "(T565, NCBITaxon, (12872, 12878), humans)\n",
      "(T566, UBERON_EXT, (13008, 13012), bone)\n",
      "(T567, UBERON, (13034, 13040), tissue)\n",
      "(T568, PR_EXT, (13093, 13098), Sam68)\n",
      "(T569, SO_EXT, (13098, 13099), +)\n",
      "(T570, SO_EXT, (13100, 13101), +)\n",
      "(T571, NCBITaxon, (13102, 13106), mice)\n",
      "(T572, NCBITaxon, (13148, 13152), mice)\n",
      "(T573, SO_EXT, (13161, 13170), genotypes)\n",
      "(T574, PR_EXT, (13201, 13206), Sam68)\n",
      "(T575, SO_EXT, (13206, 13207), −)\n",
      "(T576, SO_EXT, (13208, 13209), −)\n",
      "(T577, NCBITaxon, (13210, 13214), mice)\n",
      "(T578, UBERON, (13465, 13475), trabecular)\n",
      "(T579, PR_EXT, (13530, 13535), Sam68)\n",
      "(T580, SO_EXT, (13535, 13536), +)\n",
      "(T581, SO_EXT, (13537, 13538), +)\n",
      "(T582, NCBITaxon, (13539, 13543), mice)\n",
      "(T583, UBERON, (13664, 13674), Trabecular)\n",
      "(T584, NCBITaxon, (13733, 13737), mice)\n",
      "(T585, GO, (13802, 13812), trabeculae)\n",
      "(T586, UBERON, (13853, 13863), trabeculae)\n",
      "(T587, PR_EXT, (13885, 13890), SamSa)\n",
      "(T588, SO_EXT, (13890, 13891), +)\n",
      "(T589, SO_EXT, (13892, 13893), +)\n",
      "(T590, NCBITaxon, (13894, 13898), mice)\n",
      "(T591, NCBITaxon, (13940, 13944), mice)\n",
      "(T592, SO_EXT, (13956, 13962), deling)\n",
      "(T593, SO_EXT, (13989, 13990), −)\n",
      "(T594, SO_EXT, (13991, 13992), −)\n",
      "(T595, NCBITaxon, (13993, 13997), Mice)\n",
      "(T596, UBERON_EXT, (14064, 14068), bone)\n",
      "(T597, GO_PATO_EXT, (14077, 14081), agea)\n",
      "(T598, PR_EXT, (14082, 14087), Sam68)\n",
      "(T599, SO_EXT, (14087, 14088), −)\n",
      "(T600, SO_EXT, (14089, 14090), −)\n",
      "(T601, NCBITaxon, (14091, 14095), mice)\n",
      "(T602, UBERON, (14140, 14144), femo)\n",
      "(T603, CL, (14169, 14179), osteoblast)\n",
      "(T604, CL, (14184, 14194), osteoclast)\n",
      "(T605, CHEBI_GO_SO_EXT, (14224, 14230), enzyme)\n",
      "(T606, GO_PR_EXT, (14258, 14272), alkaline phosp)\n",
      "(T607, GO_EXT, (14272, 14278), line p)\n",
      "(T608, PR_EXT, (14280, 14283), ALP)\n",
      "(T609, CHEBI_SO_EXT, (14321, 14330), biomarker)\n",
      "(T610, CL, (14335, 14346), oosteoblast)\n",
      "(T611, PR_EXT, (14370, 14373), ALP)\n",
      "(T612, CHEBI_EXT, (14394, 14398), acid)\n",
      "(T613, GO_EXT, (14399, 14400), p)\n",
      "(T614, GO, (14400, 14410), ant acid p)\n",
      "(T615, CHEBI_SO_EXT, (14444, 14450), marker)\n",
      "(T616, CL, (14455, 14466), osteoclasos)\n",
      "(T617, PR_EXT, (14503, 14508), Sam68)\n",
      "(T618, SO_EXT, (14508, 14509), +)\n",
      "(T619, SO_EXT, (14510, 14511), +)\n",
      "(T620, PR_EXT, (14535, 14540), Sam68)\n",
      "(T621, SO_EXT, (14540, 14541), −)\n",
      "(T622, SO_EXT, (14542, 14543), −)\n",
      "(T623, NCBITaxon, (14563, 14567), mice)\n",
      "(T624, PR_EXT, (14588, 14591), ALP)\n",
      "(T625, CL_GO_EXT, (14611, 14616), cells)\n",
      "(T626, PR_EXT, (14650, 14655), Sam68)\n",
      "(T627, SO_EXT, (14655, 14656), +)\n",
      "(T628, SO_EXT, (14657, 14658), +)\n",
      "(T629, NCBITaxon, (14659, 14663), mice)\n",
      "(T630, PR_EXT, (14722, 14727), Sam68)\n",
      "(T631, SO_EXT, (14727, 14728), −)\n",
      "(T632, SO_EXT, (14729, 14730), −)\n",
      "(T633, NCBITaxon, (14731, 14735), mice)\n",
      "(T634, CL, (14778, 14788), osteoboste)\n",
      "(T635, CL, (14793, 14803), osteoclast)\n",
      "(T636, PR_EXT, (14833, 14838), Sam68)\n",
      "(T637, SO_EXT, (14838, 14839), +)\n",
      "(T638, SO_EXT, (14840, 14841), +)\n",
      "(T639, NCBITaxon, (14842, 14846), mice)\n",
      "(T640, CL, (14918, 14928), osteoclast)\n",
      "(T641, CL, (14934, 14944), osteoblast)\n",
      "(T642, UBERON, (14976, 14979), tur)\n",
      "(T643, UBERON, (15039, 15044), bbone)\n",
      "(T644, UBERON_EXT, (15107, 15111), bone)\n",
      "(T645, UBERON, (15152, 15159), osteoid)\n",
      "(T646, UBERON, (15173, 15180), mineral)\n",
      "(T647, PR_EXT, (15250, 15255), Sam68)\n",
      "(T648, SO_EXT, (15255, 15256), +)\n",
      "(T649, SO_EXT, (15257, 15258), +)\n",
      "(T650, NCBITaxon, (15259, 15263), mice)\n",
      "(T651, PR_EXT, (15290, 15295), Sam68)\n",
      "(T652, SO_EXT, (15295, 15296), +)\n",
      "(T653, SO_EXT, (15297, 15298), +)\n",
      "(T654, NCBITaxon, (15299, 15303), mice)\n",
      "(T655, CHEBI_UBERON_EXT, (15376, 15379), fat)\n",
      "(T656, CL, (15413, 15424), osteoblasts)\n",
      "(T657, CL, (15438, 15449), osteoclasts)\n",
      "(T658, UBERON, (15463, 15469), tissue)\n",
      "(T659, PR_EXT, (15548, 15553), Sam6S)\n",
      "(T660, SO_EXT, (15553, 15554), −)\n",
      "(T661, SO_EXT, (15555, 15556), −)\n",
      "(T662, NCBITaxon, (15557, 15561), mice)\n",
      "(T663, CHEBI_UBERON_EXT, (15622, 15625), fat)\n",
      "(T664, NCBITaxon, (15652, 15656), mice)\n",
      "(T665, SO_EXT, (15667, 15675), genotype)\n",
      "(T666, CL_GO_EXT, (15692, 15697), cells)\n",
      "(T667, UBERON_EXT, (15734, 15738), bone)\n",
      "(T668, CHEBI, (15744, 15748), mete)\n",
      "(T669, CL, (15822, 15833), osteoblasts)\n",
      "(T670, CL, (15837, 15848), osteoclasts)\n",
      "(T671, NCBITaxon, (15878, 15882), mice)\n",
      "(T672, GO, (15895, 15906), Circulating)\n",
      "(T673, CHEBI, (15917, 15922), serum)\n",
      "(T674, CHEBI_SO_EXT, (15923, 15936), C-telopeptide)\n",
      "(T675, CHEBI, (15938, 15942), sCTX)\n",
      "(T676, PR_EXT, (16077, 16082), Sam68)\n",
      "(T677, SO_EXT, (16082, 16083), −)\n",
      "(T678, SO_EXT, (16084, 16085), −)\n",
      "(T679, NCBITaxon, (16086, 16090), mice)\n",
      "(T680, UBERON, (16109, 16114), Serum)\n",
      "(T681, CHEBI_EXT, (16115, 16123), estrogen)\n",
      "(T682, NCBITaxon, (16172, 16176), mice)\n",
      "(T683, SO_EXT, (16191, 16199), ggenotyp)\n",
      "(T684, PR_EXT, (16230, 16243), interleukin-6)\n",
      "(T685, CHEBI_PR_EXT, (16290, 16296), leptin)\n",
      "(T686, GO, (16300, 16310), regulating)\n",
      "(T687, UBERON_EXT, (16311, 16315), body)\n",
      "(T688, UBERON_EXT, (16320, 16324), bone)\n",
      "(T689, UBERON, (16331, 16336), serum)\n",
      "(T690, CHEBI_PR_EXT, (16337, 16343), leptin)\n",
      "(T691, PR_EXT, (16360, 16365), Sam68)\n",
      "(T692, SO_EXT, (16365, 16366), +)\n",
      "(T693, SO_EXT, (16367, 16368), +)\n",
      "(T694, PR_EXT, (16373, 16378), Sam68)\n",
      "(T695, SO_EXT, (16378, 16379), −)\n",
      "(T696, SO_EXT, (16380, 16381), −)\n",
      "(T697, NCBITaxon, (16382, 16386), mimi)\n",
      "(T698, PR_EXT, (16405, 16410), Sam68)\n",
      "(T699, SO_EXT, (16410, 16411), −)\n",
      "(T700, SO_EXT, (16412, 16413), −)\n",
      "(T701, NCBITaxon, (16414, 16418), mice)\n",
      "(T702, PR_EXT, (16469, 16474), Sam68)\n",
      "(T703, SO_EXT, (16474, 16475), +)\n",
      "(T704, SO_EXT, (16476, 16477), +)\n",
      "(T705, NCBITaxon, (16478, 16482), mice)\n",
      "(T706, PR_EXT, (16493, 16498), Sam68)\n",
      "(T707, SO_EXT, (16498, 16499), −)\n",
      "(T708, SO_EXT, (16500, 16501), −)\n",
      "(T709, NCBITaxon, (16502, 16506), mice)\n",
      "(T710, UBERON_EXT, (16587, 16591), bone)\n",
      "(T711, PR_EXT, (16604, 16609), Sam68)\n",
      "(T712, SO_EXT, (16609, 16610), −)\n",
      "(T713, SO_EXT, (16611, 16612), −)\n",
      "(T714, NCBITaxon, (16613, 16617), mice)\n",
      "(T715, CHEBI_EXT, (16651, 16659), estrogen)\n",
      "(T716, GO, (16716, 16727), circulating)\n",
      "(T717, CHEBI_PR_EXT, (16728, 16734), leptin)\n",
      "(T718, CL, (16744, 16754), Osteoblast)\n",
      "(T719, CL, (16764, 16768), Oste)\n",
      "(T720, GO, (16768, 16774), Osteoc)\n",
      "(T721, PR_EXT, (16799, 16804), Sam68)\n",
      "(T722, SO_EXT, (16804, 16805), −)\n",
      "(T723, SO_EXT, (16806, 16807), −)\n",
      "(T724, NCBITaxon, (16808, 16812), Mice)\n",
      "(T725, UBERON_EXT, (16837, 16841), bone)\n",
      "(T726, UBERON, (16858, 16863), adult)\n",
      "(T727, GO, (16864, 16880), remodeling cycle)\n",
      "(T728, CL, (16913, 16923), osteoblast)\n",
      "(T729, CL, (16927, 16937), osteoclast)\n",
      "(T730, UBERON, (16990, 16994), bone)\n",
      "(T731, PR_EXT, (17049, 17054), Sam68)\n",
      "(T732, SO_EXT, (17054, 17055), −)\n",
      "(T733, SO_EXT, (17056, 17057), −)\n",
      "(T734, NCBITaxon, (17058, 17062), mice)\n",
      "(T735, UBERON_EXT, (17079, 17083), bone)\n",
      "(T736, PR_EXT, (17137, 17142), Sam68)\n",
      "(T737, SO_EXT, (17142, 17143), −)\n",
      "(T738, SO_EXT, (17144, 17145), −)\n",
      "(T739, CL, (17146, 17157), osteobosteo)\n",
      "(T740, CL, (17162, 17173), osteoclasts)\n",
      "(T741, UBERON, (17214, 17225), bobone marr)\n",
      "(T742, CL, (17226, 17234), stromal )\n",
      "(T743, CL_GO_EXT, (17234, 17239), cells)\n",
      "(T744, PR_EXT, (17266, 17271), Sam68)\n",
      "(T745, SO_EXT, (17271, 17272), −)\n",
      "(T746, SO_EXT, (17273, 17274), −)\n",
      "(T747, NCBITaxon, (17275, 17279), mice)\n",
      "(T748, CL, (17310, 17320), osteoblast)\n",
      "(T749, GO, (17321, 17336), differentiation)\n",
      "(T750, PR_EXT, (17383, 17386), ALP)\n",
      "(T751, PR_EXT, (17491, 17496), Sam68)\n",
      "(T752, SO_EXT, (17496, 17497), +)\n",
      "(T753, SO_EXT, (17498, 17499), +)\n",
      "(T754, NCBITaxon, (17500, 17504), mice)\n",
      "(T755, CL, (17537, 17547), fibroblast)\n",
      "(T756, GO_EXT, (17625, 17627), RT)\n",
      "(T757, CHEBI_EXT, (17644, 17653), molecular)\n",
      "(T758, CHEBI_SO_EXT, (17654, 17661), markers)\n",
      "(T759, CL, (17665, 17675), osteoblast)\n",
      "(T760, GO, (17676, 17691), differentiation)\n",
      "(T761, CHEBI_SO_EXT, (17745, 17748), RNA)\n",
      "(T762, PR_EXT, (17754, 17759), Sam68)\n",
      "(T763, SO_EXT, (17759, 17760), +)\n",
      "(T764, SO_EXT, (17761, 17762), +)\n",
      "(T765, PR_EXT, (17767, 17772), Sam68)\n",
      "(T766, SO_EXT, (17772, 17773), −)\n",
      "(T767, SO_EXT, (17774, 17775), −)\n",
      "(T768, NCBITaxon, (17776, 17780), mice)\n",
      "(T769, CHEBI_PR_EXT, (17798, 17806), collagen)\n",
      "(T770, GO_EXT, (17822, 17834), up-regulated)\n",
      "(T771, PR_EXT, (17861, 17866), Sam68)\n",
      "(T772, SO_EXT, (17866, 17867), −)\n",
      "(T773, SO_EXT, (17868, 17869), −)\n",
      "(T774, NCBITaxon, (17870, 17874), mice)\n",
      "(T775, CL, (17906, 17917), osteoclasts)\n",
      "(T776, GO_EXT, (17918, 17926), rereleas)\n",
      "(T777, UBERON, (17944, 17954), long bones)\n",
      "(T778, PR_EXT, (17958, 17963), Sam68)\n",
      "(T779, SO_EXT, (17963, 17964), +)\n",
      "(T780, SO_EXT, (17965, 17966), +)\n",
      "(T781, PR_EXT, (17971, 17976), Sam68)\n",
      "(T782, SO_EXT, (17976, 17977), −)\n",
      "(T783, SO_EXT, (17978, 17979), −)\n",
      "(T784, NCBITaxon, (17980, 17984), mice)\n",
      "(T785, CHEBI, (18010, 18014), TRAP)\n",
      "(T786, CHEBI, (18123, 18131), electron)\n",
      "(T787, CL, (18188, 18199), osteoclasts)\n",
      "(T788, PR_EXT, (18233, 18238), Sam68)\n",
      "(T789, SO_EXT, (18238, 18239), −)\n",
      "(T790, SO_EXT, (18240, 18241), −)\n",
      "(T791, NCBITaxon, (18242, 18246), mice)\n",
      "(T792, PR_EXT, (18263, 18266), Src)\n",
      "(T793, SO_EXT, (18267, 18271), null)\n",
      "(T794, NCBITaxon, (18272, 18276), mice)\n",
      "(T795, PR_EXT, (18299, 18304), Sam68)\n",
      "(T796, CL, (18314, 18323), Adipocyte)\n",
      "(T797, GO, (18324, 18339), Differentiation)\n",
      "(T798, CL, (18353, 18363), Osteoblast)\n",
      "(T799, GO, (18364, 18379), DiffDifferentia)\n",
      "(T800, UBERON, (18408, 18419), bone marrow)\n",
      "(T801, CL, (18420, 18428), stromal )\n",
      "(T802, CL_GO_EXT, (18428, 18433), cellc)\n",
      "(T803, CL, (18452, 18463), osteoblasts)\n",
      "(T804, CL, (18468, 18478), adipocytes)\n",
      "(T805, UBERON_EXT, (18500, 18504), bone)\n",
      "(T806, GO, (18543, 18563), differentiation dnti)\n",
      "(T807, CL, (18568, 18577), adipocyte)\n",
      "(T808, PR_EXT, (18615, 18620), Sam68)\n",
      "(T809, UBERON, (18641, 18652), bone marrow)\n",
      "(T810, CL, (18653, 18661), stromal )\n",
      "(T811, CL_GO_EXT, (18661, 18666), cells)\n",
      "(T812, GO_RO_EXT, (18670, 18683), differentiate)\n",
      "(T813, GO, (18694, 18704), osteogenic)\n",
      "(T814, GO, (18716, 18734), adipogenic pathway)\n",
      "(T815, PR_EXT, (18763, 18768), Sam68)\n",
      "(T816, GO, (18786, 18794), regulate)\n",
      "(T817, UBERON_EXT, (18795, 18799), bone)\n",
      "(T818, CL, (18833, 18847), neuroendocrine)\n",
      "(T819, CHEBI_PR_EXT, (18874, 18880), leptin)\n",
      "(T820, UBERON, (18901, 18915), nervous system)\n",
      "(T821, GO_EXT, (18935, 18954), negativelnegatively)\n",
      "(T822, UBERON_EXT, (18955, 18959), bone)\n",
      "(T823, PR_EXT, (18992, 18997), Sam68)\n",
      "(T824, GO, (19005, 19015), regregulat)\n",
      "(T825, CL, (19019, 19028), adipocyte)\n",
      "(T826, GO, (19029, 19044), differentiation)\n",
      "(T827, PR_EXT, (19089, 19094), Sam68)\n",
      "(T828, SO_EXT, (19094, 19095), +)\n",
      "(T829, SO_EXT, (19096, 19097), +)\n",
      "(T830, PR_EXT, (19102, 19107), Sam68)\n",
      "(T831, SO_EXT, (19107, 19108), −)\n",
      "(T832, SO_EXT, (19109, 19110), −)\n",
      "(T833, UBERON, (19111, 19118), embryos)\n",
      "(T834, PR_EXT, (19132, 19137), Sam6S)\n",
      "(T835, SO_EXT, (19137, 19138), −)\n",
      "(T836, SO_EXT, (19139, 19140), −)\n",
      "(T837, CL, (19171, 19181), adipocytes)\n",
      "(T838, GO, (19248, 19260), adipogenesis)\n",
      "(T839, CL_GO_EXT, (19262, 19267), CeCel)\n",
      "(T840, GO, (19331, 19343), adipogenesis)\n",
      "(T841, GO, (19345, 19357), Adipogenesis)\n",
      "(T842, SO_EXT, (19385, 19394), wild-tywi)\n",
      "(T843, PR_EXT, (19421, 19426), Sam68)\n",
      "(T844, SO_EXT, (19426, 19427), −)\n",
      "(T845, SO_EXT, (19428, 19429), −)\n",
      "(T846, PR_EXT, (19484, 19489), Sam68)\n",
      "(T847, CL, (19493, 19502), adipocyte)\n",
      "(T848, GO, (19503, 19518), differentiation)\n",
      "(T849, GO, (19535, 19545), expression)\n",
      "(T850, GO_EXT, (19553, 19574), transcription factors)\n",
      "(T851, PR_EXT, (19589, 19594), PPARγ)\n",
      "(T852, PR_EXT, (19599, 19603), KLF5)\n",
      "(T853, PR_EXT, (19620, 19625), Sam68)\n",
      "(T854, SO_EXT, (19625, 19626), −)\n",
      "(T855, SO_EXT, (19627, 19628), −)\n",
      "(T856, PR_EXT, (19663, 19668), Sam68)\n",
      "(T857, SO_EXT, (19668, 19669), +)\n",
      "(T858, SO_EXT, (19670, 19671), +)\n",
      "(T859, GO, (19703, 19715), adipogeneadi)\n",
      "(T860, PR_EXT, (19734, 19739), Sam68)\n",
      "(T861, PR_EXT, (19814, 19819), Sam68)\n",
      "(T862, SO_EXT, (19819, 19820), −)\n",
      "(T863, SO_EXT, (19821, 19822), −)\n",
      "(T864, NCBITaxon, (19823, 19827), mice)\n",
      "(T865, PR_EXT, (19902, 19907), SaSam)\n",
      "(T866, GO, (19908, 19917), modulates)\n",
      "(T867, GO, (19922, 19941), differentiation of )\n",
      "(T868, CL, (19941, 19953), mesenchymal )\n",
      "(T869, CL_GO_EXT, (19953, 19958), cells)\n",
      "(T870, CL_GO_EXT, (20000, 20004), cell)\n",
      "(T871, UBERON_EXT, (20037, 20046), embryonic)\n",
      "(T872, UBERON, (20047, 20058), mesenchymal)\n",
      "(T873, CL, (20059, 20073), multipotential)\n",
      "(T874, CL_GO_EXT, (20085, 20090), cells)\n",
      "(T875, PR_EXT, (20118, 20123), BMP-2)\n",
      "(T876, GO, (20132, 20158), osteoblast differentiation)\n",
      "(T877, GO, (20214, 20224), expression)\n",
      "(T878, PR_EXT, (20232, 20243), osteocalcin)\n",
      "(T879, CL, (20245, 20248), OCN)\n",
      "(T880, SO_EXT, (20250, 20254), gene)\n",
      "(T881, CL_GO_EXT, (20286, 20291), cecel)\n",
      "(T882, GO, (20299, 20310), transfected)\n",
      "(T883, UBERON, (20383, 20388), irpin)\n",
      "(T884, PR_EXT, (20397, 20402), Sam68)\n",
      "(T885, CHEBI, (20432, 20441), puromycin)\n",
      "(T886, GO, (20447, 20457), expression)\n",
      "(T887, PR_EXT, (20461, 20466), Sam68)\n",
      "(T888, PR_EXT, (20542, 20549), β-β-act)\n",
      "(T889, GO, (20584, 20610), Osteoblast differentiatife)\n",
      "(T890, GO, (20635, 20645), expressing)\n",
      "(T891, PR_EXT, (20675, 20682), Sam68sh)\n",
      "(T892, PR_EXT, (20698, 20703), BMP-2)\n",
      "(T893, GO, (20733, 20743), expexpress)\n",
      "(T894, PR_EXT, (20755, 20762), β-actin)\n",
      "(T895, CHEBI_SO_EXT, (20763, 20768), mRNAs)\n",
      "(T896, GO_EXT, (20802, 20804), RT)\n",
      "(T897, PR_EXT, (20817, 20824), Sam68sh)\n",
      "(T898, GO, (20825, 20835), expressing)\n",
      "(T899, CL_GO_EXT, (20836, 20841), cells)\n",
      "(T900, CL, (20870, 20880), osteoblast)\n",
      "(T901, CL_GO_EXT, (20913, 20918), cells)\n",
      "(T902, GO, (20939, 20949), expression)\n",
      "(T903, GO_EXT, (21005, 21016), mineralized)\n",
      "(T904, GO, (21017, 21033), nodule formation)\n",
      "(T905, PR_EXT, (21037, 21042), Sam68)\n",
      "(T906, SO_EXT, (21042, 21043), −)\n",
      "(T907, SO_EXT, (21044, 21045), −)\n",
      "(T908, UBERON_EXT, (21046, 21050), bone)\n",
      "(T909, UBERON, (21056, 21057), b)\n",
      "(T910, CL, (21058, 21066), stromal )\n",
      "(T911, CL_GO_EXT, (21066, 21071), cells)\n",
      "(T912, GO, (21118, 21120), ha)\n",
      "(T913, UBERON, (21120, 21125), irpin)\n",
      "(T914, CHEBI_SO_EXT, (21126, 21129), RNA)\n",
      "(T915, CHEBI_SO_EXT, (21131, 21136), shRNA)\n",
      "(T916, UBERON_EXT, (21180, 21184), bone)\n",
      "(T917, NCBITaxon, (21210, 21214), mice)\n",
      "(T918, UBERON_EXT, (21301, 21305), bone)\n",
      "(T919, PR_EXT, (21331, 21336), Sam68)\n",
      "(T920, SO_EXT, (21336, 21337), +)\n",
      "(T921, SO_EXT, (21338, 21339), +)\n",
      "(T922, PR_EXT, (21344, 21349), Sam68)\n",
      "(T923, SO_EXT, (21349, 21350), −)\n",
      "(T924, SO_EXT, (21351, 21352), −)\n",
      "(T925, NCBITaxon, (21353, 21357), mice)\n",
      "(T926, UBERON, (21420, 21426), tissue)\n",
      "(T927, CL, (21457, 21467), adipocytes)\n",
      "(T928, CHEBI_EXT, (21514, 21526), fluorochrome)\n",
      "(T929, CHEBI_SO_EXT, (21527, 21535), labeling)\n",
      "(T930, PR_EXT, (21595, 21600), Sam68)\n",
      "(T931, SO_EXT, (21600, 21601), +)\n",
      "(T932, SO_EXT, (21602, 21603), +)\n",
      "(T933, NCBITaxon, (21604, 21608), mice)\n",
      "(T934, UBERON, (21641, 21656), trabecular bone)\n",
      "(T935, CHEBI_EXT, (21768, 21780), fluorochrome)\n",
      "(T936, CHEBI_SO_EXT, (21781, 21787), labels)\n",
      "(T937, UBERON_EXT, (21848, 21853), bones)\n",
      "(T938, PR_EXT, (21870, 21875), Sam68)\n",
      "(T939, SO_EXT, (21875, 21876), −)\n",
      "(T940, SO_EXT, (21877, 21878), −)\n",
      "(T941, NCBITaxon, (21879, 21883), mice)\n",
      "(T942, NCBITaxon, (21929, 21933), mice)\n",
      "(T943, SO_EXT, (21944, 21952), genotype)\n",
      "(T944, PR_EXT, (21982, 21987), Sam68)\n",
      "(T945, GO, (21988, 21997), regulates)\n",
      "(T946, GO, (22002, 22021), differentiatioerent)\n",
      "(T947, UBERON, (22021, 22032), bone marrow)\n",
      "(T948, CL, (22033, 22045), mesenchymal )\n",
      "(T949, CL_GO_EXT, (22045, 22050), cells)\n",
      "(T950, CL, (22062, 22071), adipocyte)\n",
      "(T951, GO, (22072, 22087), differene diffe)\n",
      "(T952, GO, (22100, 22140), osteoblast differentiation in aging bone)\n",
      "(T953, GO_PATO_EXT, (22198, 22209), physiologip)\n",
      "(T954, PR_EXT, (22218, 22223), Sam68)\n",
      "(T955, GO, (22230, 22251), modulate bone marrow )\n",
      "(T956, CL, (22251, 22268), mesenchymal stem )\n",
      "(T957, CL_GO_EXT, (22268, 22273), cellc)\n",
      "(T958, PR_EXT, (22281, 22286), Sam68)\n",
      "(T959, SO_EXT, (22286, 22287), −)\n",
      "(T960, SO_EXT, (22288, 22289), −)\n",
      "(T961, NCBITaxon, (22290, 22294), mice)\n",
      "(T962, UBERON_EXT, (22336, 22340), bone)\n",
      "(T963, SO_EXT, (22360, 22369), wild-type)\n",
      "(T964, PR_EXT, (22400, 22405), Sam68)\n",
      "(T965, SO_EXT, (22405, 22406), −)\n",
      "(T966, SO_EXT, (22407, 22408), −)\n",
      "(T967, NCBITaxon, (22409, 22413), mice)\n",
      "(T968, UBERON_EXT, (22431, 22435), bone)\n",
      "(T969, PR_EXT, (22465, 22470), Sam68)\n",
      "(T970, SO_EXT, (22470, 22471), +)\n",
      "(T971, SO_EXT, (22472, 22473), +)\n",
      "(T972, SO_EXT, (22491, 22500), wild-type)\n",
      "(T973, UBERON_EXT, (22535, 22539), bone)\n",
      "(T974, NCBITaxon, (22570, 22577), mammals)\n",
      "(T975, PR_EXT, (22589, 22594), SamSa)\n",
      "(T976, SO_EXT, (22594, 22595), −)\n",
      "(T977, SO_EXT, (22596, 22597), −)\n",
      "(T978, NCBITaxon, (22598, 22605), animals)\n",
      "(T979, UBERON_EXT, (22622, 22626), bone)\n",
      "(T980, GO, (22637, 22642), aging)\n",
      "(T981, GO, (22648, 22667), differene different)\n",
      "(T982, UBERON, (22667, 22678), bone marrow)\n",
      "(T983, CL, (22679, 22684), stem )\n",
      "(T984, CL_GO_EXT, (22684, 22689), cells)\n",
      "(T985, PR_EXT, (22704, 22709), Sam68)\n",
      "(T986, SO_EXT, (22709, 22710), −)\n",
      "(T987, SO_EXT, (22711, 22712), −)\n",
      "(T988, NCBITaxon, (22713, 22717), mice)\n",
      "(T989, UBERON, (22722, 22743), embryonic mesenchymal)\n",
      "(T990, CL_GO_EXT, (22770, 22775), cells)\n",
      "(T991, PR_EXT, (22799, 22804), Sam68)\n",
      "(T992, SO_EXT, (22805, 22810), shRNA)\n",
      "(T993, CL, (22841, 22851), osteoblost)\n",
      "(T994, GO, (22852, 22867), differentiation)\n",
      "(T995, PR_EXT, (22913, 22918), Sam68)\n",
      "(T996, GO, (22928, 22954), osteoblast differentiation)\n",
      "(T997, PR_EXT, (23006, 23011), Sam68)\n",
      "(T998, SO_EXT, (23011, 23012), −)\n",
      "(T999, SO_EXT, (23013, 23014), −)\n",
      "(T1000, NCBITaxon, (23015, 23022), animals)\n",
      "(T1001, GO, (23065, 23090), adipocyte differentiation)\n",
      "(T1002, PR_EXT, (23105, 23110), Sam68)\n",
      "(T1003, SO_EXT, (23110, 23111), +)\n",
      "(T1004, SO_EXT, (23112, 23113), +)\n",
      "(T1005, GO_PATO_EXT, (23150, 23161), physiologic)\n",
      "(T1006, PR_EXT, (23171, 23176), Sam68)\n",
      "(T1007, GO, (23183, 23191), regulate)\n",
      "(T1008, GO, (23212, 23261), adipogenic and osteoosteogenic differentiation of)\n",
      "(T1009, UBERON, (23261, 23284), bone marrow mesenchymal)\n",
      "(T1010, PR_EXT, (23287, 23292), Sam68)\n",
      "(T1011, CHEBI_PR_EXT, (23293, 23300), proprot)\n",
      "(T1012, GO, (23301, 23311), expression)\n",
      "(T1013, NCBITaxon, (23351, 23356), mouse)\n",
      "(T1014, UBERON, (23357, 23363), embemb)\n",
      "(T1015, PR_EXT, (23418, 23423), Sam68)\n",
      "(T1016, CHEBI_SO_EXT, (23424, 23428), mRNA)\n",
      "(T1017, GO, (23442, 23451), expressed)\n",
      "(T1018, PR_EXT, (23469, 23474), Sam68)\n",
      "(T1019, UBERON, (23491, 23496), brain)\n",
      "(T1020, UBERON, (23498, 23503), heart)\n",
      "(T1021, UBERON, (23509, 23518), intestine)\n",
      "(T1022, UBERON, (23545, 23550), liver)\n",
      "(T1023, UBERON_EXT, (23552, 23556), skin)\n",
      "(T1024, UBERON, (23562, 23568), kidney)\n",
      "(T1025, GO, (23591, 23601), late-stage)\n",
      "(T1026, UBERON, (23602, 23609), embryos)\n",
      "(T1027, GO, (23616, 23626), expression)\n",
      "(T1028, PR_EXT, (23686, 23691), Sam68)\n",
      "(T1029, CL, (23695, 23702), neurons)\n",
      "(T1030, UBERON, (23734, 23744), intestinal)\n",
      "(T1031, CL, (23745, 23755), SIK/breast)\n",
      "(T1032, GO_EXT, (23762, 23768), kinase)\n",
      "(T1033, GO, (23779, 23789), expression)\n",
      "(T1034, PR_EXT, (23793, 23798), Sam68)\n",
      "(T1035, GO, (23818, 23823), aging)\n",
      "(T1036, UBERON, (23824, 23835), bone marrow)\n",
      "(T1037, CL, (23836, 23844), stromal )\n",
      "(T1038, CL_GO_EXT, (23844, 23849), cells)\n",
      "(T1039, CL, (23869, 23872), WI-)\n",
      "(T1040, CL_GO_EXT, (23875, 23880), cells)\n",
      "(T1041, PR_EXT, (23917, 23922), Sam68)\n",
      "(T1042, CL, (23926, 23938), chondrocytch)\n",
      "(T1043, CL, (23940, 23951), osteoblasts)\n",
      "(T1044, CL, (23956, 23967), osteoclasts)\n",
      "(T1045, UBERON_EXT, (23982, 23991), cartilage)\n",
      "(T1046, UBERON_EXT, (23996, 24000), bone)\n",
      "(T1047, CHEBI_PR_EXT, (24034, 24041), protein)\n",
      "(T1048, GO, (24045, 24065), skeletal developmend)\n",
      "(T1049, PR_EXT, (24072, 24077), Sam68)\n",
      "(T1050, SO_EXT, (24077, 24078), −)\n",
      "(T1051, SO_EXT, (24079, 24080), −)\n",
      "(T1052, NCBITaxon, (24081, 24085), mice)\n",
      "(T1053, SO_EXT, (24164, 24170), domain)\n",
      "(T1054, SO_EXT, (24175, 24182), deleted)\n",
      "(T1055, PR_EXT, (24218, 24223), Sam68)\n",
      "(T1056, SO_EXT, (24223, 24224), −)\n",
      "(T1057, SO_EXT, (24225, 24226), −)\n",
      "(T1058, NCBITaxon, (24227, 24231), mice)\n",
      "(T1059, UBERON, (24244, 24253), adulthood)\n",
      "(T1060, PR_EXT, (24324, 24329), Sam68)\n",
      "(T1061, PR_EXT, (24417, 24422), SLM-1)\n",
      "(T1062, PR_EXT, (24427, 24432), SLM-2)\n",
      "(T1063, PR_EXT, (24454, 24459), Sam68)\n",
      "(T1064, GO, (24483, 24504), embryonic development)\n",
      "(T1065, PR_EXT, (24533, 24538), Sam68)\n",
      "(T1066, SO_EXT, (24538, 24539), −)\n",
      "(T1067, SO_EXT, (24540, 24541), −)\n",
      "(T1068, PR_EXT, (24555, 24560), Sam68)\n",
      "(T1069, SO_EXT, (24560, 24561), +)\n",
      "(T1070, SO_EXT, (24562, 24563), -)\n",
      "(T1071, NCBITaxon_UBERON_EXT, (24564, 24568), pups)\n",
      "(T1072, PR_EXT, (24591, 24596), Sam68)\n",
      "(T1073, SO_EXT, (24596, 24597), +)\n",
      "(T1074, SO_EXT, (24598, 24599), -)\n",
      "(T1075, PR_EXT, (24717, 24722), Sam68)\n",
      "(T1076, SO_EXT, (24722, 24723), −)\n",
      "(T1077, SO_EXT, (24724, 24725), −)\n",
      "(T1078, NCBITaxon, (24726, 24730), mice)\n",
      "(T1079, UBERON, (24745, 24754), life span)\n",
      "(T1080, PR_EXT, (24787, 24792), Sam68)\n",
      "(T1081, SO_EXT, (24792, 24793), −)\n",
      "(T1082, SO_EXT, (24794, 24795), −)\n",
      "(T1083, PATO_UBERON_EXT, (24796, 24801), males)\n",
      "(T1084, PR_EXT, (24823, 24828), Sam68)\n",
      "(T1085, SO_EXT, (24828, 24829), −)\n",
      "(T1086, SO_EXT, (24830, 24831), −)\n",
      "(T1087, PATO_UBERON_EXT, (24832, 24839), females)\n",
      "(T1088, NCBITaxon_UBERON_EXT, (24889, 24893), pups)\n",
      "(T1089, PR_EXT, (24944, 24948), FosB)\n",
      "(T1090, SO_EXT, (24948, 24949), −)\n",
      "(T1091, SO_EXT, (24950, 24951), −)\n",
      "(T1092, NCBITaxon, (24952, 24956), mice)\n",
      "(T1093, UBERON, (24963, 24968), Serum)\n",
      "(T1094, CHEBI_EXT, (24979, 24987), estrogen)\n",
      "(T1095, GO, (25001, 25006), aging)\n",
      "(T1096, PR_EXT, (25007, 25012), Sam68)\n",
      "(T1097, SO_EXT, (25012, 25013), −)\n",
      "(T1098, SO_EXT, (25014, 25015), −)\n",
      "(T1099, PATO_UBERON_EXT, (25016, 25023), females)\n",
      "(T1100, CHEBI_PR_EXT, (25050, 25056), leptin)\n",
      "(T1101, GO_PATO_EXT, (25077, 25081), aged)\n",
      "(T1102, PR_EXT, (25082, 25087), Sam68)\n",
      "(T1103, SO_EXT, (25087, 25088), −)\n",
      "(T1104, SO_EXT, (25089, 25090), −)\n",
      "(T1105, PATO_UBERON_EXT, (25091, 25098), females)\n",
      "(T1106, GO_PATO_EXT, (25104, 25108), aged)\n",
      "(T1107, PR_EXT, (25109, 25114), Sam68)\n",
      "(T1108, SO_EXT, (25114, 25115), −)\n",
      "(T1109, SO_EXT, (25116, 25117), −)\n",
      "(T1110, PATO_UBERON_EXT, (25118, 25125), females)\n",
      "(T1111, GO, (25257, 25262), aging)\n",
      "(T1112, CHEBI_PR_EXT, (25338, 25344), leptin)\n",
      "(T1113, GO, (25415, 25423), appetite)\n",
      "(T1114, PATO_UBERON_EXT, (25428, 25434), female)\n",
      "(T1115, UBERON_EXT, (25456, 25464), skeletal)\n",
      "(T1116, PR_EXT, (25491, 25496), Sam68)\n",
      "(T1117, SO_EXT, (25496, 25497), +)\n",
      "(T1118, SO_EXT, (25498, 25499), +)\n",
      "(T1119, PR_EXT, (25504, 25509), Sam68)\n",
      "(T1120, SO_EXT, (25509, 25510), −)\n",
      "(T1121, SO_EXT, (25511, 25512), −)\n",
      "(T1122, NCBITaxon, (25513, 25517), mice)\n",
      "(T1123, UBERON_EXT, (25530, 25534), bone)\n",
      "(T1124, GO_PATO_EXT, (25557, 25561), aged)\n",
      "(T1125, PR_EXT, (25562, 25567), Sam68)\n",
      "(T1126, SO_EXT, (25567, 25568), −)\n",
      "(T1127, SO_EXT, (25569, 25570), −)\n",
      "(T1128, NCBITaxon, (25571, 25575), mice)\n",
      "(T1129, CL, (25674, 25684), osteoblast)\n",
      "(T1130, CL, (25689, 25699), osteoclast)\n",
      "(T1131, PR_EXT, (25737, 25742), Sam68)\n",
      "(T1132, GO, (25743, 25753), regulatory)\n",
      "(T1133, CHEBI_PR_EXT, (25754, 25761), protein)\n",
      "(T1134, PR_EXT, (25763, 25766), Src)\n",
      "(T1135, GO, (25771, 25784), osteopetrosis)\n",
      "(T1136, PR_EXT, (25838, 25843), Sam68)\n",
      "(T1137, SO_EXT, (25843, 25844), −)\n",
      "(T1138, SO_EXT, (25845, 25846), −)\n",
      "(T1139, CL, (25847, 25858), osteoclasos)\n",
      "(T1140, PR_EXT, (25872, 25875), Src)\n",
      "(T1141, CHEBI_SO_EXT, (25876, 25884), tyrosine)\n",
      "(T1142, GO_EXT, (25885, 25891), kinase)\n",
      "(T1143, GO, (25920, 25935), bone remodeling)\n",
      "(T1144, PR_EXT, (25941, 25944), Src)\n",
      "(T1145, SO_EXT, (25944, 25945), −)\n",
      "(T1146, SO_EXT, (25946, 25947), −)\n",
      "(T1147, NCBITaxon, (25948, 25952), mice)\n",
      "(T1148, GO, (25953, 25957), died)\n",
      "(T1149, CL, (25985, 25998), osteopetrotic)\n",
      "(T1150, CL, (26057, 26067), osteoclast)\n",
      "(T1151, CL, (26115, 26126), osteoclasts)\n",
      "(T1152, PR_EXT, (26142, 26147), Sam68)\n",
      "(T1153, SO_EXT, (26147, 26148), +)\n",
      "(T1154, SO_EXT, (26149, 26150), +)\n",
      "(T1155, PR_EXT, (26155, 26160), Sam68)\n",
      "(T1156, SO_EXT, (26160, 26161), −)\n",
      "(T1157, SO_EXT, (26162, 26163), −)\n",
      "(T1158, NCBITaxon, (26164, 26168), mice)\n",
      "(T1159, PR_EXT, (26247, 26252), Sam68)\n",
      "(T1160, SO_EXT, (26252, 26253), −)\n",
      "(T1161, SO_EXT, (26254, 26255), −)\n",
      "(T1162, CL, (26256, 26267), osteoclasts)\n",
      "(T1163, PR_EXT, (26290, 26295), Sam68)\n",
      "(T1164, SO_EXT, (26295, 26296), +)\n",
      "(T1165, SO_EXT, (26297, 26298), +)\n",
      "(T1166, CL, (26299, 26310), osteoosteoc)\n",
      "(T1167, UBERON_EXT, (26402, 26406), bone)\n",
      "(T1168, GO, (26407, 26417), metabolism)\n",
      "(T1169, PR_EXT, (26434, 26439), Sam68)\n",
      "(T1170, SO_EXT, (26439, 26440), −)\n",
      "(T1171, SO_EXT, (26441, 26442), −)\n",
      "(T1172, NCBITaxon, (26443, 26447), mice)\n",
      "(T1173, CHEBI, (26467, 26470), CTX)\n",
      "(T1174, PR_EXT, (26506, 26511), Sam68)\n",
      "(T1175, SO_EXT, (26511, 26512), −)\n",
      "(T1176, SO_EXT, (26513, 26514), −)\n",
      "(T1177, NCBITaxon, (26515, 26519), mice)\n",
      "(T1178, GO, (26552, 26567), bone resresorpt)\n",
      "(T1179, SO_EXT, (26582, 26591), wild-type)\n",
      "(T1180, UBERON_EXT, (26640, 26644), bone)\n",
      "(T1181, GO, (26645, 26655), resorption)\n",
      "(T1182, CL, (26677, 26687), osteoclast)\n",
      "(T1183, PR_EXT, (26776, 26781), Sam68)\n",
      "(T1184, SO_EXT, (26781, 26782), −)\n",
      "(T1185, SO_EXT, (26783, 26784), −)\n",
      "(T1186, NCBITaxon, (26785, 26789), mice)\n",
      "(T1187, UBERON, (26810, 26814), bone)\n",
      "(T1188, PR_EXT, (26883, 26888), Sam68)\n",
      "(T1189, SO_EXT, (26888, 26889), −)\n",
      "(T1190, SO_EXT, (26890, 26891), −)\n",
      "(T1191, NCBITaxon, (26892, 26896), mice)\n",
      "(T1192, GO, (26897, 26907), osteoclast)\n",
      "(T1193, UBERON, (26946, 26950), life)\n",
      "(T1194, UBERON_EXT, (26978, 26982), bone)\n",
      "(T1195, GO_RO_EXT, (27051, 27055), tion)\n",
      "(T1196, UBERON, (27067, 27078), bone mary b)\n",
      "(T1197, CL, (27079, 27087), stromal )\n",
      "(T1198, CL_GO_EXT, (27087, 27092), cells)\n",
      "(T1199, PR_EXT, (27109, 27114), Sam68)\n",
      "(T1200, SO_EXT, (27114, 27115), +)\n",
      "(T1201, SO_EXT, (27116, 27117), +)\n",
      "(T1202, PR_EXT, (27122, 27127), Sam68)\n",
      "(T1203, SO_EXT, (27127, 27128), −)\n",
      "(T1204, SO_EXT, (27129, 27130), −)\n",
      "(T1205, NCBITaxon, (27131, 27135), mice)\n",
      "(T1206, CL, (27146, 27156), osteoblast)\n",
      "(T1207, CHEBI_EXT, (27182, 27187), genic)\n",
      "(T1208, CL_GO_EXT, (27217, 27222), cells)\n",
      "(T1209, PR_EXT, (27240, 27245), Sam68)\n",
      "(T1210, SO_EXT, (27245, 27246), −)\n",
      "(T1211, SO_EXT, (27247, 27248), −)\n",
      "(T1212, NCBITaxon, (27249, 27253), mice)\n",
      "(T1213, UBERON, (27339, 27350), bone marrow)\n",
      "(T1214, CL, (27351, 27359), stromal )\n",
      "(T1215, CL_GO_EXT, (27359, 27364), cells)\n",
      "(T1216, GO_PATO_EXT, (27370, 27374), aged)\n",
      "(T1217, PR_EXT, (27375, 27380), Sam68)\n",
      "(T1218, SO_EXT, (27380, 27381), −)\n",
      "(T1219, SO_EXT, (27382, 27383), −)\n",
      "(T1220, NCBITaxon, (27384, 27388), mice)\n",
      "(T1221, UBERON, (27426, 27456), embryonic mesenchymal multipot)\n",
      "(T1222, CL_GO_EXT, (27474, 27479), cells)\n",
      "(T1223, PR_EXT, (27503, 27508), Sam68)\n",
      "(T1224, CHEBI_SO_EXT, (27509, 27514), shRNA)\n",
      "(T1225, CL, (27541, 27552), osteoblasts)\n",
      "(T1226, PR_EXT, (27558, 27562), BMP2)\n",
      "(T1227, GO_PATO_EXT, (27582, 27586), agag)\n",
      "(T1228, PR_EXT, (27587, 27592), Sam68)\n",
      "(T1229, SO_EXT, (27592, 27593), −)\n",
      "(T1230, SO_EXT, (27594, 27595), −)\n",
      "(T1231, NCBITaxon, (27596, 27600), mice)\n",
      "(T1232, PR_EXT, (27661, 27666), Sam68)\n",
      "(T1233, SO_EXT, (27667, 27668), −)\n",
      "(T1234, SO_EXT, (27669, 27670), −)\n",
      "(T1235, NCBITaxon, (27671, 27675), mice)\n",
      "(T1236, CL, (27690, 27699), adipocyte)\n",
      "(T1237, GO, (27700, 27715), differentiatffe)\n",
      "(T1238, PR_EXT, (27731, 27736), Sam68)\n",
      "(T1239, GO, (27737, 27746), regulates)\n",
      "(T1240, CL, (27752, 27761), adipocyte)\n",
      "(T1241, CL, (27766, 27776), osteoblast)\n",
      "(T1242, GO, (27776, 27792), osteoblast diffe)\n",
      "(T1243, PR_EXT, (27818, 27823), Sam68)\n",
      "(T1244, CHEBI_SO_EXT, (27837, 27840), RNA)\n",
      "(T1245, CHEMINF_GO_EXT, (27841, 27848), binding)\n",
      "(T1246, CHEBI_PR_EXT, (27849, 27856), protein)\n",
      "(T1247, GO, (27860, 27868), regulate)\n",
      "(T1248, CL, (27869, 27881), mesenchymal )\n",
      "(T1249, GO, (27881, 27901), cell differentiation)\n",
      "(T1250, CHEBI_SO_EXT, (27953, 27956), RNA)\n",
      "(T1251, GO, (27973, 27982), regulates)\n",
      "(T1252, CL, (28018, 28028), osteoblast)\n",
      "(T1253, PR_EXT, (28052, 28055), Src)\n",
      "(T1254, SO_EXT, (28055, 28056), −)\n",
      "(T1255, SO_EXT, (28057, 28058), −)\n",
      "(T1256, NCBITaxon, (28059, 28063), mice)\n",
      "(T1257, UBERON_EXT, (28116, 28120), bone)\n",
      "(T1258, PR_EXT, (28133, 28138), Sam68)\n",
      "(T1259, SO_EXT, (28138, 28139), −)\n",
      "(T1260, SO_EXT, (28140, 28141), −)\n",
      "(T1261, NCBITaxon, (28142, 28146), mice)\n",
      "(T1262, GO, (28172, 28181), regulated)\n",
      "(T1263, PR_EXT, (28185, 28188), Src)\n",
      "(T1264, GO, (28212, 28228), leptin regulregu)\n",
      "(T1265, GO, (28229, 28244), bone resorption)\n",
      "(T1266, UBERON, (28287, 28301), nnervous syste)\n",
      "(T1267, CL, (28318, 28329), osteoblasts)\n",
      "(T1268, GO, (28338, 28352), β-adrenergic p)\n",
      "(T1269, GO_EXT, (28374, 28381), release)\n",
      "(T1270, GO_EXT, (28385, 28399), growth factors)\n",
      "(T1271, GO_EXT, (28410, 28415), RANKL)\n",
      "(T1272, CL, (28434, 28443), teoclasts)\n",
      "(T1273, CHEBI_PR_EXT, (28481, 28487), leptin)\n",
      "(T1274, GO_PATO_EXT, (28498, 28502), aged)\n",
      "(T1275, PR_EXT, (28503, 28508), Sam68)\n",
      "(T1276, SO_EXT, (28508, 28509), −)\n",
      "(T1277, SO_EXT, (28510, 28511), −)\n",
      "(T1278, NCBITaxon, (28512, 28516), mice)\n",
      "(T1279, NCBITaxon, (28542, 28546), mimi)\n",
      "(T1280, UBERON_EXT, (28561, 28565), bone)\n",
      "(T1281, GO_PATO_EXT, (28591, 28595), aged)\n",
      "(T1282, CHEBI_PR_EXT, (28643, 28649), leptin)\n",
      "(T1283, PR_EXT, (28686, 28691), Sam68)\n",
      "(T1284, SO_EXT, (28691, 28692), −)\n",
      "(T1285, SO_EXT, (28693, 28694), −)\n",
      "(T1286, NCBITaxon, (28695, 28699), mice)\n",
      "(T1287, CHEBI_PR_EXT, (28725, 28731), leptin)\n",
      "(T1288, CHEBI, (28764, 28767), CTX)\n",
      "(T1289, UBERON, (28775, 28780), serum)\n",
      "(T1290, PR_EXT, (28784, 28789), Sam68)\n",
      "(T1291, SO_EXT, (28789, 28790), −)\n",
      "(T1292, SO_EXT, (28791, 28792), −)\n",
      "(T1293, NCBITaxon, (28793, 28797), mice)\n",
      "(T1294, PR_EXT, (28827, 28832), Sam68)\n",
      "(T1295, GO, (28840, 28850), regulating)\n",
      "(T1296, GO, (28851, 28866), bone metabolime)\n",
      "(T1297, PR_EXT, (28911, 28916), Sam68)\n",
      "(T1298, CHEBI_PR_EXT, (28934, 28940), leptin)\n",
      "(T1299, GO, (28964, 28979), bone resorption)\n",
      "(T1300, UBERON, (29000, 29014), nervous system)\n",
      "(T1301, PR_EXT, (29038, 29043), Sam68)\n",
      "(T1302, CL, (29051, 29061), osteoosteo)\n",
      "(T1303, CL, (29075, 29084), adipocyte)\n",
      "(T1304, GO, (29086, 29101), differentiation)\n",
      "(T1305, GO_PATO_EXT, (29137, 29148), physiologic)\n",
      "(T1306, PR_EXT, (29158, 29163), Sam68)\n",
      "(T1307, UBERON_EXT, (29167, 29171), bone)\n",
      "(T1308, GO, (29172, 29182), metabolism)\n",
      "(T1309, GO, (29184, 29198), tabolism and b)\n",
      "(T1310, CL, (29199, 29216), mesenchymal stem )\n",
      "(T1311, GO, (29216, 29236), cell differentiation)\n",
      "(T1312, UBERON_EXT, (29242, 29246), bone)\n",
      "(T1313, PR_EXT, (29269, 29274), Sam68)\n",
      "(T1314, SO_EXT, (29274, 29275), −)\n",
      "(T1315, SO_EXT, (29276, 29277), −)\n",
      "(T1316, NCBITaxon, (29278, 29282), mice)\n",
      "(T1317, CHEBI_EXT, (29294, 29304), inhibitors)\n",
      "(T1318, PR_EXT, (29308, 29313), Sam6S)\n",
      "(T1319, UBERON_EXT, (29340, 29344), bone)\n",
      "(T1320, PR_EXT, (29394, 29399), Sam68)\n",
      "(T1321, GO, (29400, 29410), expression)\n",
      "(T1322, SO_EXT, (29437, 29446), mutmutati)\n",
      "(T1323, NCBITaxon, (29450, 29456), humans)\n",
      "(T1324, CL, (29496, 29505), adipocyta)\n",
      "(T1325, GO, (29523, 29535), osteoporosis)\n",
      "(T1326, NCBITaxon, (29570, 29576), animal)\n",
      "(T1327, GO, (29592, 29602), aging bone)\n",
      "(T1328, UBERON, (29781, 29790), embryonic)\n",
      "(T1329, NCBITaxon, (29791, 29795), mice)\n",
      "(T1330, GO, (29820, 29828), pregpreg)\n",
      "(T1331, CHEBI_EXT, (29885, 29901), parparaformaldeh)\n",
      "(T1332, PR_EXT, (30142, 30147), SaSam)\n",
      "(T1333, GO, (30148, 30156), antibody)\n",
      "(T1334, CHEBI, (30193, 30199), methyl)\n",
      "(T1335, CHEBI, (30209, 30220), hematoxylin)\n",
      "(T1336, UBERON, (30223, 30228), Adult)\n",
      "(T1337, NCBITaxon, (30229, 30233), mice)\n",
      "(T1338, UBERON, (30253, 30263), peritoneal)\n",
      "(T1339, CHEBI, (30317, 30329), tetracycline)\n",
      "(T1340, GO_EXT, (30349, 30358), sacrifice)\n",
      "(T1341, CHEBI_SO_EXT, (30362, 30367), label)\n",
      "(T1342, GO, (30390, 30398), surfaces)\n",
      "(T1343, CHEBI_EXT, (30431, 30447), paraformaldehyde)\n",
      "(T1344, UBERON, (30472, 30482), left femur)\n",
      "(T1345, UBERON, (30487, 30492), tibia)\n",
      "(T1346, CHEBI_EXT, (30510, 30518), polymeth)\n",
      "(T1347, GO_MOP_EXT, (30518, 30528), ylmethacry)\n",
      "(T1348, UBERON, (30528, 30532), late)\n",
      "(T1349, CHEBI, (30544, 30551), mixture)\n",
      "(T1350, CHEBI, (30571, 30589), glycolmethacrylate)\n",
      "(T1351, UBERON, (30640, 30647), tissues)\n",
      "(T1352, PR_EXT, (30788, 30792), TRAP)\n",
      "(T1353, PR_EXT, (30797, 30800), ALP)\n",
      "(T1354, GO, (30971, 30976), prima)\n",
      "(T1355, GO_EXT, (31178, 31189), recommended)\n",
      "(T1356, NCBITaxon, (31265, 31269), mice)\n",
      "(T1357, PR_EXT, (31302, 31307), sam68)\n",
      "(T1358, SO_EXT, (31308, 31312), gene)\n",
      "(T1359, SO_EXT, (31323, 31338), eriophage clone)\n",
      "(T1360, PR_EXT, (31352, 31357), Sam68)\n",
      "(T1361, SO_EXT, (31358, 31363), exexo)\n",
      "(T1362, SO_EXT, (31399, 31406), genomic)\n",
      "(T1363, PR_EXT, (31433, 31438), Sam68)\n",
      "(T1364, SO_EXT, (31439, 31443), cDNA)\n",
      "(T1365, CHEBI_SO_EXT, (31449, 31454), probe)\n",
      "(T1366, SO_EXT, (31476, 31484), genomic )\n",
      "(T1367, CHEBI_SO_EXT, (31484, 31487), DNA)\n",
      "(T1368, CHEBI_SO_EXT, (31504, 31505), b)\n",
      "(T1369, SO_EXT, (31520, 31524), exon)\n",
      "(T1370, SO_EXT, (31531, 31543), part of exon)\n",
      "(T1371, CHEBI_SO_EXT, (31553, 31554), b)\n",
      "(T1372, SO_EXT, (31563, 31577), g part of exon)\n",
      "(T1373, SO_EXT, (31584, 31588), exon)\n",
      "(T1374, GO_EXT, (31621, 31623), SK)\n",
      "(T1375, CHEBI_SO_EXT, (31668, 31671), DNA)\n",
      "(T1376, CHEBI_SO_EXT, (31724, 31740), oligonucleotides)\n",
      "(T1377, SO_EXT, (31805, 31811), pripri)\n",
      "(T1378, CHEBI_SO_EXT, (31834, 31835), b)\n",
      "(T1379, CHEBI_SO_EXT, (31836, 31839), DNA)\n",
      "(T1380, CHEBI_SO_EXT, (31971, 31972), b)\n",
      "(T1381, SO_EXT, (32182, 32198), targeting target)\n",
      "(T1382, SO_EXT, (32210, 32218), replaces)\n",
      "(T1383, SO_EXT, (32219, 32223), exon)\n",
      "(T1384, SO_EXT, (32230, 32242), part of exon)\n",
      "(T1385, CHEBI, (32252, 32260), neomneom)\n",
      "(T1386, SO_EXT, (32271, 32275), gene)\n",
      "(T1387, SO_EXT, (32276, 32284), cassette)\n",
      "(T1388, CHEBI_SO_EXT, (32338, 32343), b DNA)\n",
      "(T1389, SO_EXT, (32373, 32378), arize)\n",
      "(T1390, SO_EXT, (32383, 32390), pplasmi)\n",
      "(T1391, CL, (32416, 32436), embryonic stem (ES) )\n",
      "(T1392, CL_GO_EXT, (32436, 32441), cells)\n",
      "(T1393, CL, (32463, 32465), ES)\n",
      "(T1394, SO_EXT, (32497, 32503), clones)\n",
      "(T1395, PR_EXT, (32539, 32544), Sam68)\n",
      "(T1396, SO_EXT, (32545, 32551), mutant)\n",
      "(T1397, SO_EXT, (32552, 32558), allele)\n",
      "(T1398, CL, (32605, 32608), ES )\n",
      "(T1399, CL_GO_EXT, (32608, 32613), cells)\n",
      "(T1400, UBERON, (32652, 32663), blastocysts)\n",
      "(T1401, GO_EXT, (32673, 32684), transferred)\n",
      "(T1402, NCBITaxon, (32715, 32722), animals)\n",
      "(T1403, GO, (32765, 32770), matma)\n",
      "(T1404, NCBITaxon, (32783, 32787), mice)\n",
      "(T1405, NCBITaxon, (32833, 32837), mice)\n",
      "(T1406, NCBITaxon, (32881, 32885), mice)\n",
      "(T1407, NCBITaxon, (32916, 32920), mice)\n",
      "(T1408, NCBITaxon, (33022, 33026), mimi)\n",
      "(T1409, NCBITaxon, (33125, 33130), mouse)\n",
      "(T1410, NCBITaxon, (33247, 33253), Animal)\n",
      "(T1411, SO_EXT, (33260, 33268), Genomic )\n",
      "(T1412, CHEBI_SO_EXT, (33268, 33271), DNA)\n",
      "(T1413, UBERON, (33290, 33294), tail)\n",
      "(T1414, SO_EXT, (33342, 33349), gegenom)\n",
      "(T1415, CHEBI_SO_EXT, (33368, 33371), DNA)\n",
      "(T1416, CHEBI_SO_EXT, (33397, 33402), probe)\n",
      "(T1417, CHEBI_SO_EXT, (33475, 33491), oligonucleotides)\n",
      "(T1418, SO_EXT, (33570, 33579), wild-type)\n",
      "(T1419, PR_EXT, (33580, 33585), sam68)\n",
      "(T1420, SO_EXT, (33586, 33592), allele)\n",
      "(T1421, SO_EXT, (33611, 33618), genomic)\n",
      "(T1422, CHEBI_SO_EXT, (33643, 33659), oligonucleotides)\n",
      "(T1423, SO_EXT, (33759, 33765), allele)\n",
      "(T1424, SO_EXT, (33784, 33791), genomic)\n",
      "(T1425, CHEBI_SO_EXT, (33816, 33832), oligonucleotides)\n",
      "(T1426, UBERON, (33923, 33928), serum)\n",
      "(T1427, PR_EXT, (33945, 33950), Sam68)\n",
      "(T1428, SO_EXT, (33950, 33951), +)\n",
      "(T1429, SO_EXT, (33952, 33953), +)\n",
      "(T1430, PR_EXT, (33958, 33963), Sam68)\n",
      "(T1431, SO_EXT, (33963, 33964), −)\n",
      "(T1432, SO_EXT, (33965, 33966), −)\n",
      "(T1433, NCBITaxon, (33967, 33971), mice)\n",
      "(T1434, NCBITaxon, (34062, 34066), Mice)\n",
      "(T1435, GO_EXT, (34087, 34093), lethal)\n",
      "(T1436, CHEBI_EXT, (34102, 34112), anesthetic)\n",
      "(T1437, UBERON_EXT, (34269, 34273), Body)\n",
      "(T1438, CHEBI_EXT, (34424, 34436), anesthetanes)\n",
      "(T1439, NCBITaxon, (34437, 34441), mice)\n",
      "(T1440, GO_EXT, (34462, 34466), fice)\n",
      "(T1441, UBERON, (34501, 34509), Faxitron)\n",
      "(T1442, UBERON, (34560, 34563), lef)\n",
      "(T1443, UBERON, (34575, 34590), lumbar vertebra)\n",
      "(T1444, UBERON, (34613, 34620), tissues)\n",
      "(T1445, CHEBI_EXT, (34650, 34666), paraformaldehyde)\n",
      "(T1446, UBERON, (34679, 34688), metaphysi)\n",
      "(T1447, UBERON, (35032, 35037), Serum)\n",
      "(T1448, NCBITaxon, (35092, 35098), Rodent)\n",
      "(T1449, CHEBI_EXT, (35167, 35174), routine)\n",
      "(T1450, UBERON, (35238, 35243), serum)\n",
      "(T1451, CHEBI, (35254, 35257), CTX)\n",
      "(T1452, CHEBI_GO_EXT, (35320, 35330), BiologicBi)\n",
      "(T1453, CHEBI_PR_EXT, (35351, 35357), leptin)\n",
      "(T1454, PR_EXT, (35418, 35431), interleukin-6)\n",
      "(T1455, CL, (35472, 35482), osteoblast)\n",
      "(T1456, CL, (35487, 35497), osteoclast)\n",
      "(T1457, UBERON, (35542, 35547), tibia)\n",
      "(T1458, UBERON, (35552, 35558), femora)\n",
      "(T1459, PATO_UBERON_EXT, (35562, 35570), juvenile)\n",
      "(T1460, PR_EXT, (35582, 35587), SaSam)\n",
      "(T1461, SO_EXT, (35587, 35588), +)\n",
      "(T1462, SO_EXT, (35589, 35590), +)\n",
      "(T1463, PR_EXT, (35595, 35600), Sam68)\n",
      "(T1464, SO_EXT, (35600, 35601), −)\n",
      "(T1465, SO_EXT, (35602, 35603), −)\n",
      "(T1466, NCBITaxon, (35604, 35608), mice)\n",
      "(T1467, CL, (35619, 35627), stromal )\n",
      "(T1468, CL_GO_EXT, (35627, 35632), cells)\n",
      "(T1469, GO, (35657, 35672), differentiation)\n",
      "(T1470, PR_EXT, (35750, 35753), ALP)\n",
      "(T1471, CHEBI_SO_EXT, (35825, 35828), RNA)\n",
      "(T1472, GO_EXT, (35870, 35872), RT)\n",
      "(T1473, CL, (35889, 35899), osteoblast)\n",
      "(T1474, GO, (35908, 35923), gene expression)\n",
      "(T1475, CL, (35965, 35976), OstOsteocla)\n",
      "(T1476, PATO_UBERON_EXT, (36022, 36030), juvenile)\n",
      "(T1477, PR_EXT, (36031, 36036), SSam6)\n",
      "(T1478, SO_EXT, (36036, 36037), +)\n",
      "(T1479, SO_EXT, (36038, 36039), +)\n",
      "(T1480, PR_EXT, (36044, 36049), Sam68)\n",
      "(T1481, SO_EXT, (36049, 36050), −)\n",
      "(T1482, SO_EXT, (36051, 36052), −)\n",
      "(T1483, NCBITaxon, (36053, 36057), mice)\n",
      "(T1484, CL_GO_EXT, (36120, 36125), cells)\n",
      "(T1485, CL_GO_EXT, (36222, 36226), cece)\n",
      "(T1486, CHEBI_EXT, (36296, 36312), paraformaldehyde)\n",
      "(T1487, GO_PR_EXT, (36329, 36333), TRAP)\n",
      "(T1488, CL_GO_EXT, (36407, 36412), cells)\n",
      "(T1489, CHEBI, (36422, 36440), ammonium hydroxide)\n",
      "(T1490, CHEBI, (36520, 36528), electron)\n",
      "(T1491, CHEBI, (36548, 36556), Electron)\n",
      "(T1492, NCBITaxon, (36898, 36903), mouse)\n",
      "(T1493, UBERON, (36904, 36913), embryonic)\n",
      "(T1494, CL, (36914, 36924), fibroblast)\n",
      "(T1495, CL, (36942, 36951), adipocyte)\n",
      "(T1496, GO, (36952, 36967), differentiation)\n",
      "(T1497, UBERON, (37007, 37014), embryos)\n",
      "(T1498, CL, (37097, 37106), adipocyte)\n",
      "(T1499, GO, (37107, 37122), differentiatife)\n",
      "(T1500, CL, (37191, 37200), Cultured )\n",
      "(T1501, CL_GO_EXT, (37200, 37205), cells)\n",
      "(T1502, CHEBI_SO_EXT, (37254, 37257), RNA)\n",
      "(T1503, GO_EXT, (37274, 37276), RT)\n",
      "(T1504, GO, (37291, 37303), adipogenesis)\n",
      "(T1505, PR_EXT, (37307, 37312), Sam68)\n",
      "(T1506, SO_EXT, (37312, 37313), −)\n",
      "(T1507, SO_EXT, (37314, 37315), −)\n",
      "(T1508, CL_GO_EXT, (37329, 37337), cellular)\n",
      "(T1509, CHEBI_SO_EXT, (37338, 37341), RNA)\n",
      "(T1510, CHEBI_EXT, (37365, 37372), reagent)\n",
      "(T1511, CHEBI_SO_EXT, (37471, 37474), RNA)\n",
      "(T1512, GO, (37486, 37504), reverse-transcribe)\n",
      "(T1513, GO_EXT, (37504, 37505), t)\n",
      "(T1514, SO_EXT, (37511, 37515), cDNA)\n",
      "(T1515, GO_EXT, (37547, 37549), RT)\n",
      "(T1516, GO_EXT, (37576, 37591), transcriptional)\n",
      "(T1517, GO_PR_EXT, (37601, 37606), GAPDH)\n",
      "(T1518, SO_EXT, (37632, 37639), primers)\n",
      "(T1519, GO, (37662, 37688), adipogenic differentiation)\n",
      "(T1520, PR_EXT, (37690, 37694), KLF5)\n",
      "(T1521, PR_EXT, (38010, 38015), Sam68)\n",
      "(T1522, GO_EXT, (38016, 38031), down-regulation)\n",
      "(T1523, PR_EXT, (38038, 38045), Sam68sh)\n",
      "(T1524, CHEBI_SO_EXT, (38063, 38068), shRNA)\n",
      "(T1525, CHEBI_SO_EXT, (38073, 38077), base)\n",
      "(T1526, CHEBI_SO_EXT, (38078, 38088), duduplex D)\n",
      "(T1527, CHEBI_SO_EXT, (38089, 38100), nucleotides)\n",
      "(T1528, CHEBI_SO_EXT, (38160, 38164), base)\n",
      "(T1529, CHEBI_EXT, (38165, 38173), residues)\n",
      "(T1530, NCBITaxon, (38186, 38191), mouse)\n",
      "(T1531, PR_EXT, (38192, 38197), Sam68)\n",
      "(T1532, SO_EXT, (38287, 38293), cloned)\n",
      "(T1533, GO, (38363, 38376), Transfections)\n",
      "(T1534, SO_EXT, (38435, 38441), cloned)\n",
      "(T1535, CHEBI_SO_EXT, (38442, 38445), DNA)\n",
      "(T1536, SO_EXT, (38464, 38470), vector)\n",
      "(T1537, GO, (38486, 38498), transfection)\n",
      "(T1538, CHEBI, (38540, 38549), puromycin)\n",
      "(T1539, PR_EXT, (38605, 38610), Sam68)\n",
      "(T1540, PR_EXT, (38612, 38615), AD1)\n",
      "(T1541, GO, (38617, 38625), antibody)\n",
      "(T1542, GO, (38628, 38654), Osteogenic differentiation)\n",
      "(T1543, CL_GO_EXT, (38677, 38682), cells)\n",
      "(T1544, GO, (38689, 38715), osteogenic differentiation)\n",
      "(T1545, CL_GO_EXT, (38734, 38739), cells)\n",
      "(T1546, UBERON, (38766, 38772), tissue)\n",
      "(T1547, CL_GO_EXT, (38802, 38807), cells)\n",
      "(T1548, PR_EXT, (38904, 38909), BMP-2)\n",
      "(T1549, CL_GO_EXT, (38961, 38969), cellular)\n",
      "(T1550, CHEBI_SO_EXT, (38970, 38973), RNA)\n",
      "(T1551, PR_EXT, (39011, 39022), osteocalcin)\n",
      "(T1552, PR_EXT, (39024, 39031), β-actin)\n",
      "(T1553, GO_PR_EXT, (39037, 39042), GAPGA)\n",
      "(T1554, SO_EXT, (39043, 39047), gene)\n",
      "(T1555, GO, (39048, 39058), expression)\n",
      "(T1556, PR_EXT, (39084, 39089), BMP-2)\n",
      "(T1557, GO_EXT, (39118, 39120), RT)\n",
      "(T1558, GO_PATO_EXT, (39163, 39175), LocalLocaliz)\n",
      "(T1559, PR_EXT, (39179, 39184), Sam68)\n",
      "(T1560, NCBITaxon, (39196, 39201), Mouse)\n",
      "(T1561, CL, (39202, 39213), Osteoblasts)\n",
      "(T1562, CL, (39218, 39229), Osteoclasts)\n",
      "(T1563, SO_EXT, (39295, 39296), G)\n",
      "(T1564, GO, (39296, 39310), Gene Expressio)\n",
      "(T1565, CL, (39331, 39339), Stromal )\n",
      "(T1566, CL_GO_EXT, (39339, 39344), Cells)\n",
      "(T1567, PR_EXT, (39387, 39392), Sam68)\n",
      "(T1568, SO_EXT, (39392, 39393), +)\n",
      "(T1569, SO_EXT, (39394, 39395), +)\n",
      "(T1570, PR_EXT, (39400, 39405), Sam68)\n",
      "(T1571, SO_EXT, (39405, 39406), −)\n",
      "(T1572, SO_EXT, (39407, 39408), −)\n",
      "(T1573, NCBITaxon, (39409, 39413), Mice)\n",
      "(T1574, UBERON, (39479, 39484), Serum)\n",
      "(T1575, CHEBI_SO_EXT, (39507, 39517), Biomarkers)\n",
      "(T1576, NCBITaxon, (39541, 39545), Mice)\n",
      "(T1577, SO_EXT, (39725, 39735), Transgenic)\n",
      "(T1578, CHEBI, (40127, 40128), A)\n",
      "(T1579, PR_EXT, (40128, 40130), AL)\n",
      "(T1580, GO_PR_EXT, (40133, 40153), alkaline phosphatase)\n",
      "(T1581, PR_EXT, (40155, 40158), BMC)\n",
      "(T1582, GO, (40161, 40166), bone )\n",
      "(T1583, CHEBI, (40166, 40173), mineral)\n",
      "(T1584, UBERON_EXT, (40189, 40193), bonb)\n",
      "(T1585, CHEBI, (40194, 40201), mineral)\n",
      "(T1586, PR_EXT, (40211, 40216), BMP-2)\n",
      "(T1587, PR_EXT, (40219, 40238), bone morphogenetic )\n",
      "(T1588, CHEBI_PR_EXT, (40238, 40245), protein)\n",
      "(T1589, PR_EXT, (40245, 40247), -2)\n",
      "(T1590, CHEBI, (40275, 40278), CTX)\n",
      "(T1591, CHEBI_SO_EXT, (40281, 40294), C-telopeptide)\n",
      "(T1592, NCBITaxon, (40302, 40307), mouse)\n",
      "(T1593, UBERON, (40308, 40314), embryo)\n",
      "(T1594, CL, (40315, 40325), fibrofibro)\n",
      "(T1595, PR_EXT, (40327, 40332), PPARγ)\n",
      "(T1596, PR_EXT, (40335, 40369), peroxisome proliferator–activated )\n",
      "(T1597, GO_EXT, (40369, 40377), receptor)\n",
      "(T1598, PR_EXT, (40377, 40379),  γ)\n",
      "(T1599, PR_EXT, (40381, 40386), shRsh)\n",
      "(T1600, GO, (40395, 40406), hairpin RNA)\n",
      "(T1601, PR_EXT, (40408, 40412), TRAP)\n",
      "(T1602, GO_PR_EXT, (40415, 40423), tartrate)\n",
      "(T1603, CHEBI_EXT, (40434, 40438), acid)\n",
      "(T1604, GO_PR_EXT, (40439, 40448), phosphata)\n",
      "(T1605, GO_EXT, (40448, 40450), ph)\n",
      "(T1606, GO_PATO_EXT, (40502, 40514), LocalizatiLo)\n",
      "(T1607, PR_EXT, (40518, 40523), Sam68)\n",
      "(T1608, UBERON, (40527, 40536), Embryonic)\n",
      "(T1609, NCBITaxon, (40537, 40541), Mice)\n",
      "(T1610, UBERON, (40547, 40556), Embryonic)\n",
      "(T1611, NCBITaxon, (40557, 40561), mice)\n",
      "(T1612, SO_EXT, (40580, 40588), pregnant)\n",
      "(T1613, CHEBI_EXT, (40626, 40642), paraformaldehyfo)\n",
      "(T1614, UBERON, (40681, 40687), embryo)\n",
      "(T1615, PR_EXT, (40724, 40729), Sam68)\n",
      "(T1616, GO, (40730, 40738), antibody)\n",
      "(T1617, CHEBI, (40763, 40769), methym)\n",
      "(T1618, UBERON, (40832, 40841), Embryonic)\n",
      "(T1619, UBERON, (40847, 40854), tissues)\n",
      "(T1620, UBERON, (40864, 40869), brain)\n",
      "(T1621, UBERON, (40871, 40876), heart)\n",
      "(T1622, UBERON, (40881, 40884), gut)\n",
      "(T1623, CHEBI, (40903, 40914), hematoxylin)\n",
      "(T1624, PR_EXT, (40950, 40955), Sam68)\n",
      "(T1625, GO, (40956, 40964), antianti)\n",
      "(T1626, PR_EXT, (41039, 41044), Sam68)\n",
      "(T1627, CL, (41074, 41086), chondrocytes)\n",
      "(T1628, UBERON, (41094, 41106), nasal septum)\n",
      "(T1629, UBERON, (41135, 41143), vertebra)\n",
      "(T1630, UBERON, (41169, 41186), femoral epiphysis)\n",
      "(T1631, UBERON, (41215, 41225), ddiaphysea)\n",
      "(T1632, CL, (41226, 41237), osteoblasts)\n",
      "(T1633, CHEBI, (41285, 41296), hematoxylin)\n",
      "(T1634, CHEBI_EXT, (41301, 41306), eosin)\n",
      "(T1635, GO, (41336, 41344), antibody)\n",
      "(T1636, CHEBI_SO_EXT, (41377, 41384), peptide)\n",
      "(T1637, PR_EXT, (41407, 41408), S)\n",
      "(T1638, GO_PATO_EXT, (41417, 41426), localized)\n",
      "(T1639, GO, (41444, 41451), nucleus)\n",
      "(T1640, CL_GO_EXT, (41455, 41460), cells)\n",
      "(T1641, UBERON, (41477, 41484), tissues)\n",
      "(T1642, GO, (41524, 41533), cytoplasm)\n",
      "(T1643, UBERON, (41665, 41672), embryos)\n",
      "(T1644, PR_EXT, (41699, 41704), Sam68)\n",
      "(T1645, NCBITaxon, (41715, 41719), Mice)\n",
      "(T1646, SO_EXT, (41729, 41736), genomic)\n",
      "(T1647, SO_EXT, (41758, 41767), wild-type)\n",
      "(T1648, SO_EXT, (41787, 41794), allelal)\n",
      "(T1649, GO_SO_EXT, (41812, 41825), recombination)\n",
      "(T1650, CHEBI_SO_EXT, (41860, 41863), DNA)\n",
      "(T1651, CHEBI_SO_EXT, (41883, 41888), probe)\n",
      "(T1652, SO_EXT, (41991, 42000), wild-type)\n",
      "(T1653, SO_EXT, (42020, 42027), alleles)\n",
      "(T1654, SO_EXT, (42042, 42048), allele)\n",
      "(T1655, SO_EXT, (42049, 42057), replaces)\n",
      "(T1656, SO_EXT, (42058, 42062), exon)\n",
      "(T1657, SO_EXT, (42069, 42081), part of exon)\n",
      "(T1658, GO_EXT, (42100, 42103), PGK)\n",
      "(T1659, CHEBI, (42104, 42112), neomycin)\n",
      "(T1660, SO_EXT, (42113, 42121), cassette)\n",
      "(T1661, SO_EXT, (42154, 42162), genomic )\n",
      "(T1662, CHEBI_SO_EXT, (42162, 42165), DNA)\n",
      "(T1663, SO_EXT, (42171, 42180), wild-wild)\n",
      "(T1664, SO_EXT, (42182, 42183), +)\n",
      "(T1665, SO_EXT, (42184, 42185), +)\n",
      "(T1666, SO_EXT, (42202, 42203), +)\n",
      "(T1667, SO_EXT, (42204, 42205), −)\n",
      "(T1668, SO_EXT, (42224, 42225), −)\n",
      "(T1669, SO_EXT, (42226, 42227), −)\n",
      "(T1670, NCBITaxon, (42229, 42233), mice)\n",
      "(T1671, CHEBI_SO_EXT, (42235, 42238), DNA)\n",
      "(T1672, SO_EXT, (42266, 42275), wild-type)\n",
      "(T1673, CHEBI_SO_EXT, (42282, 42283), b)\n",
      "(T1674, CHEBI_SO_EXT, (42308, 42309), b)\n",
      "(T1675, SO_EXT, (42311, 42318), alleles)\n",
      "(T1676, PR_EXT, (42366, 42371), SaSam)\n",
      "(T1677, GO, (42372, 42382), expression)\n",
      "(T1678, CHEBI_PR_EXT, (42384, 42391), Protein)\n",
      "(T1679, SO_EXT, (42406, 42415), wild-type)\n",
      "(T1680, CL_GO_EXT, (42446, 42451), cells)\n",
      "(T1681, NCBITaxon, (42498, 42504), rabbit)\n",
      "(T1682, UBERON, (42505, 42510), serum)\n",
      "(T1683, PR_EXT, (42517, 42526), Sam68 AD1)\n",
      "(T1684, GO, (42527, 42535), antibody)\n",
      "(T1685, CHEBI_SO_EXT, (42541, 42548), peptide)\n",
      "(T1686, GO, (42549, 42557), antibody)\n",
      "(T1687, PR_EXT, (42558, 42561), ADA)\n",
      "(T1688, CHEBI_SO_EXT, (42595, 42602), peptide)\n",
      "(T1689, CHEBI_SO_EXT, (42620, 42631), aminamino a)\n",
      "(T1690, NCBITaxon, (42643, 42648), mouse)\n",
      "(T1691, PR_EXT, (42649, 42654), Sam68)\n",
      "(T1692, PR_EXT, (42661, 42666), Sam68)\n",
      "(T1693, GO, (42673, 42681), antibody)\n",
      "(T1694, CHEBI_SO_EXT, (42702, 42712), C-terminal)\n",
      "(T1695, CHEBI_SO_EXT, (42716, 42727), amino acids)\n",
      "(T1696, PR_EXT, (42731, 42736), Sam68)\n",
      "(T1697, PR_EXT, (42742, 42752), anti-actin)\n",
      "(T1698, GO, (42752, 42763), anti-actin )\n",
      "(T1699, GO, (42775, 42782), control)\n",
      "(T1700, GO_EXT, (42788, 42797), migration)\n",
      "(T1701, CHEBI_EXT, (42805, 42814), molecular)\n",
      "(T1702, CHEBI_SO_EXT, (42820, 42827), markers)\n",
      "(T1703, PR_EXT, (42920, 42925), Sam68)\n",
      "(T1704, SO_EXT, (42925, 42926), +)\n",
      "(T1705, SO_EXT, (42927, 42928), +)\n",
      "(T1706, PR_EXT, (42933, 42938), Sam68)\n",
      "(T1707, SO_EXT, (42938, 42939), −)\n",
      "(T1708, SO_EXT, (42940, 42941), −)\n",
      "(T1709, NCBITaxon, (42942, 42946), MiMi)\n",
      "(T1710, NCBITaxon, (42952, 42956), Mice)\n",
      "(T1711, CHEBI_EXT, (42985, 42995), anesthetic)\n",
      "(T1712, UBERON, (43058, 43064), femora)\n",
      "(T1713, UBERON, (43171, 43183), distal femur)\n",
      "(T1714, PR_EXT, (43187, 43192), Sam68)\n",
      "(T1715, SO_EXT, (43192, 43193), +)\n",
      "(T1716, SO_EXT, (43194, 43195), +)\n",
      "(T1717, SO_EXT, (43197, 43198), +)\n",
      "(T1718, SO_EXT, (43199, 43200), +)\n",
      "(T1719, PR_EXT, (43206, 43211), Sam68)\n",
      "(T1720, SO_EXT, (43211, 43212), −)\n",
      "(T1721, SO_EXT, (43213, 43214), −)\n",
      "(T1722, SO_EXT, (43216, 43217), −)\n",
      "(T1723, SO_EXT, (43218, 43219), −)\n",
      "(T1724, NCBITaxon, (43221, 43225), mice)\n",
      "(T1725, UBERON, (43300, 43308), cortical)\n",
      "(T1726, UBERON, (43382, 43387), femur)\n",
      "(T1727, SO_EXT, (43391, 43392), +)\n",
      "(T1728, SO_EXT, (43393, 43394), +)\n",
      "(T1729, NCBITaxon, (43395, 43399), mice)\n",
      "(T1730, SO_EXT, (43408, 43409), −)\n",
      "(T1731, SO_EXT, (43410, 43411), −)\n",
      "(T1732, NCBITaxon, (43412, 43416), mice)\n",
      "(T1733, UBERON, (43423, 43428), Bones)\n",
      "(T1734, UBERON, (43457, 43463), tissue)\n",
      "(T1735, CHEBI_EXT, (43490, 43506), paraformaldehyde)\n",
      "(T1736, UBERON, (43738, 43750), distal femur)\n",
      "(T1737, PR_EXT, (43754, 43759), Sam68)\n",
      "(T1738, SO_EXT, (43759, 43760), +)\n",
      "(T1739, SO_EXT, (43761, 43762), +)\n",
      "(T1740, SO_EXT, (43764, 43765), +)\n",
      "(T1741, SO_EXT, (43766, 43767), +)\n",
      "(T1742, PR_EXT, (43773, 43778), SamSa)\n",
      "(T1743, SO_EXT, (43778, 43779), −)\n",
      "(T1744, SO_EXT, (43780, 43781), −)\n",
      "(T1745, SO_EXT, (43783, 43784), −)\n",
      "(T1746, SO_EXT, (43785, 43786), −)\n",
      "(T1747, NCBITaxon, (43788, 43792), mice)\n",
      "(T1748, UBERON, (43843, 43858), trabecular bone)\n",
      "(T1749, UBERON, (43874, 43882), cortical)\n",
      "(T1750, UBERON, (43921, 43926), femur)\n",
      "(T1751, SO_EXT, (43943, 43944), +)\n",
      "(T1752, SO_EXT, (43945, 43946), +)\n",
      "(T1753, NCBITaxon, (43947, 43951), mice)\n",
      "(T1754, NCBITaxon, (44042, 44049), animals)\n",
      "(T1755, CHEBI_GO_EXT, (44112, 44116), Bone)\n",
      "(T1756, SO_EXT, (44163, 44169), tissue)\n",
      "(T1757, UBERON, (44240, 44245), femur)\n",
      "(T1758, UBERON, (44257, 44272), lumbar vertebra)\n",
      "(T1759, NCBITaxon, (44289, 44293), mice)\n",
      "(T1760, GO, (44380, 44389), expressed)\n",
      "(T1761, PR_EXT, (44469, 44474), Sam68)\n",
      "(T1762, SO_EXT, (44474, 44475), +)\n",
      "(T1763, SO_EXT, (44476, 44477), +)\n",
      "(T1764, NCBITaxon, (44478, 44482), mimi)\n",
      "(T1765, PR_EXT, (44514, 44519), Sam68)\n",
      "(T1766, SO_EXT, (44519, 44520), +)\n",
      "(T1767, SO_EXT, (44521, 44522), +)\n",
      "(T1768, NCBITaxon, (44523, 44527), mice)\n",
      "(T1769, PR_EXT, (44572, 44577), Sam68)\n",
      "(T1770, SO_EXT, (44577, 44578), −)\n",
      "(T1771, SO_EXT, (44579, 44580), −)\n",
      "(T1772, NCBITaxon, (44581, 44585), mice)\n",
      "(T1773, CHEBI_EXT, (44587, 44592), solid)\n",
      "(T1774, PR_EXT, (44617, 44622), Sam68)\n",
      "(T1775, SO_EXT, (44622, 44623), −)\n",
      "(T1776, SO_EXT, (44624, 44625), −)\n",
      "(T1777, NCBITaxon, (44626, 44630), mice)\n",
      "(T1778, UBERON, (44675, 44685), trabeculae)\n",
      "(T1779, PR_EXT, (44768, 44773), Sam68)\n",
      "(T1780, SO_EXT, (44773, 44774), +)\n",
      "(T1781, SO_EXT, (44775, 44776), +)\n",
      "(T1782, PR_EXT, (44804, 44809), Sam68)\n",
      "(T1783, SO_EXT, (44809, 44810), +)\n",
      "(T1784, SO_EXT, (44811, 44812), +)\n",
      "(T1785, PR_EXT, (44843, 44848), Sam68)\n",
      "(T1786, SO_EXT, (44848, 44849), +)\n",
      "(T1787, SO_EXT, (44850, 44851), +)\n",
      "(T1788, PR_EXT, (44877, 44882), Sam68)\n",
      "(T1789, SO_EXT, (44882, 44883), −)\n",
      "(T1790, SO_EXT, (44884, 44885), −)\n",
      "(T1791, PR_EXT, (44915, 44920), Sam68)\n",
      "(T1792, SO_EXT, (44920, 44921), −)\n",
      "(T1793, SO_EXT, (44922, 44923), −)\n",
      "(T1794, UBERON_EXT, (45004, 45008), Bone)\n",
      "(T1795, PR_EXT, (45014, 45019), Sam68)\n",
      "(T1796, SO_EXT, (45019, 45020), +)\n",
      "(T1797, SO_EXT, (45021, 45022), +)\n",
      "(T1798, PR_EXT, (45027, 45032), Sam68)\n",
      "(T1799, SO_EXT, (45032, 45033), −)\n",
      "(T1800, SO_EXT, (45034, 45035), −)\n",
      "(T1801, NCBITaxon, (45036, 45040), Mice)\n",
      "(T1802, CHEBI_EXT, (45072, 45088), paraformaldehyde)\n",
      "(T1803, PR_EXT, (45130, 45133), ALP)\n",
      "(T1804, CL, (45166, 45177), osteoblasts)\n",
      "(T1805, PR_EXT, (45185, 45189), TRAP)\n",
      "(T1806, CL, (45222, 45233), osteoclasts)\n",
      "(T1807, PR_EXT, (45281, 45286), Sam68)\n",
      "(T1808, SO_EXT, (45286, 45287), +)\n",
      "(T1809, SO_EXT, (45288, 45289), +)\n",
      "(T1810, PR_EXT, (45313, 45318), Sam68)\n",
      "(T1811, SO_EXT, (45318, 45319), −)\n",
      "(T1812, SO_EXT, (45320, 45321), −)\n",
      "(T1813, PR_EXT, (45350, 45355), Sam68)\n",
      "(T1814, SO_EXT, (45355, 45356), −)\n",
      "(T1815, SO_EXT, (45357, 45358), −)\n",
      "(T1816, NCBITaxon, (45369, 45373), mice)\n",
      "(T1817, PR_EXT, (45401, 45406), Sam68)\n",
      "(T1818, SO_EXT, (45406, 45407), +)\n",
      "(T1819, SO_EXT, (45408, 45409), +)\n",
      "(T1820, NCBITaxon, (45410, 45414), mice)\n",
      "(T1821, NCBITaxon, (45580, 45587), animals)\n",
      "(T1822, PR_EXT, (45620, 45625), Sam68)\n",
      "(T1823, SO_EXT, (45625, 45626), +)\n",
      "(T1824, SO_EXT, (45627, 45628), +)\n",
      "(T1825, PR_EXT, (45633, 45638), Sam68)\n",
      "(T1826, SO_EXT, (45638, 45639), −)\n",
      "(T1827, SO_EXT, (45640, 45641), −)\n",
      "(T1828, CL, (45642, 45653), Osteoblasts)\n",
      "(T1829, CL, (45658, 45669), Osteoclasts)\n",
      "(T1830, CL, (45678, 45686), stromal )\n",
      "(T1831, CL_GO_EXT, (45686, 45691), cells)\n",
      "(T1832, PATO_UBERON_EXT, (45729, 45737), juvenile)\n",
      "(T1833, NCBITaxon, (45738, 45742), mice)\n",
      "(T1834, GO, (45788, 45814), osteoblast differentiation)\n",
      "(T1835, CHEBI_EXT, (45847, 45863), paraformaldehyde)\n",
      "(T1836, PR_EXT, (45907, 45910), ALP)\n",
      "(T1837, CHEBI_EXT, (45929, 45943), silver nitrate)\n",
      "(T1838, PR_EXT, (45949, 45952), Kos)\n",
      "(T1839, PR_EXT, (45987, 45992), Sam68)\n",
      "(T1840, SO_EXT, (45992, 45993), −)\n",
      "(T1841, SO_EXT, (45994, 45995), −)\n",
      "(T1842, PR_EXT, (46032, 46035), ALP)\n",
      "(T1843, CL, (46176, 46187), osteoclasts)\n",
      "(T1844, NCBITaxon, (46242, 46246), mice)\n",
      "(T1845, CL, (46346, 46357), Osteoclasts)\n",
      "(T1846, CL_GO_EXT, (46377, 46382), cells)\n",
      "(T1847, GO, (46402, 46408), nuclei)\n",
      "(T1848, GO_PR_EXT, (46435, 46439), TRAP)\n",
      "(T1849, PR_EXT, (46604, 46608), TRAP)\n",
      "(T1850, CL_GO_EXT, (46618, 46623), cells)\n",
      "(T1851, GO, (46676, 46688), Adipogenesis)\n",
      "(T1852, PR_EXT, (46701, 46706), Sam68)\n",
      "(T1853, SO_EXT, (46706, 46707), −)\n",
      "(T1854, SO_EXT, (46708, 46709), −)\n",
      "(T1855, NCBITaxon, (46710, 46715), Mouse)\n",
      "(T1856, UBERON, (46716, 46725), EmbrEmbry)\n",
      "(T1857, CL, (46726, 46737), Fibroblasts)\n",
      "(T1858, NCBITaxon, (46763, 46768), mouse)\n",
      "(T1859, UBERON, (46769, 46776), embryos)\n",
      "(T1860, UBERON, (46780, 46789), embrembry)\n",
      "(T1861, PR_EXT, (46826, 46831), Sam68)\n",
      "(T1862, SO_EXT, (46831, 46832), +)\n",
      "(T1863, SO_EXT, (46833, 46834), +)\n",
      "(T1864, PR_EXT, (46839, 46844), Sam68)\n",
      "(T1865, SO_EXT, (46844, 46845), −)\n",
      "(T1866, SO_EXT, (46846, 46847), −)\n",
      "(T1867, CL, (46899, 46908), Adipocyte)\n",
      "(T1868, GO_RO_EXT, (46909, 46912), dif)\n",
      "(T1869, GO, (46912, 46924), differentiat)\n",
      "(T1870, CHEBI_EXT, (47054, 47070), paraformaldehyde)\n",
      "(T1871, CL, (47135, 47145), adipocytes)\n",
      "(T1872, CL_GO_EXT, (47174, 47178), cell)\n",
      "(T1873, GO_EXT, (47232, 47234), RT)\n",
      "(T1874, CL_GO_EXT, (47264, 47268), cell)\n",
      "(T1875, GO, (47268, 47307), ular RNA isolated after diffdifferentia)\n",
      "(T1876, CHEBI_SO_EXT, (47352, 47355), DNA)\n",
      "(T1877, CHEBI, (47385, 47392), agarose)\n",
      "(T1878, CHEBI, (47411, 47427), ethidium bromidi)\n",
      "(T1879, GO, (47433, 47443), expression)\n",
      "(T1880, GO, (47452, 47457), genic)\n",
      "(T1881, CHEBI_SO_EXT, (47458, 47465), markers)\n",
      "(T1882, PR_EXT, (47468, 47472), EBPβ)\n",
      "(T1883, PR_EXT, (47476, 47480), EBPδ)\n",
      "(T1884, PR_EXT, (47482, 47487), PPARα)\n",
      "(T1885, PR_EXT, (47493, 47497), KLF5)\n",
      "(T1886, GO, (47526, 47536), expression)\n",
      "(T1887, PR_EXT, (47559, 47564), Sam68)\n",
      "(T1888, PR_EXT, (47566, 47573), β-actin)\n",
      "(T1889, GO_PR_EXT, (47579, 47584), GAPDH)\n",
      "(T1890, GO, (47606, 47641), OsteogenicOsteogenic Differentiatio)\n",
      "(T1891, CL, (47650, 47660), Embryonic )\n",
      "(T1892, CL_GO_EXT, (47660, 47664), Cell)\n",
      "(T1893, PR_EXT, (47693, 47698), Sam68)\n",
      "(T1894, CL_GO_EXT, (47714, 47719), cells)\n",
      "(T1895, GO, (47720, 47731), transfected)\n",
      "(T1896, SO_EXT, (47746, 47752), vector)\n",
      "(T1897, SO_EXT, (47773, 47779), vector)\n",
      "(T1898, CHEBI_SO_EXT, (47794, 47799), shRNA)\n",
      "(T1899, PR_EXT, (47801, 47806), Sam68)\n",
      "(T1900, SO_EXT, (47807, 47808), s)\n",
      "(T1901, CHEBI_SO_EXT, (47808, 47812), shRN)\n",
      "(T1902, CHEBI, (47833, 47842), puromycin)\n",
      "(T1903, PR_EXT, (47882, 47887), Sam68)\n",
      "(T1904, PR_EXT, (47922, 47927), Sam68)\n",
      "(T1905, CHEBI_PR_EXT, (47928, 47935), protein)\n",
      "(T1906, PR_EXT, (47977, 47982), Sam68)\n",
      "(T1907, PR_EXT, (47984, 47987), AD1)\n",
      "(T1908, GO, (47989, 47997), antibody)\n",
      "(T1909, GO, (48002, 48006), anti)\n",
      "(T1910, PR_EXT, (48007, 48014), β-actin)\n",
      "(T1911, GO, (48015, 48025), antibodies)\n",
      "(T1912, GO, (48052, 48062), Osteogenic)\n",
      "(T1913, GO, (48064, 48078), teogenic diffe)\n",
      "(T1914, PR_EXT, (48130, 48135), BMP-2)\n",
      "(T1915, GO, (48184, 48210), osteogenosteogenic differe)\n",
      "(T1916, CL_GO_EXT, (48220, 48225), cells)\n",
      "(T1917, GO, (48227, 48237), expression)\n",
      "(T1918, CL, (48246, 48256), osteoblast)\n",
      "(T1919, CHEBI_SO_EXT, (48257, 48263), marker)\n",
      "(T1920, PR_EXT, (48265, 48276), osteocalcin)\n",
      "(T1921, CL, (48278, 48281), OCN)\n",
      "(T1922, GO_EXT, (48300, 48302), RT)\n",
      "(T1923, PR_EXT, (48325, 48332), β-actin)\n",
      "(T1924, GO_PR_EXT, (48337, 48342), GAPDH)\n",
      "(T1925, GO, (48343, 48351), controls)\n",
      "(T1926, CHEBI_SO_EXT, (48357, 48360), DNA)\n",
      "(T1927, CHEBI, (48390, 48397), agarose)\n",
      "(T1928, CHEBI, (48415, 48431), ethidium bromide)\n",
      "(T1929, PR_EXT, (48448, 48453), Sam68)\n",
      "(T1930, SO_EXT, (48453, 48454), −)\n",
      "(T1931, SO_EXT, (48455, 48456), −)\n",
      "(T1932, NCBITaxon, (48457, 48461), Mice)\n",
      "(T1933, SO_EXT, (48545, 48549), bone)\n",
      "(T1934, UBERON, (48693, 48699), tissue)\n",
      "(T1935, CL, (48719, 48729), adipocytes)\n",
      "(T1936, PR_EXT, (48812, 48817), Sam68)\n",
      "(T1937, SO_EXT, (48817, 48818), +)\n",
      "(T1938, SO_EXT, (48819, 48820), +)\n",
      "(T1939, UBERON_EXT, (48821, 48825), bone)\n",
      "(T1940, UBERON_EXT, (48866, 48870), bone)\n",
      "(T1941, CL, (48898, 48908), adipocytes)\n",
      "(T1942, CHEBI_EXT, (48971, 48980), orochrome)\n",
      "(T1943, CHEBI_SO_EXT, (48981, 48987), labels)\n",
      "(T1944, NCBITaxon, (49098, 49105), animals)\n",
      "(T1945, PR_EXT, (49128, 49133), Sam68)\n",
      "(T1946, GO_EXT, (49147, 49155), BreedBre)\n",
      "(T1947, PATO_UBERON_EXT, (49225, 49231), Female)\n",
      "(T1948, NCBITaxon, (49232, 49236), Mice)\n",
      "(T1949, NCBITaxon, (49313, 49317), Mice)\n",
      "(T1950, NCBITaxon, (49620, 49624), mice)\n",
      "(T1951, PR_EXT, (49882, 49887), Sam68)\n",
      "(T1952, CHEBI_SO_EXT, (49888, 49891), RNA)\n",
      "(T1953, CHEMINF_GO_EXT, (49892, 49899), binding)\n",
      "(T1954, CHEBI_PR_EXT, (49900, 49907), protein)\n",
      "(T1955, NCBITaxon, (49917, 49921), micm)\n",
      "(T1956, UBERON_EXT, (49939, 49943), bone)\n"
     ]
    }
   ],
   "source": [
    "mylist = []\n",
    "for i in pred_docs[sample_doc_id].ents:\n",
    "    print(i)\n",
    "    str_entity = str(i).split(\",\")\n",
    "    mylist.append((str_entity[1].strip(),str_entity[-1][:-1].strip()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('PR_EXT', 'Sam68'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('CHEMINF_GO_EXT', 'Binding'),\n",
       " ('CHEBI_PR_EXT', 'Protein'),\n",
       " ('NCBITaxon', 'Mice'),\n",
       " ('PR_EXT', 'Src'),\n",
       " ('GO', 'mimitos'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('PR_EXT', 'KH'),\n",
       " ('SO_EXT', '-type'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('CHEMINF_GO_EXT', 'binding'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('GO', 'regulate'),\n",
       " ('GO', 'RNA metabolism'),\n",
       " ('GO_PATO_EXT', 'physiologic'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', 'null'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('GO_SO_EXT', 'recombination'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('SO_EXT', 'wild-type'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('SO_EXT', 'wild-type'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON', 'bone m'),\n",
       " ('CL', 'stromal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('GO', 'differentiation'),\n",
       " ('GO', 'ostosteogenic path'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'hahairpin R'),\n",
       " ('UBERON', 'embryonic'),\n",
       " ('UBERON', 'mesenchymal'),\n",
       " ('GO', 'multipotential'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('GO', 'expression'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('CHEBI_SO_EXT', 'marker'),\n",
       " ('CHEBI', 'osteocalcin'),\n",
       " ('GO', 'differentiation'),\n",
       " ('PR_EXT', 'bone morphogenetic'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('PR_EXT', '-2'),\n",
       " ('NCBITaxon', 'mouse'),\n",
       " ('UBERON', 'embryo'),\n",
       " ('CL', 'fibroblasts'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('CL', 'adipocytes'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mouse'),\n",
       " ('UBERON', 'embryo'),\n",
       " ('CL', 'fibroblastf'),\n",
       " ('CL', 'adipocyte'),\n",
       " ('GO', 'differentiation'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('PR_EXT', 'SaSam'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CL', 'adipocytes'),\n",
       " ('SO_EXT', 'wild-type'),\n",
       " ('UBERON', 'bone'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO_EXT', 'regregula'),\n",
       " ('CL', 'adipocyte'),\n",
       " ('GO', 'differentiation and a negat'),\n",
       " ('GO_EXT', 'regulator'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('GO', 'differentiation'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'modulator of bone marrow'),\n",
       " ('CL', 'mesenchymal'),\n",
       " ('GO', 'cell differentiation'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO', 'metabolism'),\n",
       " ('GO_PATO_EXT', 'aged'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('GO', 'Osteoporosis'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON_EXT', 'bbon'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('SO_EXT', 'bone'),\n",
       " ('NCBITaxon', 'humans'),\n",
       " ('GO', 'tosteoporo'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('CHEBI_SO_EXT', 'RNR'),\n",
       " ('CHEMINF_GO_EXT', 'binding'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('GO_PATO_EXT', 'physiologic'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO', 'aging'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('CL', 'adipocytes'),\n",
       " ('UBERON', 'mesenchymal'),\n",
       " ('CL', 'osteoblasts'),\n",
       " ('UBERON', 'bone marrow'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'regulates'),\n",
       " ('GO', 'differentiation of this'),\n",
       " ('UBERON', 'mesenchymme'),\n",
       " ('CL', 'osteoblasts'),\n",
       " ('GO', 'aging bone'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO_PATO_EXT', 'physiologic'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO_EXT', 'modulatmo'),\n",
       " ('UBERON', 'bone marrow'),\n",
       " ('CL', 'stem'),\n",
       " ('CL_GO_EXT', 'cell'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO', 'metabolime'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO', 'skeletal development'),\n",
       " ('GO', 'anabolic'),\n",
       " ('CL', 'ososteoblas'),\n",
       " ('GO', 'catabolic'),\n",
       " ('CL', 'osteoclaost'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON_EXT', 'skeletal'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('CL', 'osteoblasts'),\n",
       " ('CL', 'osteoclasts'),\n",
       " ('GO', 'remodeling cycle'),\n",
       " ('GO', 'skeletal aging'),\n",
       " ('GO', 'teoclast'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('UBERON', 'net bone'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO', 'develo'),\n",
       " ('GO', 'aging'),\n",
       " ('OBI_SO_EXT', 'genegene'),\n",
       " ('GO', 'response of'),\n",
       " ('CL', 'bone'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('GO', 'circulating'),\n",
       " ('CHEBI_GO_EXT', 'hormonho'),\n",
       " ('GO_EXT', 'growth factors'),\n",
       " ('SO_EXT', 'gengene'),\n",
       " ('GO', 'regulate'),\n",
       " ('GO', 'bone development'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO', 'bonebone resorp'),\n",
       " ('NCBITaxon_UBERON_EXT', 'women'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('CHEBI_SO_EXT', 'bbiomarker'),\n",
       " ('CHEBI_PR_EXT', 'parathyroid'),\n",
       " ('CHEBI_EXT', 'a'),\n",
       " ('CHEBI_GO_EXT', 'hormone'),\n",
       " ('UBERON', 'gonadal'),\n",
       " ('CHEBI_GO_EXT', 'hormone'),\n",
       " ('CHEBI_PR_EXT', 'leptin'),\n",
       " ('UBERON', 'nervous system'),\n",
       " ('GO', 'bone cell apoptosis'),\n",
       " ('UBERON_EXT', 'Bone'),\n",
       " ('GO_EXT', 'responsr'),\n",
       " ('UBERON', 'bone marrow'),\n",
       " ('CL', 'stromal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('GO', 'differentiation down'),\n",
       " ('CL', 'adipocyte'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('GO', 'Aging'),\n",
       " ('CHEBI_UBERON_EXT', 'fat'),\n",
       " ('CL', 'adipocytes'),\n",
       " ('CL', 'osteoblasts'),\n",
       " ('CL', 'Osteoblasts'),\n",
       " ('CL', 'adipocytes'),\n",
       " ('UBERON', 'mesenchymal'),\n",
       " ('CL_GO_EXT', 'cell'),\n",
       " ('UBERON', 'bone mabone'),\n",
       " ('GO', 'control'),\n",
       " ('GO', 'adipogenic differentiation'),\n",
       " ('GO_EXT', 'transcriptional'),\n",
       " ('GO', 'regulatory'),\n",
       " ('CHEBI_PR_EXT', 'proteins'),\n",
       " ('GO', 'cell fate determination of'),\n",
       " ('UBERON', 'bone marrow'),\n",
       " ('CL', 'mesenchymal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('PR_EXT', 'peroxisome proliferator–activated'),\n",
       " ('GO_EXT', 'receptor'),\n",
       " ('PR_EXT', 'γ'),\n",
       " ('PR_EXT', 'PPARγ'),\n",
       " ('PR_EXT', 'KLF5'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('CHEMINF_GO_EXT', 'binding'),\n",
       " ('CHEBI_PR_EXT', 'proteins'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('CHEMINF_GO_EXT', 'binding'),\n",
       " ('CHEBI_PR_EXT', 'proteins'),\n",
       " ('SO_EXT', 'type'),\n",
       " ('GO_EXT', 'regulators'),\n",
       " ('GO', 'cellular differentiation'),\n",
       " ('GO', 'expression'),\n",
       " ('SO_EXT', 'domain'),\n",
       " ('CHEBI_PR_EXT', 'proteins'),\n",
       " ('PR_EXT', 'FMRP'),\n",
       " ('UBERON', 'neurologic'),\n",
       " ('NCBITaxon', 'humans'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('CHEMINF_GO_EXT', 'binding'),\n",
       " ('CHEBI_PR_EXT', 'protpro'),\n",
       " ('GO', 'oligodendrocytes'),\n",
       " ('GO_EXT', 'myelination'),\n",
       " ('GO', 'expression'),\n",
       " ('PR_EXT', 'QKI-6/7'),\n",
       " ('SO_EXT', 'isoforms'),\n",
       " ('GO', 'formatioe for'),\n",
       " ('CL', 'glial'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('CL', 'neurons'),\n",
       " ('UBERON_EXT', 'neural'),\n",
       " ('GO', 'cell fate determination'),\n",
       " ('PR_EXT', 'GLD-1'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('NCBITaxon', 'Caenorhabditis elegans'),\n",
       " ('CL', 'stem'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('SO_EXT', 'domain'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('PR_EXT', 'HOH'),\n",
       " ('NCBITaxon', 'Drosophila'),\n",
       " ('UBERON_EXT', 'muscle'),\n",
       " ('GO', 'differentiation'),\n",
       " ('CHEBI_EXT', 'held'),\n",
       " ('UBERON', 'wings'),\n",
       " ('PR_EXT', 'Src'),\n",
       " ('GO', 'mitosis'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', 'domain'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('CHEMINF_GO_EXT', 'binding'),\n",
       " ('CHEBI_PR_EXT', 'proteins'),\n",
       " ('GO_PATO_EXT', 'physiologic'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', 'domain'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('PR_EXT', 'Src family'),\n",
       " ('GO_EXT', 'kinases'),\n",
       " ('PR_EXT', 'Src'),\n",
       " ('GO_EXT', 'kinases'),\n",
       " ('NCBITaxon', 'breast'),\n",
       " ('PR_EXT', 'tumor'),\n",
       " ('GO_EXT', 'tumor'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'ununsplic'),\n",
       " ('PR_EXT', 'HIV'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('GO', 'regulate'),\n",
       " ('SO_EXT', 'pre-'),\n",
       " ('CHEBI_SO_EXT', 'mRNA'),\n",
       " ('SO_EXT', 'processing'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'skeletal'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', 'bone'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('SO_EXT', 'wild-type'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'regulates'),\n",
       " ('GO', 'differentiation of'),\n",
       " ('UBERON', 'bone marrow'),\n",
       " ('CL', 'stromal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'animals'),\n",
       " ('GO', 'osteogenic'),\n",
       " ('GO', 'adipogenic'),\n",
       " ('SO_EXT', 'wild-type'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mouse'),\n",
       " ('UBERON', 'embryo'),\n",
       " ('CL', 'fibfibrobla'),\n",
       " ('GO_RO_EXT', 'differentiate'),\n",
       " ('CL', 'adipocytes'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO_EXT', 'regulator'),\n",
       " ('GO', 'bontor of b'),\n",
       " ('UBERON', 'mesenchymal'),\n",
       " ('GO', 'cell differentiation'),\n",
       " ('NCBITaxon', 'animal'),\n",
       " ('GO', 'metabolism'),\n",
       " ('GO', 'regenerarege'),\n",
       " ('GO', 'repair'),\n",
       " ('GO', 'aging'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'Expressed'),\n",
       " ('UBERON', 'Skeleton of Embryonic'),\n",
       " ('NCBITaxon', 'Mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('CHEBI_SO_EXT', 'mRNA'),\n",
       " ('GO', 'expressed'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('GO', 'exexpressi'),\n",
       " ('SO_EXT', 'wild-type'),\n",
       " ('UBERON', 'embryonic'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'AD1'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'antibody'),\n",
       " ('NCBITaxon', 'rabbits'),\n",
       " ('CHEBI_SO_EXT', 'peptide'),\n",
       " ('CHEBI_SO_EXT', 'aminoamino'),\n",
       " ('NCBITaxon', 'mouse'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('UBERON', 'skeleton'),\n",
       " ('UBERON', 'tissues'),\n",
       " ('SO_EXT', 'wild-type'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('GO', 'nucleus of'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('UBERON', 'developing brain'),\n",
       " ('UBERON', 'hhear'),\n",
       " ('UBERON', 'small intestine'),\n",
       " ('CL', 'chondrocyteh'),\n",
       " ('UBERON', 'nasal septum'),\n",
       " ('UBERON', 'glandular'),\n",
       " ('UBERON', 'tissue'),\n",
       " ('UBERON', 'nnasa'),\n",
       " ('UBERON_EXT', 'cartilage'),\n",
       " ('UBERON', 'vertebra'),\n",
       " ('UBERON', 'inteintervertebral d'),\n",
       " ('UBERON', 'epiphysis'),\n",
       " ('UBERON', 'metaphysis'),\n",
       " ('UBERON', 'bones'),\n",
       " ('GO', 'Nuclear'),\n",
       " ('GO', 'proliferating'),\n",
       " ('CL', 'chondrocytes'),\n",
       " ('CL', 'hypertrophic chondrocyteh'),\n",
       " ('CL', 'osteoblasts'),\n",
       " ('CL', 'osteoclasts'),\n",
       " ('UBERON', 'serum'),\n",
       " ('UBERON', 'antiserum'),\n",
       " ('CHEBI_SO_EXT', 'peptide'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('GO', 'expressex'),\n",
       " ('NCBITaxon', 'mouse'),\n",
       " ('UBERON', 'embryo'),\n",
       " ('GO', 'exexpressi'),\n",
       " ('UBERON_EXT', 'cartilage'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('NCBITaxon', 'MousM'),\n",
       " ('GO_PATO_EXT', 'physiologic'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('SO_EXT', 'exons'),\n",
       " ('PR_EXT', 'sam68'),\n",
       " ('SO_EXT', 'gene'),\n",
       " ('SO_EXT', 'encode'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('CHEMINF_GO_EXT', 'binding'),\n",
       " ('SO_EXT', 'domain'),\n",
       " ('SO_EXT', 'allele'),\n",
       " ('SO_EXT', 'genomic'),\n",
       " ('CHEBI_SO_EXT', 'DNA'),\n",
       " ('SO_EXT', 'transcripts'),\n",
       " ('SO_EXT', 'eencode'),\n",
       " ('SO_EXT', 'exons'),\n",
       " ('GO_EXT', 'RT'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('CHEBI_PR_EXT', 'protein'),\n",
       " ('PR_EXT', 'Sam68 AD1'),\n",
       " ('PR_EXT', 'SC-333'),\n",
       " ('GO', 'antibodiea'),\n",
       " ('GO', 'control'),\n",
       " ('NCBITaxon', 'rabbit'),\n",
       " ('UBERON', 'serum'),\n",
       " ('PR_EXT', 'Sam68 AD1'),\n",
       " ('CHEBI_SO_EXT', 'peptide'),\n",
       " ('NCBITaxon', 'rabbit'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'antibody'),\n",
       " ('CHEBI_SO_EXT', 'C-terminal'),\n",
       " ('CHEBI_SO_EXT', 'amino acids'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('NCBITaxon', 'mouse'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', 'genotypes'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon_UBERON_EXT', 'pups'),\n",
       " ('GO', 'died'),\n",
       " ('GO', 'birth'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '-'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon_UBERON_EXT', 'pups'),\n",
       " ('GO', 'natal'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('CHEBI_SO_EXT', 'mRNA'),\n",
       " ('GO', 'expressed'),\n",
       " ('GO_PATO_EXT', 'phosphorylated'),\n",
       " ('GO', 'mitosis'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mimi'),\n",
       " ('UBERON', 'illnesses'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('GO_EXT', 'breedibr'),\n",
       " ('PATO_UBERON_EXT', 'male'),\n",
       " ('PATO_UBERON_EXT', 'females'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('NCBITaxon', 'Mice'),\n",
       " ('CHEBI_SO_EXT', 'A'),\n",
       " ('PR_EXT', 'Src'),\n",
       " ('SO_EXT', 'null'),\n",
       " ('NCBITaxon', 'animals'),\n",
       " ('GO', 'metmetabol'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('PR_EXT', 'Src'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'skeletal'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'skeletal'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('PATO_UBERON_EXT', 'female'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PATO_UBERON_EXT', 'female'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'body'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'SaSam'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO', 'axial an'),\n",
       " ('UBERON', 'appendicular skeleton'),\n",
       " ('GO', 'Faxitron'),\n",
       " ('GO', 'X-ray Corporation'),\n",
       " ('GO', 'cortical'),\n",
       " ('UBERON', 'metaphyseal bone'),\n",
       " ('UBERON', 'fefemo'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('NCBITaxon', 'micm'),\n",
       " ('SO_EXT', 'genotype'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'trabecular bone'),\n",
       " ('UBERON', 'vertebrae'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'body'),\n",
       " ('CHEBI', 'mineral'),\n",
       " ('NCBITaxon', 'mouse'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('GO', 'BMC'),\n",
       " ('UBERON', 'femur'),\n",
       " ('UBERON', 'vertebra'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('SO_EXT', 'wild type'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'body'),\n",
       " ('UBERON', 'femoral'),\n",
       " ('UBERON', 'vevertebr'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'appendicular skeleton'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON_EXT', 'Bone'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'Mice'),\n",
       " ('CHEBI', 'Bone'),\n",
       " ('UBERON', 'skeletons'),\n",
       " ('GO_PATO_EXT', 'aged'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('NCBITaxon', 'humans'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON', 'tissue'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('SO_EXT', 'genotypes'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'trabecular'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'Trabecular'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('GO', 'trabeculae'),\n",
       " ('UBERON', 'trabeculae'),\n",
       " ('PR_EXT', 'SamSa'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('SO_EXT', 'deling'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'Mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO_PATO_EXT', 'agea'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'femo'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('CL', 'osteoclast'),\n",
       " ('CHEBI_GO_SO_EXT', 'enzyme'),\n",
       " ('GO_PR_EXT', 'alkaline phosp'),\n",
       " ('GO_EXT', 'line p'),\n",
       " ('PR_EXT', 'ALP'),\n",
       " ('CHEBI_SO_EXT', 'biomarker'),\n",
       " ('CL', 'oosteoblast'),\n",
       " ('PR_EXT', 'ALP'),\n",
       " ('CHEBI_EXT', 'acid'),\n",
       " ('GO_EXT', 'p'),\n",
       " ('GO', 'ant acid p'),\n",
       " ('CHEBI_SO_EXT', 'marker'),\n",
       " ('CL', 'osteoclasos'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'ALP'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CL', 'osteoboste'),\n",
       " ('CL', 'osteoclast'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CL', 'osteoclast'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('UBERON', 'tur'),\n",
       " ('UBERON', 'bbone'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON', 'osteoid'),\n",
       " ('UBERON', 'mineral'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CHEBI_UBERON_EXT', 'fat'),\n",
       " ('CL', 'osteoblasts'),\n",
       " ('CL', 'osteoclasts'),\n",
       " ('UBERON', 'tissue'),\n",
       " ('PR_EXT', 'Sam6S'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CHEBI_UBERON_EXT', 'fat'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('SO_EXT', 'genotype'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('CHEBI', 'mete'),\n",
       " ('CL', 'osteoblasts'),\n",
       " ('CL', 'osteoclasts'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('GO', 'Circulating'),\n",
       " ('CHEBI', 'serum'),\n",
       " ('CHEBI_SO_EXT', 'C-telopeptide'),\n",
       " ('CHEBI', 'sCTX'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'Serum'),\n",
       " ('CHEBI_EXT', 'estrogen'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('SO_EXT', 'ggenotyp'),\n",
       " ('PR_EXT', 'interleukin-6'),\n",
       " ('CHEBI_PR_EXT', 'leptin'),\n",
       " ('GO', 'regulating'),\n",
       " ('UBERON_EXT', 'body'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON', 'serum'),\n",
       " ('CHEBI_PR_EXT', 'leptin'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mimi'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CHEBI_EXT', 'estrogen'),\n",
       " ('GO', 'circulating'),\n",
       " ('CHEBI_PR_EXT', 'leptin'),\n",
       " ('CL', 'Osteoblast'),\n",
       " ('CL', 'Oste'),\n",
       " ('GO', 'Osteoc'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'Mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON', 'adult'),\n",
       " ('GO', 'remodeling cycle'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('CL', 'osteoclast'),\n",
       " ('UBERON', 'bone'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('CL', 'osteobosteo'),\n",
       " ('CL', 'osteoclasts'),\n",
       " ('UBERON', 'bobone marr'),\n",
       " ('CL', 'stromal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('GO', 'differentiation'),\n",
       " ('PR_EXT', 'ALP'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CL', 'fibroblast'),\n",
       " ('GO_EXT', 'RT'),\n",
       " ('CHEBI_EXT', 'molecular'),\n",
       " ('CHEBI_SO_EXT', 'markers'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('GO', 'differentiation'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CHEBI_PR_EXT', 'collagen'),\n",
       " ('GO_EXT', 'up-regulated'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CL', 'osteoclasts'),\n",
       " ('GO_EXT', 'rereleas'),\n",
       " ('UBERON', 'long bones'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('CHEBI', 'TRAP'),\n",
       " ('CHEBI', 'electron'),\n",
       " ('CL', 'osteoclasts'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Src'),\n",
       " ('SO_EXT', 'null'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('CL', 'Adipocyte'),\n",
       " ('GO', 'Differentiation'),\n",
       " ('CL', 'Osteoblast'),\n",
       " ('GO', 'DiffDifferentia'),\n",
       " ('UBERON', 'bone marrow'),\n",
       " ('CL', 'stromal'),\n",
       " ('CL_GO_EXT', 'cellc'),\n",
       " ('CL', 'osteoblasts'),\n",
       " ('CL', 'adipocytes'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO', 'differentiation dnti'),\n",
       " ('CL', 'adipocyte'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('UBERON', 'bone marrow'),\n",
       " ('CL', 'stromal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('GO_RO_EXT', 'differentiate'),\n",
       " ('GO', 'osteogenic'),\n",
       " ('GO', 'adipogenic pathway'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'regulate'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('CL', 'neuroendocrine'),\n",
       " ('CHEBI_PR_EXT', 'leptin'),\n",
       " ('UBERON', 'nervous system'),\n",
       " ('GO_EXT', 'negativelnegatively'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'regregulat'),\n",
       " ('CL', 'adipocyte'),\n",
       " ('GO', 'differentiation'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('UBERON', 'embryos'),\n",
       " ('PR_EXT', 'Sam6S'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('CL', 'adipocytes'),\n",
       " ('GO', 'adipogenesis'),\n",
       " ('CL_GO_EXT', 'CeCel'),\n",
       " ('GO', 'adipogenesis'),\n",
       " ('GO', 'Adipogenesis'),\n",
       " ('SO_EXT', 'wild-tywi'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('CL', 'adipocyte'),\n",
       " ('GO', 'differentiation'),\n",
       " ('GO', 'expression'),\n",
       " ('GO_EXT', 'transcription factors'),\n",
       " ('PR_EXT', 'PPARγ'),\n",
       " ('PR_EXT', 'KLF5'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('GO', 'adipogeneadi'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('PR_EXT', 'SaSam'),\n",
       " ('GO', 'modulates'),\n",
       " ('GO', 'differentiation of'),\n",
       " ('CL', 'mesenchymal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('CL_GO_EXT', 'cell'),\n",
       " ('UBERON_EXT', 'embryonic'),\n",
       " ('UBERON', 'mesenchymal'),\n",
       " ('CL', 'multipotential'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('PR_EXT', 'BMP-2'),\n",
       " ('GO', 'osteoblast differentiation'),\n",
       " ('GO', 'expression'),\n",
       " ('PR_EXT', 'osteocalcin'),\n",
       " ('CL', 'OCN'),\n",
       " ('SO_EXT', 'gene'),\n",
       " ('CL_GO_EXT', 'cecel'),\n",
       " ('GO', 'transfected'),\n",
       " ('UBERON', 'irpin'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('CHEBI', 'puromycin'),\n",
       " ('GO', 'expression'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('PR_EXT', 'β-β-act'),\n",
       " ('GO', 'Osteoblast differentiatife'),\n",
       " ('GO', 'expressing'),\n",
       " ('PR_EXT', 'Sam68sh'),\n",
       " ('PR_EXT', 'BMP-2'),\n",
       " ('GO', 'expexpress'),\n",
       " ('PR_EXT', 'β-actin'),\n",
       " ('CHEBI_SO_EXT', 'mRNAs'),\n",
       " ('GO_EXT', 'RT'),\n",
       " ('PR_EXT', 'Sam68sh'),\n",
       " ('GO', 'expressing'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('CL', 'osteoblast'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('GO', 'expression'),\n",
       " ('GO_EXT', 'mineralized'),\n",
       " ('GO', 'nodule formation'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('UBERON', 'b'),\n",
       " ('CL', 'stromal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('GO', 'ha'),\n",
       " ('UBERON', 'irpin'),\n",
       " ('CHEBI_SO_EXT', 'RNA'),\n",
       " ('CHEBI_SO_EXT', 'shRNA'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'tissue'),\n",
       " ('CL', 'adipocytes'),\n",
       " ('CHEBI_EXT', 'fluorochrome'),\n",
       " ('CHEBI_SO_EXT', 'labeling'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'trabecular bone'),\n",
       " ('CHEBI_EXT', 'fluorochrome'),\n",
       " ('CHEBI_SO_EXT', 'labels'),\n",
       " ('UBERON_EXT', 'bones'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('SO_EXT', 'genotype'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'regulates'),\n",
       " ('GO', 'differentiatioerent'),\n",
       " ('UBERON', 'bone marrow'),\n",
       " ('CL', 'mesenchymal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('CL', 'adipocyte'),\n",
       " ('GO', 'differene diffe'),\n",
       " ('GO', 'osteoblast differentiation in aging bone'),\n",
       " ('GO_PATO_EXT', 'physiologip'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'modulate bone marrow'),\n",
       " ('CL', 'mesenchymal stem'),\n",
       " ('CL_GO_EXT', 'cellc'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('SO_EXT', 'wild-type'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', '+'),\n",
       " ('SO_EXT', 'wild-type'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('NCBITaxon', 'mammals'),\n",
       " ('PR_EXT', 'SamSa'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'animals'),\n",
       " ('UBERON_EXT', 'bone'),\n",
       " ('GO', 'aging'),\n",
       " ('GO', 'differene different'),\n",
       " ('UBERON', 'bone marrow'),\n",
       " ('CL', 'stem'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'mice'),\n",
       " ('UBERON', 'embryonic mesenchymal'),\n",
       " ('CL_GO_EXT', 'cells'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', 'shRNA'),\n",
       " ('CL', 'osteoblost'),\n",
       " ('GO', 'differentiation'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('GO', 'osteoblast differentiation'),\n",
       " ('PR_EXT', 'Sam68'),\n",
       " ('SO_EXT', '−'),\n",
       " ('SO_EXT', '−'),\n",
       " ('NCBITaxon', 'animals'),\n",
       " ...]"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mylist"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "data_dir = 'brat/'\n",
    "sec_doc_ids = [data_dir+fname.split('.')[0]+\".ann\" for fname in os.listdir(data_dir)]\n",
    "sec_doc_ids= np.unique(sec_doc_ids)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "#load file\n",
    "def txt_strtonum_feed(filename):\n",
    "    print(filename)\n",
    "    data = []\n",
    "    flag=True\n",
    "    with open(filename, 'r', encoding='UTF-8') as f:#with auto call close()\n",
    "        line = f.readline()\n",
    "        \n",
    "        while line:\n",
    "            read_data = line.split('\\n')\n",
    "            if flag:\n",
    "                flag=False\n",
    "                line = f.readline()\n",
    "                continue\n",
    "                \n",
    "            read_data = read_data[0].split('\\t')\n",
    "            #\"brat/12585968.ann\"末尾存在不符合规则的内容\n",
    "            if len(read_data) < 3:\n",
    "                line = f.readline()\n",
    "                continue\n",
    "            \n",
    "            first = read_data[1].split()[0].split(\":\")[0]\n",
    "            second = read_data[1].split()[0]\n",
    "            third=read_data[2]\n",
    "            data.append((first,second,third))\n",
    "            line = f.readline()\n",
    "        return data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "brat/12585968.ann\n"
     ]
    }
   ],
   "source": [
    "data_ = txt_strtonum_feed(\"brat/12585968.ann\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "brat/11319941.ann\n",
      "brat/11532192.ann\n",
      "brat/11597317.ann\n",
      "brat/11604102.ann\n",
      "brat/11897010.ann\n",
      "brat/12079497.ann\n",
      "brat/12546709.ann\n",
      "brat/12585968.ann\n",
      "brat/12925238.ann\n",
      "brat/14609438.ann\n",
      "brat/14611657.ann\n",
      "brat/14624252.ann\n",
      "brat/14675480.ann\n",
      "brat/14691534.ann\n",
      "brat/14723793.ann\n",
      "brat/14737183.ann\n",
      "brat/15005800.ann\n",
      "brat/15018652.ann\n",
      "brat/15040800.ann\n",
      "brat/15061865.ann\n",
      "brat/15070402.ann\n",
      "brat/15207008.ann\n",
      "brat/15238161.ann\n",
      "brat/15314655.ann\n",
      "brat/15314659.ann\n",
      "brat/15320950.ann\n",
      "brat/15328533.ann\n",
      "brat/15328538.ann\n",
      "brat/15345036.ann\n",
      "brat/15492776.ann\n",
      "brat/15550985.ann\n",
      "brat/15560850.ann\n",
      "brat/15588329.ann\n",
      "brat/15615595.ann\n",
      "brat/15619330.ann\n",
      "brat/15630473.ann\n",
      "brat/15676071.ann\n",
      "brat/15760270.ann\n",
      "brat/15784609.ann\n",
      "brat/15819996.ann\n",
      "brat/15836427.ann\n",
      "brat/15850489.ann\n",
      "brat/15876356.ann\n",
      "brat/15882093.ann\n",
      "brat/15917436.ann\n",
      "brat/15921521.ann\n",
      "brat/15938754.ann\n",
      "brat/16026622.ann\n",
      "brat/16027110.ann\n",
      "brat/16098226.ann\n",
      "brat/16103912.ann\n",
      "brat/16109169.ann\n",
      "brat/16110338.ann\n",
      "brat/16121255.ann\n",
      "brat/16121256.ann\n",
      "brat/16216087.ann\n",
      "brat/16221973.ann\n",
      "brat/16255782.ann\n",
      "brat/16279840.ann\n",
      "brat/16362077.ann\n",
      "brat/16410827.ann\n",
      "brat/16433929.ann\n",
      "brat/16462940.ann\n",
      "brat/16504143.ann\n",
      "brat/16504174.ann\n",
      "brat/16507151.ann\n",
      "brat/16517939.ann\n",
      "brat/16539743.ann\n",
      "brat/16579849.ann\n",
      "brat/16611361.ann\n",
      "brat/16628246.ann\n",
      "brat/16670015.ann\n",
      "brat/16700629.ann\n",
      "brat/16787536.ann\n",
      "brat/16800892.ann\n",
      "brat/16870721.ann\n",
      "brat/16968134.ann\n",
      "brat/17002498.ann\n",
      "brat/17020410.ann\n",
      "brat/17022820.ann\n",
      "brat/17029558.ann\n",
      "brat/17069463.ann\n",
      "brat/17078885.ann\n",
      "brat/17083276.ann\n",
      "brat/17194222.ann\n",
      "brat/17201918.ann\n",
      "brat/17206865.ann\n",
      "brat/17244351.ann\n",
      "brat/17425782.ann\n",
      "brat/17447844.ann\n",
      "brat/17465682.ann\n",
      "brat/17503968.ann\n",
      "brat/17565376.ann\n",
      "brat/17590087.ann\n",
      "brat/17608565.ann\n",
      "brat/17677002.ann\n",
      "brat/17696610.ann\n"
     ]
    }
   ],
   "source": [
    "data_ = []\n",
    "for i in sec_doc_ids:\n",
    "    data_+=(txt_strtonum_feed(i))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "uni_data_ = list(set(data_))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('GO', 'GO:0006914', 'autophagy'),\n",
       " ('GO_EXT', 'GO_EXT:0015267', 'channel pore'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_variant_entity', 'Variant'),\n",
       " ('SO_EXT', 'SO_EXT:0000346', 'loxP ... sites'),\n",
       " ('CHEBI', 'CHEBI:52071', 'Dextran'),\n",
       " ('GO_EXT', 'GO_EXT:oligomeric_macromolecular_complex', 'oligomeric'),\n",
       " ('GO', 'GO:0061138', 'branching morphogenesis of epithelium'),\n",
       " ('GO_EXT', 'GO_EXT:0022836', 'gated channel'),\n",
       " ('CHEBI', 'CHEBI:41218', 'β-mercaptoethanol'),\n",
       " ('GO', 'GO:0065007', 'governs'),\n",
       " ('GO', 'GO:0006281', 'repairing'),\n",
       " ('CL', 'CL:0000084', 'T cell'),\n",
       " ('GO', 'GO:0021982', 'development of ... pineal gland'),\n",
       " ('UBERON', 'UBERON:0004681', 'vestibular system'),\n",
       " ('GO_EXT', 'GO_EXT:0034061', 'DNA polymerase'),\n",
       " ('UBERON', 'UBERON:0009201', 'nephric duct'),\n",
       " ('UBERON', 'UBERON:0005483', 'thymic lobes'),\n",
       " ('GO', 'GO:0001658', 'Branching morphogenesis of ... ureteric bud'),\n",
       " ('GO_EXT', 'GO_EXT:biological_mover_or_transporter', 'transporter'),\n",
       " ('UBERON', 'UBERON:0000004', 'nasal'),\n",
       " ('GO', 'GO:0003151', 'OFT morphogenesis'),\n",
       " ('UBERON', 'UBERON:0000180', 'flanks'),\n",
       " ('UBERON', 'UBERON:0001884', 'phrenic nerve'),\n",
       " ('GO', 'GO:0030141', 'secretory granules'),\n",
       " ('GO_PR_EXT', 'GO_PR_EXT:SMAD', 'SMAD'),\n",
       " ('UBERON', 'UBERON:0005335', 'chorioallantoic'),\n",
       " ('UBERON', 'UBERON:0002063', 'systemic venous sinus'),\n",
       " ('GO', 'GO:0006451', 'translational read-through'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:51217', 'fluorochrome'),\n",
       " ('GO', 'GO:0000239', 'pachynema'),\n",
       " ('PR_EXT', 'PR_EXT:000012826', 'uPA'),\n",
       " ('SO_EXT', 'SO_EXT:wild_type_entity', 'wildtype'),\n",
       " ('PR_EXT', 'PR_EXT:P22810', 'otd'),\n",
       " ('UBERON', 'UBERON:0001091', 'Teeth'),\n",
       " ('CHEBI', 'CHEBI:6121', 'Ketamine'),\n",
       " ('CHEBI', 'CHEBI:27958', 'cocaine'),\n",
       " ('PR_EXT', 'PR_EXT:000009158', 'inositol 1,4,5-triphosphate receptor 1'),\n",
       " ('CL', 'CL:0000601', 'Outer hair cells'),\n",
       " ('PR_EXT', 'PR_EXT:000013449', 'SHP-2'),\n",
       " ('GO', 'GO:0007618', 'mating'),\n",
       " ('NCBITaxon', 'NCBITaxon:9615', 'dogs'),\n",
       " ('PR_EXT', 'PR_EXT:carbonic_anhydrase_2', 'CAII'),\n",
       " ('GO_EXT', 'GO_EXT:0015666', 'Restriction enzymes'),\n",
       " ('UBERON', 'UBERON:0016538', 'isocortex temporalis'),\n",
       " ('PR_EXT', 'PR_EXT:000005591', 'CLN3'),\n",
       " ('GO', 'GO:0006412', 'protein biogenesis'),\n",
       " ('UBERON', 'UBERON:0000331', 'ileum mucosa'),\n",
       " ('GO_EXT', 'GO_EXT:0004890', 'GABAA receptors'),\n",
       " ('SO', 'SO:0000985', 'double strand'),\n",
       " ('UBERON', 'UBERON:0002107', 'hepatic'),\n",
       " ('GO', 'GO:0006750', 'glutathione synthesis'),\n",
       " ('PR_EXT', 'PR_EXT:000009640', 'lethal(3) malignant brain tumor'),\n",
       " ('CHEBI', 'CHEBI:31264', 'Hyamine'),\n",
       " ('UBERON', 'UBERON:0008200', 'forehead'),\n",
       " ('GO', 'GO:0005911', 'junction of ... cells with ... cells'),\n",
       " ('GO_EXT', 'GO_EXT:muscle_structure_or_tissue_development', 'myogenic'),\n",
       " ('PR_EXT', 'PR_EXT:000001393', 'interleukin-6'),\n",
       " ('UBERON', 'UBERON:0001885', 'dentate gyrus of ... hippocampus'),\n",
       " ('SO_EXT', 'SO_EXT:0000121', 'forward orientation primers'),\n",
       " ('UBERON', 'UBERON:0000204', 'ventral telencephalic'),\n",
       " ('GO_EXT',\n",
       "  'GO_EXT:antibody_or_immunoglobulin_biosynthesis_or_production',\n",
       "  'production of ... antibodies'),\n",
       " ('GO', 'GO:0015031', 'movement ... of proteins'),\n",
       " ('PR_EXT', 'PR_EXT:000008940', 'Ttc10'),\n",
       " ('UBERON', 'UBERON:0001790', 'outer plexiform layer ... of ... retinas'),\n",
       " ('PR_EXT',\n",
       "  'PR_EXT:vascuar_endothelial_growth_factor',\n",
       "  'Vascular endothelial growth factor'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:dNTP', 'deoxynucleotide triphosphate'),\n",
       " ('PR_EXT', 'PR_EXT:000005836', 'MCPT'),\n",
       " ('GO', 'GO:0042694', 'specification of ... muscle cells'),\n",
       " ('CHEBI', 'CHEBI:119915', 'fentanyl'),\n",
       " ('CL', 'CL:0002322', 'ES-cell'),\n",
       " ('UBERON', 'UBERON:0001720', 'cochlear nuclei'),\n",
       " ('PR_EXT', 'PR_EXT:000006543', 'Dmrt2'),\n",
       " ('PR_EXT', 'PR_EXT:000015305', 'Smug1'),\n",
       " ('PR_EXT', 'PR_EXT:000014702', 'Plg ... activator inhibitor'),\n",
       " ('GO', 'GO:0034675', 'alpha-6 beta-1 integrin'),\n",
       " ('GO', 'GO:0008355', 'olfactory ... learning'),\n",
       " ('GO', 'GO:0060173', 'limb development'),\n",
       " ('CHEBI', 'CHEBI:15346', 'CoASH'),\n",
       " ('UBERON', 'UBERON:0007688', 'anlage'),\n",
       " ('UBERON', 'UBERON:0007232', 'two-cell ... stages'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_insertion_entity_or_process', 'insertional'),\n",
       " ('CHEBI_GO_EXT',\n",
       "  'CHEBI_GO_EXT:biological_process_or_quality_or_role',\n",
       "  'Biological'),\n",
       " ('UBERON', 'UBERON:0010210', 'Thrombus'),\n",
       " ('GO', 'GO:0001503', 'ostegenic'),\n",
       " ('PR_EXT', 'PR_EXT:000007924', 'Gdf6'),\n",
       " ('PR_EXT', 'PR_EXT:000005121', 'Ccnd1'),\n",
       " ('SO_EXT', 'SO_EXT:0000153', 'BAC vector'),\n",
       " ('NCBITaxon', 'NCBITaxon:9255', 'egg-laying mammal'),\n",
       " ('UBERON', 'UBERON:0005409', 'Gastrointestinal'),\n",
       " ('GO', 'GO:0042571', 'Abs'),\n",
       " ('UBERON_EXT',\n",
       "  'UBERON_EXT:embryonic_stage_or_stage_part',\n",
       "  'embryonic ... stage'),\n",
       " ('GO', 'GO:0005930', 'axoneme'),\n",
       " ('CHEBI', 'CHEBI:16134', 'ammonia'),\n",
       " ('UBERON', 'UBERON:0001003', 'Skin Epidermis'),\n",
       " ('GO', 'GO:0032391', 'connecting cilia'),\n",
       " ('GO_SO_EXT',\n",
       "  'GO_SO_EXT:chromosomal_part_or_position_or_region_or_site',\n",
       "  'loci on chr.'),\n",
       " ('CL', 'CL:0000187', 'muscle fibre'),\n",
       " ('GO', 'GO:0060318', 'Definitive Erythropoiesis'),\n",
       " ('SO_EXT', 'SO_EXT:0000018', 'linkage groups'),\n",
       " ('GO', 'GO:0008283', 'cell ... proliferation'),\n",
       " ('PR_EXT', 'PR_EXT:000017443', 'Wnt-3a'),\n",
       " ('CHEBI', 'CHEBI:27338', 'Xylene'),\n",
       " ('UBERON', 'UBERON:0000115', 'epithelium of ... lung'),\n",
       " ('GO', 'GO:0006915', 'apoptosis'),\n",
       " ('SO_EXT', 'SO_EXT:1001187', 'alternatively spliced ... transcript'),\n",
       " ('PR_EXT', 'PR_EXT:000004080', 'AnxA7'),\n",
       " ('CHEBI_CHMO_EXT', 'CHEBI_CHMO_EXT:buffer_solution', 'Buffer'),\n",
       " ('GO_EXT', 'GO_EXT:0034061', 'DNA Polymerase'),\n",
       " ('UBERON', 'UBERON:0002063', 'sinus venosus'),\n",
       " ('GO_PR_EXT', 'GO_PR_EXT:glutathione_disulfide_reductase', 'Gsr'),\n",
       " ('PR_EXT', 'PR_EXT:000010252', 'cup-5'),\n",
       " ('GO', 'GO:0007494', 'development of ... mid ... gut'),\n",
       " ('GO', 'GO:0005980', 'glycogen breakdown'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:24869', 'ionophore'),\n",
       " ('NCBITaxon', 'NCBITaxon:40674', 'Mammalian'),\n",
       " ('GO', 'GO:0019249', 'Lactate Production'),\n",
       " ('GO_PR_EXT', 'GO_PR_EXT:estrogen_receptor', 'estrogen receptor'),\n",
       " ('UBERON', 'UBERON:0005381', 'granule cell layer of ... dentate gyrus'),\n",
       " ('CHEBI', 'CHEBI:16976', 'hygromycin B'),\n",
       " ('UBERON', 'UBERON:0000387', 'meniscus'),\n",
       " ('GO', 'GO:0031507', 'formation of ... heterochromatin domain'),\n",
       " ('PR_EXT', 'PR_EXT:000004183', 'AQP3'),\n",
       " ('GO', 'GO:0071944', 'periphery of ... cells'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'mutants'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:52217', 'pharmacological'),\n",
       " ('GO_EXT', 'GO_EXT:0030594', 'neurotransmitter receptors'),\n",
       " ('GO_PR_EXT', 'GO_PR_EXT:lipoprotein_lipase', 'Lpl'),\n",
       " ('CL', 'CL:0000214', 'synovial cells'),\n",
       " ('CHEBI', 'CHEBI:48518', 'IBMX'),\n",
       " ('CL', 'CL:0010009', 'retinal photoreceptor cells'),\n",
       " ('CHEBI_GO_EXT', 'CHEBI_GO_EXT:hemoglobin', 'haemoglobin'),\n",
       " ('PR_EXT', 'PR_EXT:000016649', 'tif1α'),\n",
       " ('GO', 'GO:0006631', 'metabolism of fatty acids'),\n",
       " ('GO_EXT', 'GO_EXT:biological_mover_or_transporter', 'carrier'),\n",
       " ('UBERON', 'UBERON:0000160', 'intestines'),\n",
       " ('UBERON', 'UBERON:0011768', 'pineal gland'),\n",
       " ('CL', 'CL:0000738', 'white blood cells'),\n",
       " ('PR_EXT', 'PR_EXT:000006516', 'guanylate kinase domain-associated protein'),\n",
       " ('GO', 'GO:0035295', 'canal formation'),\n",
       " ('SO_EXT', 'SO_EXT:wild_type_entity', 'wild-type'),\n",
       " ('PR_EXT', 'PR_EXT:000009322', 'kinesin superfamily–associated protein 3'),\n",
       " ('GO', 'GO:0032774', 'RNA synthesis'),\n",
       " ('CHEBI', 'CHEBI:23995', 'N-ethyl-N-nitrosourea'),\n",
       " ('CL', 'CL:0000451', 'dendritic cells'),\n",
       " ('GO', 'GO:0044838', 'Cellular Quiescence'),\n",
       " ('PR_EXT', 'PR_EXT:000010877', 'Myogenin'),\n",
       " ('UBERON_EXT', 'UBERON_EXT:placode', 'placode'),\n",
       " ('UBERON', 'UBERON:0003062', 'node'),\n",
       " ('UBERON', 'UBERON:0000013', 'sympathetic nervous system'),\n",
       " ('CL', 'CL:0000352', 'epiblast cells'),\n",
       " ('CL', 'CL:0000598', 'pyramidal cell'),\n",
       " ('PR_EXT', 'PR_EXT:000010335', 'c-Met'),\n",
       " ('PR_EXT', 'PR_EXT:000010925', 'Mt1'),\n",
       " ('MOP', 'MOP:0000780', 'cleavages'),\n",
       " ('PR_EXT', 'PR_EXT:000035365', 'Aurora kinases'),\n",
       " ('UBERON', 'UBERON:0000483', 'pithelial'),\n",
       " ('PR_EXT', 'PR_EXT:000037797', 'PAX'),\n",
       " ('UBERON', 'UBERON:0002282', 'Stria vascularis'),\n",
       " ('GO', 'GO:0030097', 'Hematopoiesis'),\n",
       " ('UBERON', 'UBERON:0002137', 'ao-v'),\n",
       " ('UBERON', 'UBERON:0009911', 'lobule'),\n",
       " ('GO', 'GO:0007608', 'sense of smell'),\n",
       " ('GO', 'GO:0005856', 'skeleton'),\n",
       " ('PR_EXT', 'PR_EXT:P23940', 'BamH1'),\n",
       " ('UBERON', 'UBERON:0001584', 'left subclavian artery'),\n",
       " ('CL', 'CL:0000745', 'horizontal ... cells'),\n",
       " ('UBERON', 'UBERON:0003081', 'lateral mesoderm'),\n",
       " ('GO', 'GO:0005960', 'glycine cleavage system'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:25435', 'mutagen'),\n",
       " ('GO', 'GO:0097427', 'microtubule bundles'),\n",
       " ('SO_EXT', 'SO_EXT:0000236', 'open reading frame'),\n",
       " ('GO', 'GO:0007169', 'receptor tyrosine kinase signaling'),\n",
       " ('GO', 'GO:0006812', 'cationic conductances'),\n",
       " ('UBERON', 'UBERON:0000309', 'body wall'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_rescue_process', 'Rescued'),\n",
       " ('NCBITaxon', 'NCBITaxon:7955', 'Zebrafish'),\n",
       " ('UBERON', 'UBERON:0007688', 'field'),\n",
       " ('PR_EXT', 'PR_EXT:000005015', 'm-80 k subunit'),\n",
       " ('GO', 'GO:0043652', 'apoptotic cell ... uptake'),\n",
       " ('PR_EXT', 'PR_EXT:Q92830', 'hGCN5L2'),\n",
       " ('UBERON', 'UBERON:0006766', 'r-svc'),\n",
       " ('GO', 'GO:0006406', 'mRNA nuclear export'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:glycerol_1_phosphate', 'glycerol-3-phosphate'),\n",
       " ('PR_EXT', 'PR_EXT:000001016', 'CD45RB'),\n",
       " ('GO_SO_EXT',\n",
       "  'GO_SO_EXT:sequence_transposition_entity_or_process',\n",
       "  'transposition'),\n",
       " ('SO_EXT', 'SO_EXT:0000318', 'start codon'),\n",
       " ('GO', 'GO:0033598', 'mammary epithelial cell proliferation'),\n",
       " ('PR_EXT', 'PR_EXT:000010425', 'Mki67'),\n",
       " ('GO', 'GO:0042384', 'ciliogenesis'),\n",
       " ('CHEBI', 'CHEBI:33839', 'polymer'),\n",
       " ('GO', 'GO:0005741', 'outer membrane of mitochondria'),\n",
       " ('CHEBI', 'CHEBI:16842', 'formaldehyde'),\n",
       " ('PR_EXT', 'PR_EXT:000016655', 'tif1γ'),\n",
       " ('GO_PATO_EXT',\n",
       "  'GO_PATO_EXT:biological_localization_process_or_quality',\n",
       "  'localizes'),\n",
       " ('CHEBI', 'CHEBI:52646', 'leptomycin B'),\n",
       " ('PR_EXT', 'PR_EXT:000003090', 'p27Kip1'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'Mut'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_coding_function', 'encodes'),\n",
       " ('PR_EXT', 'PR_EXT:000006901', 'early endosome antigen 1'),\n",
       " ('PR_EXT', 'PR_EXT:000007500', 'FGF9'),\n",
       " ('UBERON', 'UBERON:0004198', 'comma-shaped bodies'),\n",
       " ('PR_EXT', 'PR_EXT:000014662', 'selenoprotein W'),\n",
       " ('GO', 'GO:0019432', 'Triglyceride synthesis'),\n",
       " ('CHEBI', 'CHEBI:60004', 'Mix'),\n",
       " ('UBERON', 'UBERON:0000976', 'humeri'),\n",
       " ('PR_EXT', 'PR_EXT:000009235', 'plakoglobin'),\n",
       " ('PR', 'PR:000026878', 'activated caspase-3'),\n",
       " ('PR_EXT', 'PR_EXT:000010443', 'MLH3'),\n",
       " ('GO_EXT', 'GO_EXT:dimer_macromolecular_complex', 'dimers'),\n",
       " ('UBERON', 'UBERON:0002049', 'vasculature'),\n",
       " ('UBERON', 'UBERON:0000991', 'g'),\n",
       " ('GO', 'GO:0007219', 'notch signal pathway'),\n",
       " ('NCBITaxon', 'NCBITaxon:10090', 'Mm'),\n",
       " ('GO', 'GO:0015031', 'transport ... of ... proteins'),\n",
       " ('PR_EXT', 'PR_EXT:Q9V9W8', 'pygopus'),\n",
       " ('PR_EXT', 'PR_EXT:000010127', 'MKK5'),\n",
       " ('GO_PR_EXT',\n",
       "  'GO_PR_EXT:transforming_growth_factor_beta_receptor_type_II',\n",
       "  'type II receptors'),\n",
       " ('GO_PR_EXT',\n",
       "  'GO_PR_EXT:transforming_growth_factor_beta_receptor_type_I',\n",
       "  'TGF-β ... type I receptors'),\n",
       " ('GO', 'GO:0015031', 'transport of proteins'),\n",
       " ('UBERON', 'UBERON:0002135', 'mv'),\n",
       " ('PR_EXT', 'PR_EXT:P90916', 'lin-53'),\n",
       " ('CL', 'CL:0000746', 'cardiomyocytes'),\n",
       " ('GO', 'GO:0008610', 'lipogenesis'),\n",
       " ('GO_PR_EXT',\n",
       "  'GO_PR_EXT:transforming_growth_factor_beta_receptor_type_II',\n",
       "  'Tgf-β2'),\n",
       " ('UBERON', 'UBERON:0001872', 'parietal lobe'),\n",
       " ('UBERON', 'UBERON:0001853', 'utricular'),\n",
       " ('UBERON', 'UBERON:0006562', 'pharyngeal'),\n",
       " ('GO_EXT', 'GO_EXT:reaction_or_response', 'react'),\n",
       " ('CHEBI', 'CHEBI:35366', 'fatty-acid'),\n",
       " ('GO_PR_EXT',\n",
       "  'GO_PR_EXT:transforming_growth_factor_beta_receptor_type_II',\n",
       "  'TGF-β ... type II receptor'),\n",
       " ('NCBITaxon', 'NCBITaxon:10088', 'mice'),\n",
       " ('CL', 'CL:0000007', 'early embryonic cells'),\n",
       " ('CHEBI', 'CHEBI:35607', 'sodium ortho-vanadate'),\n",
       " ('PR_EXT', 'PR_EXT:P39723', 'spc72'),\n",
       " ('GO', 'GO:0007601', 'visually'),\n",
       " ('SO_EXT', 'SO_EXT:0000200', 'first coding exon'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:EDTA_sodium_salt', 'NaEDTA'),\n",
       " ('UBERON', 'UBERON:0003450', 'maxillary incisors'),\n",
       " ('PR_EXT', 'PR_EXT:P31111', 'ZIP1'),\n",
       " ('PR_EXT', 'PR_EXT:000006427', 'desmin'),\n",
       " ('CHEBI', 'CHEBI:29103', 'K+'),\n",
       " ('GO', 'GO:0006887', 'exocytotic'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:riboprobe', 'Riboprobe'),\n",
       " ('SO_EXT', 'SO_EXT:0000155', 'plasmids'),\n",
       " ('SO_EXT', 'SO_EXT:0000842', 'regions of ... gene'),\n",
       " ('GO', 'GO:0046983', 'dimerization'),\n",
       " ('SO_EXT', 'SO_EXT:0000132', 'reverse-strand ... primer'),\n",
       " ('GO_EXT', 'GO_EXT:reaction_or_response', 'responding'),\n",
       " ('MOP', 'MOP:0000629', 'polymerizes'),\n",
       " ('PR_EXT', 'PR_EXT:000001177', 'dopamine D2Rs'),\n",
       " ('UBERON', 'UBERON:0001872', 'parietal'),\n",
       " ('GO', 'GO:0065007', 'Controlling'),\n",
       " ('UBERON', 'UBERON:0003215', 'alveolus'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_duplication_process', 'duplicated'),\n",
       " ('GO', 'GO:0007212', 'dopamine signaling'),\n",
       " ('PR_EXT', 'PR_EXT:000016642', 'Tripartite motif protein family member 11'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:alanine', 'Ala'),\n",
       " ('UBERON', 'UBERON:0011919', 'Yolk sac blood islands'),\n",
       " ('PR_EXT', 'PR_EXT:000003912', 'Akt2'),\n",
       " ('UBERON', 'UBERON:0001811', 'conjuctival'),\n",
       " ('UBERON', 'UBERON:0004369', 'rm'),\n",
       " ('GO', 'GO:0060215', 'primitive embryonic ... hematopoiesis'),\n",
       " ('CL', 'CL:0000010', 'Cultured ... Cells'),\n",
       " ('CHEBI_SO_EXT',\n",
       "  'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag',\n",
       "  'markers'),\n",
       " ('GO', 'GO:0048870', 'movement of ... cells'),\n",
       " ('PR_EXT', 'PR_EXT:000016340', 'Timeless'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_alteration_entity_or_process', 'Modification'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:C_terminus_or_C_terminal_region', 'C-termini'),\n",
       " ('GO', 'GO:0030301', 'transfer of cholesterol'),\n",
       " ('CHEBI', 'CHEBI:17996', 'chloride'),\n",
       " ('UBERON', 'UBERON:0009911', 'lobules'),\n",
       " ('PR_EXT', 'PR_EXT:000003041', 'TOR'),\n",
       " ('PR_EXT', 'PR_EXT:000012879', 'PLP'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:phosphoprotein', 'phosphoprotein'),\n",
       " ('GO_EXT', 'GO_EXT:myelin_assembly_or_myelination', 'myelination'),\n",
       " ('GO', 'GO:0050673', 'epithelial cell proliferation'),\n",
       " ('CL', 'CL:0000128', 'oligodendrocyte'),\n",
       " ('NCBITaxon', 'NCBITaxon:9606', 'human individual'),\n",
       " ('UBERON', 'UBERON:0002049', 'vascular network'),\n",
       " ('NCBITaxon', 'NCBITaxon:11801', 'M-MLV'),\n",
       " ('GO', 'GO:0001503', 'osteogenic'),\n",
       " ('GO', 'GO:0036367', 'photopic ... responses'),\n",
       " ('PR_EXT', 'PR_EXT:000010873', 'Myoc'),\n",
       " ('CL', 'CL:0000335', 'condensing ... mesenchymal cells'),\n",
       " ('GO', 'GO:0030218', 'erythropoiesis'),\n",
       " ('GO', 'GO:0006826', 'iron transport'),\n",
       " ('CL', 'CL:0000763', 'myeloid cells'),\n",
       " ('GO', 'GO:0097511', 'dendritic'),\n",
       " ('PR_EXT', 'PR_EXT:000004984', 'calreticulin'),\n",
       " ('GO_EXT', 'GO_EXT:0019212', 'phosphatase inhibitors'),\n",
       " ('UBERON', 'UBERON:0002387', 'hindfeet'),\n",
       " ('GO', 'GO:0050917', 'umami taste'),\n",
       " ('UBERON', 'UBERON:0002137', 'aortic valve'),\n",
       " ('CHEBI', 'CHEBI:51766', 'Alexa 568'),\n",
       " ('CHEBI_GO_EXT',\n",
       "  'CHEBI_GO_EXT:phosphoprotein_phosphatase_inhibitor',\n",
       "  'protein phosphatase inhibitor'),\n",
       " ('UBERON', 'UBERON:0001488', 'joints ... ankle'),\n",
       " ('PR_EXT', 'PR_EXT:000014364', 'runx2'),\n",
       " ('PR_EXT', 'PR_EXT:000013773', 'retinoblastoma protein'),\n",
       " ('CL', 'CL:0002212', 'type ... II fibers'),\n",
       " ('UBERON', 'UBERON:0002450', 'deciduas'),\n",
       " ('UBERON', 'UBERON:0000080', 'mesonephric'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:glycine', 'glycine'),\n",
       " ('CHEBI', 'CHEBI:23447', 'cyclic nucleotide'),\n",
       " ('GO', 'GO:0048339', 'paraxial mesoderm formation'),\n",
       " ('UBERON', 'UBERON:0005805', 'dorsal aorta'),\n",
       " ('PR_EXT', 'PR_EXT:000013524', 'Pygo2'),\n",
       " ('CHEBI', 'CHEBI:37983', '35S'),\n",
       " ('CHEBI_SO_EXT',\n",
       "  'CHEBI_SO_EXT:molecular_label_or_mark_or_tag_process',\n",
       "  'labels'),\n",
       " ('UBERON', 'UBERON:0003651', 'metatarsal II'),\n",
       " ('GO', 'GO:0048665', 'neuron fate specification'),\n",
       " ('GO_EXT', 'GO_EXT:0001055', 'Pol II'),\n",
       " ('GO', 'GO:0006272', '3′- ... extension'),\n",
       " ('PR_EXT', 'PR_EXT:000001831', 'Prdm1'),\n",
       " ('CL', 'CL:0000117', 'CNS neurons'),\n",
       " ('CHEBI', 'CHEBI:51461', 'Sybr green'),\n",
       " ('PR_EXT', 'PR_EXT:P46675', 'stu2'),\n",
       " ('CL', 'CL:0000609', 'VHC'),\n",
       " ('NCBITaxon_UBERON_EXT', 'NCBITaxon_UBERON_EXT:pup', 'pup'),\n",
       " ('UBERON', 'UBERON:0003983', 'conus'),\n",
       " ('CL', 'CL:0000145', 'antigen presenting cells'),\n",
       " ('GO', 'GO:0061743', 'motor learning'),\n",
       " ('NCBITaxon', 'NCBITaxon:4679', 'onion'),\n",
       " ('GO_PR_EXT',\n",
       "  'GO_PR_EXT:epidermal_growth_factor_receptor',\n",
       "  'epidermal growth factor receptor'),\n",
       " ('CL', 'CL:0000813', 'memory T-cells'),\n",
       " ('CL', 'CL:0000080', 'circulating ... cells'),\n",
       " ('GO', 'GO:0009048', 'X-inactivation'),\n",
       " ('PR_EXT', 'PR_EXT:000016043', 'Tal1'),\n",
       " ('PR_EXT', 'PR_EXT:P47043', 'zinc-responsive activator protein 1'),\n",
       " ('UBERON', 'UBERON:0008776', 'primitive endoderm'),\n",
       " ('CHEBI', 'CHEBI:76777', 'polyinosinic ... acid'),\n",
       " ('UBERON', 'UBERON:0001853', 'ut'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:proline', 'Pro'),\n",
       " ('CHEBI', 'CHEBI:14314', 'glucose 6-phosphate'),\n",
       " ('NCBITaxon', 'NCBITaxon:8088', 'Medaka fish'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:lead', 'lead'),\n",
       " ('GO', 'GO:0016071', 'mRNA metabolism'),\n",
       " ('UBERON', 'UBERON:0002107', 'L'),\n",
       " ('UBERON', 'UBERON:0002106', 'Spleen'),\n",
       " ('PR_EXT', 'PR_EXT:000016321', 'THRB'),\n",
       " ('GO', 'GO:0014051', 'gamma-aminobutyric acid release'),\n",
       " ('NCBITaxon', 'NCBITaxon:7165', 'anopheles gambiae'),\n",
       " ('UBERON', 'UBERON:0002489', 'coronal sutures'),\n",
       " ('CHEBI', 'CHEBI:80774', 'tauroursodeoxycholic acid'),\n",
       " ('PR_EXT', 'PR_EXT:000002061', 'Lamp 2'),\n",
       " ('CHEBI', 'CHEBI:15377', 'Aqueous'),\n",
       " ('UBERON', 'UBERON:0011270', 'back'),\n",
       " ('PR_EXT', 'PR_EXT:000021997', 'Trk receptors'),\n",
       " ('PR_EXT', 'PR_EXT:000016904', 'Tas2r124'),\n",
       " ('UBERON', 'UBERON:0000958', 'medullary zone'),\n",
       " ('GO', 'GO:0048568', 'embryonic ... organogenesis'),\n",
       " ('PR_EXT', 'PR_EXT:000009495', 'keratin 8'),\n",
       " ('PR_EXT', 'PR_EXT:000014702', 'PAI'),\n",
       " ('CL', 'CL:0000137', 'osteocytes'),\n",
       " ('UBERON', 'UBERON:0008959', 'bullae'),\n",
       " ('PR_EXT', 'PR_EXT:000013776', 'p48'),\n",
       " ('UBERON', 'UBERON:0001473', 'lymphatics'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:NMDA', 'NMDA'),\n",
       " ('GO', 'GO:0007059', 'segregation of ... chromosomes'),\n",
       " ('GO', 'GO:0006915', 'cellular ... apoptosis'),\n",
       " ('GO', 'GO:0008282', 'KATP ... channel'),\n",
       " ('PATO_UBERON_EXT',\n",
       "  'PATO_UBERON_EXT:trabeculation_entity_or_quality',\n",
       "  'trabecular'),\n",
       " ('GO', 'GO:0008406', 'gonad organogenesis'),\n",
       " ('PR_EXT', 'PR_EXT:000001904', 'PECAM1'),\n",
       " ('CHEBI', 'CHEBI:53424', 'T'),\n",
       " ('CHEBI', 'CHEBI:16866', 'alizarin red'),\n",
       " ('CHEBI', 'CHEBI:8502', 'PROP'),\n",
       " ('NCBITaxon', 'NCBITaxon:7227', 'D. melanogaster'),\n",
       " ('UBERON', 'UBERON:0005358', 'ventricular'),\n",
       " ('SO_EXT', 'SO_EXT:0000317', 'cDNA clone'),\n",
       " ('CL_EXT', 'CL_EXT:neural_crest_cell', 'neural crest ... cell'),\n",
       " ('GO', 'GO:0006413', 'translation start'),\n",
       " ('GO_EXT', 'GO_EXT:regulator', 'Regulator'),\n",
       " ('CHEBI_GO_EXT', 'CHEBI_GO_EXT:ligand', 'Ligand'),\n",
       " ('UBERON', 'UBERON:0001841', 'anterior ... canals'),\n",
       " ('CHEBI', 'CHEBI:37972', '32P'),\n",
       " ('GO', 'GO:0003406', 'formation of ... retinal-pigmented epithelium'),\n",
       " ('GO', 'GO:0010468', 'regulation of ... expression'),\n",
       " ('UBERON', 'UBERON:0002929', 'pyramidal'),\n",
       " ('PR_EXT', 'PR_EXT:000006928', 'epidermal growth factor'),\n",
       " ('GO', 'GO:0042384', 'Cilia Formation'),\n",
       " ('CHEBI', 'CHEBI:3312', 'CaCl2'),\n",
       " ('PR_EXT', 'PR_EXT:000016652', 'TIF1β'),\n",
       " ('GO', 'GO:0005730', 'nucleoli'),\n",
       " ('CHEBI', 'CHEBI:18022', 'thiocyanate'),\n",
       " ('UBERON', 'UBERON:0000955', 'brain'),\n",
       " ('CHEBI', 'CHEBI:4450', 'dDAVP'),\n",
       " ('UBERON', 'UBERON:0004339', 'calvarial'),\n",
       " ('UBERON', 'UBERON:0016530', 'parietal neocortex'),\n",
       " ('PR_EXT', 'PR_EXT:000002087', 'Stat1'),\n",
       " ('PR_EXT', 'PR_EXT:000013059', 'PGC-1α'),\n",
       " ('CL', 'CL:0000775', 'N'),\n",
       " ('GO_EXT', 'GO_EXT:0005017', 'PDGFR'),\n",
       " ('PR_EXT', 'PR_EXT:000011441', 'NSD1'),\n",
       " ('GO', 'GO:0005769', 'early ... endosomes'),\n",
       " ('PR_EXT', 'PR_EXT:000022320', 'CorA'),\n",
       " ('GO_EXT', 'GO_EXT:biological_direction_or_guidance', 'guide'),\n",
       " ('PR_EXT', 'PR_EXT:000015417', 'Sox1'),\n",
       " ('PR_EXT', 'PR_EXT:000004503', 'Atrx'),\n",
       " ('GO', 'GO:0030168', 'platelet-activating'),\n",
       " ('GO', 'GO:0030510', 'modulation of ... BMP signaling pathway'),\n",
       " ('UBERON', 'UBERON:0002389', 'digits of ... forelimb'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:dATP', 'dATP'),\n",
       " ('UBERON', 'UBERON:0001844', 'cochlear'),\n",
       " ('GO', 'GO:0090307', 'formation of ... mitotic spindle'),\n",
       " ('GO', 'GO:0005657', 'replication forks'),\n",
       " ('CHEBI', 'CHEBI:31624', 'fluorescein'),\n",
       " ('GO', 'GO:0008406', 'gonadal development'),\n",
       " ('CHEBI', 'CHEBI:8925', 'ryanodine'),\n",
       " ('GO', 'GO:0006909', 'phagocytosed'),\n",
       " ('GO', 'GO:0005768', 'endosomes'),\n",
       " ('MOP', 'MOP:0000124', 'myristoylated'),\n",
       " ('GO_EXT', 'GO_EXT:transcription_factor', 'transcriptional factors'),\n",
       " ('GO', 'GO:0000793', 'condensed chromosomes'),\n",
       " ('GO', 'GO:0040007', 'grown'),\n",
       " ('PR_EXT', 'PR_EXT:000009751', 'lymphoid enhancer factor-1'),\n",
       " ('GO', 'GO:0045333', 'respiratory'),\n",
       " ('UBERON', 'UBERON:0002046', 'Th'),\n",
       " ('CL', 'CL:0000855', 'HaC'),\n",
       " ('GO_PR_EXT',\n",
       "  'GO_PR_EXT:glutathione_S_transferase',\n",
       "  'glutathione-S-transferase'),\n",
       " ('PR_EXT', 'PR_EXT:000010501', 'Hb9'),\n",
       " ('UBERON', 'UBERON:0002616', 'brain sites'),\n",
       " ('UBERON', 'UBERON:0002124', 'm'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:nucleic_acid', 'nucleic acids'),\n",
       " ('CL', 'CL:0000359', 'V ... cell'),\n",
       " ('CL', 'CL:1001502', 'olfactory bulb mitral ... cells'),\n",
       " ('GO_EXT',\n",
       "  'GO_EXT:hexameric_macromolecular_complex',\n",
       "  'single hexameric complex'),\n",
       " ('SO_EXT', 'SO_EXT:0002031', 'shRNA'),\n",
       " ('UBERON', 'UBERON:0004721', 'Cristae'),\n",
       " ('PR_EXT', 'PR_EXT:000001327', 'cadherin'),\n",
       " ('UBERON', 'UBERON:0001836', 'salivary'),\n",
       " ('PR_EXT', 'PR_EXT:000009279', 'Sam68'),\n",
       " ('SO_EXT', 'SO_EXT:0001248', 'Scaffold'),\n",
       " ('GO', 'GO:0051145', 'differentiation ... into smooth muscle cells'),\n",
       " ('UBERON', 'UBERON:0000084', 'ub'),\n",
       " ('PR_EXT', 'PR_EXT:000011390', 'Dax1'),\n",
       " ('SO_EXT', 'SO_EXT:0000006', 'PCR products'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:tyrosine', 'Tyrosines'),\n",
       " ('PR_EXT', 'PR_EXT:000008735', 'Hprt1'),\n",
       " ('CL', 'CL:0002178', 'gastric epithelial cells'),\n",
       " ('GO_EXT', 'GO_EXT:reaction_or_response', 'responded'),\n",
       " ('GO', 'GO:0060817', 'inactivation of ... Xp'),\n",
       " ('GO', 'GO:0007631', 'fed'),\n",
       " ('GO', 'GO:0007399', 'neurodevelopmental'),\n",
       " ('UBERON', 'UBERON:0001388', 'gastrocnemius'),\n",
       " ('NCBITaxon', 'NCBITaxon:93934', 'Coturnix japonica'),\n",
       " ('PR_EXT', 'PR_EXT:000013672', 'Rad51'),\n",
       " ('GO_EXT', 'GO_EXT:0004180', 'carboxypeptidase'),\n",
       " ('UBERON', 'UBERON:0002836', 'lumbar ... DRG'),\n",
       " ('UBERON', 'UBERON:0004029', 'SC'),\n",
       " ('NCBITaxon', 'NCBITaxon:33511', 'deuterostomes'),\n",
       " ('UBERON', 'UBERON:0006934', 'sensory epithelia'),\n",
       " ('NCBITaxon', 'NCBITaxon:31033', 'tr'),\n",
       " ('GO', 'GO:0051301', 'Cell Division'),\n",
       " ('GO', 'GO:0065007', 'regulatory'),\n",
       " ('SO_EXT', 'SO_EXT:0000112', 'Primer'),\n",
       " ('PR_EXT', 'PR_EXT:000007241', 'Evx1'),\n",
       " ('CHEBI_PR_EXT', 'CHEBI_PR_EXT:glucagon', 'glucagon'),\n",
       " ('UBERON', 'UBERON:0000023', 'wing'),\n",
       " ('SO_EXT', 'SO_EXT:0000061', 'restriction endonuclease cleavage sites'),\n",
       " ('GO', 'GO:0005622', 'intracellular'),\n",
       " ('GO', 'GO:0002009', 'epithelial morphogenesis'),\n",
       " ('UBERON', 'UBERON:0002370', 'Thymus'),\n",
       " ('UBERON', 'UBERON:0006849', 'scapula'),\n",
       " ('GO', 'GO:0030424', 'projections of ... axons'),\n",
       " ('UBERON', 'UBERON:0001843', 'lateral canal'),\n",
       " ('GO', 'GO:0005912', 'adherens junction'),\n",
       " ('PR_EXT', 'PR_EXT:000016321', 'thyroid hormone receptor β2'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:paraformaldehye', 'PFA'),\n",
       " ('PR_EXT', 'PR_EXT:000010445', 'mixed lineage leukemia'),\n",
       " ('UBERON', 'UBERON:0002106', 'spleen'),\n",
       " ('CHEBI', 'CHEBI:16865', 'GABA'),\n",
       " ('PR_EXT', 'PR_EXT:000015890', 'synaptophysin'),\n",
       " ('PR_EXT', 'PR_EXT:000017718', 'BFCOL1'),\n",
       " ('CL', 'CL:0000235', 'M'),\n",
       " ('CL', 'CL:0000670', 'PCGs'),\n",
       " ('GO_EXT', 'GO_EXT:0004886', 'RXR'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:biochemical', 'biochemically'),\n",
       " ('PR_EXT', 'PR_EXT:000005776', 'cytochrome c oxidase ... IV'),\n",
       " ('PR_EXT', 'PR_EXT:000000133', 'Sp1'),\n",
       " ('UBERON', 'UBERON:0001132', 'parathyroid ... glands'),\n",
       " ('PR_EXT', 'PR_EXT:000024939', 'interferon-β'),\n",
       " ('CHEBI', 'CHEBI:28262', 'DMSO'),\n",
       " ('SO_EXT', 'SO_EXT:0001416', \"5' ... flanking regions\"),\n",
       " ('GO', 'GO:0060817', 'inactivation of ... paternal X chromosome'),\n",
       " ('UBERON', 'UBERON:0000916', 'bellied'),\n",
       " ('CHEBI', 'CHEBI:51739', 'acridine orange'),\n",
       " ('GO_EXT', 'GO_EXT:0004402', 'histone acetylase'),\n",
       " ('SO_EXT', 'SO_EXT:0000704', 'gene(s)'),\n",
       " ('UBERON', 'UBERON:0002028', 'hindbrain'),\n",
       " ('GO_PR_EXT', 'GO_PR_EXT:glucose_6_phosphate_dehydrogenase', 'G6PD'),\n",
       " ('UBERON', 'UBERON:0001224', 'renal pelvis'),\n",
       " ('UBERON', 'UBERON:0000033', 'Crown'),\n",
       " ('GO', 'GO:0007548', 'Sexual differentiation'),\n",
       " ('PR_EXT', 'PR_EXT:000013530', 'PR'),\n",
       " ('CHEBI', 'CHEBI:21008', 'phosphoglucose'),\n",
       " ('GO_PR_EXT', 'GO_PR_EXT:SMAD', 'Smad'),\n",
       " ('UBERON', 'UBERON:0000301', 'amniotic ... cavities'),\n",
       " ('GO_PR_EXT',\n",
       "  'GO_PR_EXT:dihydrolipoamide_dehydrogenase',\n",
       "  'dihydrolipoyl dehydrogenase'),\n",
       " ('UBERON', 'UBERON:0002495', 'Long Bones'),\n",
       " ('CL', 'CL:0002062', 'type I AEC'),\n",
       " ('UBERON', 'UBERON:0011137', 'axial ... skeleton'),\n",
       " ('CHEBI', 'CHEBI:44557', 'NTA'),\n",
       " ('GO', 'GO:0019221', 'cytokine signaling'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:35472', 'anti-inflammatory drug'),\n",
       " ('GO', 'GO:0000725', 'recombinational repair'),\n",
       " ('CL', 'CL:0000445', 'Apoptotic cells'),\n",
       " ('UBERON', 'UBERON:0000025', 'tubules'),\n",
       " ('SO_EXT', 'SO_EXT:0001026', 'genomically'),\n",
       " ('UBERON', 'UBERON:0002217', 'synovial joint'),\n",
       " ('GO', 'GO:0007129', 'Homologous Chromosome Synapsis'),\n",
       " ('GO', 'GO:0044297', 'cell bodies'),\n",
       " ('UBERON', 'UBERON:0000004', 'Nose'),\n",
       " ('GO', 'GO:0008306', 'associative learning'),\n",
       " ('GO', 'GO:0065007', 'Regulatory'),\n",
       " ('GO', 'GO:0016477', 'cell migration'),\n",
       " ('GO', 'GO:0048538', 'Development of ... Thymus'),\n",
       " ('PR_EXT', 'PR_EXT:000001168', 'Htr2c'),\n",
       " ('UBERON', 'UBERON:0015178', 'somitic frontier'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_alteration_entity_or_process', 'alterations'),\n",
       " ('GO', 'GO:0043588', 'development of skin'),\n",
       " ('UBERON', 'UBERON:0000009', 'submucosa'),\n",
       " ('UBERON', 'UBERON:0002836', 'lumbar dorsal roots'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:23888', 'drugs'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:glutamic_acid', 'Glu'),\n",
       " ('GO_EXT', 'GO_EXT:hexameric_macromolecular_complex', 'hexameric'),\n",
       " ('UBERON', 'UBERON:0006364', 'ureteric tips'),\n",
       " ('PR_EXT', 'PR_EXT:000013709', 'Ran-binding protein 1'),\n",
       " ('PR_EXT', 'PR_EXT:000004071', 'annexin I'),\n",
       " ('GO_UBERON_EXT', 'GO_UBERON_EXT:lumen', 'lumens'),\n",
       " ('NCBITaxon', 'NCBITaxon:31033', 'T. rubripes'),\n",
       " ('CHEBI', 'CHEBI:17138', 'glyceraldehyde 3 phosphate'),\n",
       " ('UBERON', 'UBERON:0016467', 'antitragus'),\n",
       " ('PR_EXT', 'PR_EXT:000002140', 'Xcl1'),\n",
       " ('GO', 'GO:1990794', 'basolateral face of ... cells'),\n",
       " ('SO_EXT', 'SO_EXT:0000704', 'genetic loci'),\n",
       " ('UBERON', 'UBERON:0004148', 'coronary ... veins'),\n",
       " ('PR_EXT', 'PR_EXT:000010668', 'MSH4'),\n",
       " ('PR_EXT', 'PR_EXT:000017354', 'Vsx1'),\n",
       " ('PR_EXT', 'PR_EXT:000015393', 'Socs2'),\n",
       " ('NCBITaxon', 'NCBITaxon:6462', 'limpet'),\n",
       " ('PR_EXT', 'PR_EXT:000013159', 'PGC-1 related coactivator'),\n",
       " ('GO', 'GO:0014069', 'post-synaptic density'),\n",
       " ('GO', 'GO:0046903', 'secrete'),\n",
       " ('CHEBI', 'CHEBI:32599', 'MgSO4'),\n",
       " ('SO_EXT', 'SO_EXT:0000350', 'frt sites'),\n",
       " ('PR_EXT', 'PR_EXT:000010208', 'Mat4'),\n",
       " ('PR_EXT', 'PR_EXT:000001023', 'NCAM'),\n",
       " ('GO', 'GO:0009566', 'fertilisation'),\n",
       " ('PR_EXT', 'PR_EXT:000003715', 'Adam2'),\n",
       " ('UBERON', 'UBERON:0001040', 'YS'),\n",
       " ('CL', 'CL:0000232', 'RBCs'),\n",
       " ('UBERON_EXT', 'UBERON_EXT:cartilage_element_or_tissue', 'cartilage'),\n",
       " ('GO_EXT', 'GO_EXT:regulator', 'regulators'),\n",
       " ('GO_PR_EXT',\n",
       "  'GO_PR_EXT:glucose_6_phosphate_dehydrogenase',\n",
       "  'glucose-6-phosphate dehydrogenase'),\n",
       " ('GO', 'GO:0006119', 'oxidative phosphorylation'),\n",
       " ('SO_EXT', 'SO_EXT:0000704', 'Gene'),\n",
       " ('SO_EXT', 'SO_EXT:0000185', 'pre-mRNA'),\n",
       " ('CL', 'CL:0000222', 'mesodermal cells'),\n",
       " ('GO', 'GO:0007605', 'auditory'),\n",
       " ('PR_EXT', 'PR_EXT:000007778', 'γ2 subunit of ... GABAA-R'),\n",
       " ('UBERON', 'UBERON:0002313', 'Stratum pyramidalis ... of ... hippocampus'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:tyrosine', 'Y'),\n",
       " ('GO', 'GO:0042983', 'APP synthesis'),\n",
       " ('UBERON', 'UBERON:0005396', 'cartoid artery'),\n",
       " ('CHEBI_EXT',\n",
       "  'CHEBI_EXT:thymine_nucleobase_or_nucleoside_or_nucleotide_molecular_entity_or_group',\n",
       "  'T nucleotide'),\n",
       " ('NCBITaxon', 'NCBITaxon:543', 'Enterobacteriaceae'),\n",
       " ('UBERON', 'UBERON:0001787', 'photoreceptor layer of ... retina'),\n",
       " ('GO_EXT', 'GO_EXT:biological_movement_or_translocation_process', 'Motor'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:60311', 'thyroid hormone'),\n",
       " ('CHEBI', 'CHEBI:472552', 'bromodeoxyuridine'),\n",
       " ('GO', 'GO:1990124', 'mRNP complexes'),\n",
       " ('PR_EXT', 'PR_EXT:000001940', 'tissue factor'),\n",
       " ('SO_EXT', 'SO_EXT:0000239', 'bordering regions'),\n",
       " ('UBERON', 'UBERON:0001593', 'venous plexus'),\n",
       " ('CHEBI', 'CHEBI:46261', 'phenylthiocarbamide'),\n",
       " ('GO', 'GO:0042995', 'cell processes'),\n",
       " ('PR_EXT', 'PR_EXT:000000020', 'MYC'),\n",
       " ('PR_EXT', 'PR_EXT:000029950', 'GSTP1'),\n",
       " ('CHEBI_PR_EXT', 'CHEBI_PR_EXT:amyloid_beta', 'Aβ ... peptide'),\n",
       " ('CHEBI_PR_EXT', 'CHEBI_PR_EXT:gastrin', 'GASTRIN'),\n",
       " ('PR_EXT', 'PR_EXT:000013709', 'RanBP1'),\n",
       " ('GO', 'GO:0005720', 'nuclear heterochromatin'),\n",
       " ('UBERON', 'UBERON:0004381', 'limb skeletons'),\n",
       " ('GO', 'GO:0098762', 'meiotic stage'),\n",
       " ('NCBITaxon', 'NCBITaxon:10140', 'guinea pig'),\n",
       " ('PR_EXT', 'PR_EXT:000008947', 'IGFBP-1'),\n",
       " ('GO_SO_EXT',\n",
       "  'GO_SO_EXT:chromosomal_part_or_position_or_region_or_site',\n",
       "  'interval on chromosome'),\n",
       " ('GO', 'GO:0036367', 'photopic response'),\n",
       " ('CHEBI', 'CHEBI:52117', 'Lysotracker Red DND-99'),\n",
       " ('GO', 'GO:0007530', 'sex-determination'),\n",
       " ('PR_EXT', 'PR_EXT:000023696', 'RecA'),\n",
       " ('SO_EXT', 'SO_EXT:0000646', 'small interfering RNA'),\n",
       " ('UBERON', 'UBERON:0004922', 'SVZ'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:amino_acid', 'Amino acids'),\n",
       " ('PR_EXT', 'PR_EXT:P46863', 'dmKLP2'),\n",
       " ('CL', 'CL:0002495', 'neonatal cardiac myocytes'),\n",
       " ('UBERON', 'UBERON:0004621', 'L5'),\n",
       " ('PR_EXT', 'PR_EXT:000041110', 'synapsin 2a'),\n",
       " ('PR_EXT', 'PR_EXT:000008523', 'Hesx1'),\n",
       " ('PR_EXT', 'PR_EXT:000009861', 'lamin B2'),\n",
       " ('GO_EXT', 'GO_EXT:trimeric_macromolecular_complex', 'trimeric'),\n",
       " ('CL', 'CL:0012001', 'neurons of forebrain areas'),\n",
       " ('CHEBI', 'CHEBI:35702', 'diethyl ether'),\n",
       " ('UBERON_EXT', 'UBERON_EXT:embryonic_stage_or_stage_part', 'embryonic stage'),\n",
       " ('GO', 'GO:0016192', 'vesicular trafficking'),\n",
       " ('PR_EXT', 'PR_EXT:P34766', 'PAL1'),\n",
       " ('PR_EXT', 'PR_EXT:000001280', 'ADAM8'),\n",
       " ('CHEBI', 'CHEBI:3098', 'bile acid'),\n",
       " ('GO', 'GO:0016265', 'lost'),\n",
       " ('GO', 'GO:0030168', 'platelet activation'),\n",
       " ('UBERON', 'UBERON:0003987', \"Hassall's corpuscle\"),\n",
       " ('NCBITaxon', 'NCBITaxon:9986', 'oc'),\n",
       " ('GO_EXT', 'GO_EXT:fatality_or_lethality', 'fatally'),\n",
       " ('GO', 'GO:0005657', 'replication fork'),\n",
       " ('CHEBI', 'CHEBI:20060', 'beta-hydroxyacyl CoA'),\n",
       " ('UBERON', 'UBERON:0002385', 'muscle tissue'),\n",
       " ('PR_EXT',\n",
       "  'PR_EXT:000004683',\n",
       "  'mitochondrial branched-chain aminotransferase'),\n",
       " ('CL', 'CL:0000103', 'Bipolar cell'),\n",
       " ('UBERON', 'UBERON:0001981', 'blood vessels'),\n",
       " ('CL', 'CL:0000210', 'photosensory ... neurons'),\n",
       " ('PR_EXT', 'PR_EXT:000013412', 'ptc1'),\n",
       " ('CHEBI', 'CHEBI:53248', 'polyvinylpyrrolidone'),\n",
       " ('PR_EXT', 'PR_EXT:000008680', 'HOMER3'),\n",
       " ('CHEBI', 'CHEBI:18059', 'lipid'),\n",
       " ('GO', 'GO:0007131', 'CO ... recombination'),\n",
       " ('CHEBI', 'CHEBI:53251', 'Teflon'),\n",
       " ('UBERON', 'UBERON:0004721', 'crista ampullaris'),\n",
       " ('CL', 'CL:0000601', 'outer hair cell'),\n",
       " ('GO', 'GO:0050673', 'proliferation of ... epithelial ... cells'),\n",
       " ('PR_EXT', 'PR_EXT:000008523', 'Hesx'),\n",
       " ('PR_EXT', 'PR_EXT:Q9NPA3', 'hMIG12'),\n",
       " ('GO', 'GO:0002224', 'toll-like receptor signaling'),\n",
       " ('CL', 'CL:0000670', 'gonocytes'),\n",
       " ('GO_PATO_EXT',\n",
       "  'GO_PATO_EXT:biological_adhesion_entity_or_process',\n",
       "  'adhesion'),\n",
       " ('CL', 'CL:1000426', 'adrenal chromaffin cells'),\n",
       " ('CHEBI', 'CHEBI:26605', 'saponin'),\n",
       " ('UBERON', 'UBERON:0002819', 'apical ... cochlear'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_cloning_process', 'cloning'),\n",
       " ('UBERON', 'UBERON:0006378', 'whisker'),\n",
       " ('PR_EXT', 'PR_EXT:000017442', 'Wnt-3'),\n",
       " ('PR_EXT', 'PR_EXT:000007479', 'α-FGF'),\n",
       " ('CL', 'CL:0000545', 'T helper ... 1'),\n",
       " ('PR_EXT', 'PR_EXT:000004686', 'α ... subunits'),\n",
       " ('UBERON', 'UBERON:0008776', 'primitive ... endoderm'),\n",
       " ('UBERON', 'UBERON:0005169', 'interstitial'),\n",
       " ('CHEBI', 'CHEBI:5054', 'fibrin'),\n",
       " ('CL', 'CL:0000646', 'basal cells'),\n",
       " ('UBERON', 'UBERON:0002146', 'pulmonary valve'),\n",
       " ('PR_EXT', 'PR_EXT:P58771', 'mmTPM1'),\n",
       " ('GO', 'GO:0006006', 'glucose ... metabolism'),\n",
       " ('GO', 'GO:0007276', 'gamete development'),\n",
       " ('GO_EXT', 'GO_EXT:muscle_structure_or_tissue_development', 'myogenesis'),\n",
       " ('CHEBI', 'CHEBI:15346', 'CoA'),\n",
       " ('UBERON', 'UBERON:0003902', 'NR'),\n",
       " ('NCBITaxon', 'NCBITaxon:7586', 'echinodermata'),\n",
       " ('CL', 'CL:0002540', 'bone marrow mesenchymal stem cells'),\n",
       " ('UBERON', 'UBERON:0000468', 'whole body'),\n",
       " ('CHEBI', 'CHEBI:53250', 'polyvinylidene difluoride'),\n",
       " ('GO_EXT',\n",
       "  'GO_EXT:biological_movement_or_translocation_process',\n",
       "  'transport'),\n",
       " ('CL', 'CL:0000064', 'ciliated cells'),\n",
       " ('GO', 'GO:0007585', 'gas-exchange'),\n",
       " ('CHEBI', 'CHEBI:23414', 'CuSO4'),\n",
       " ('CL', 'CL:1000415', 'gallbladder epithelial cells'),\n",
       " ('PR_EXT', 'PR_EXT:000016585', 'tripeptidyl-peptidase I'),\n",
       " ('GO_EXT', 'GO_EXT:0098821', 'bone morphogenetic protein receptor'),\n",
       " ('GO_EXT', 'GO_EXT:0033549', 'MAPK phosphatase'),\n",
       " ('PR_EXT', 'PR_EXT:000022190', 'subunit c'),\n",
       " ('CHEBI_SO_EXT',\n",
       "  'CHEBI_SO_EXT:C_terminus_or_C_terminal_region',\n",
       "  'carboxy terminus'),\n",
       " ('CL', 'CL:1001571', 'hippocampal pyramidal neurons'),\n",
       " ('GO_SO_EXT',\n",
       "  'GO_SO_EXT:chromosomal_part_or_position_or_region_or_site',\n",
       "  'regions on Chromosome'),\n",
       " ('UBERON', 'UBERON:0006333', 'snout'),\n",
       " ('CL', 'CL:0011107', 'm'),\n",
       " ('CL', 'CL:1001451', 'proprioceptive sensory neuron'),\n",
       " ('CHMO_UBERON_EXT',\n",
       "  'CHMO_UBERON_EXT:bodily_fluid_or_bodily_fluid_experimental_method',\n",
       "  'serological'),\n",
       " ('UBERON', 'UBERON:0001637', 'arteries'),\n",
       " ('GO', 'GO:0046982', 'heterodimer formation'),\n",
       " ('UBERON', 'UBERON:0000926', 'mesoderm'),\n",
       " ('GO', 'GO:0035106', 'operant conditioning'),\n",
       " ('SO_EXT', 'SO_EXT:0001416', '5′ ... flanking regions'),\n",
       " ('GO', 'GO:0042088', 'Th1 response'),\n",
       " ('PR_EXT', 'PR_EXT:000012289', 'Adprt1'),\n",
       " ('CL', 'CL:0000771', 'eosinophil'),\n",
       " ('NCBITaxon', 'NCBITaxon:9793', 'donkey'),\n",
       " ('GO', 'GO:0030324', 'lung developmental'),\n",
       " ('SO_EXT', 'SO_EXT:0000417', 'protein domains'),\n",
       " ('UBERON_EXT', 'UBERON_EXT:body', 'bodies'),\n",
       " ('GO_PR_EXT', 'GO_PR_EXT:fMet_Leu_Phe_receptor', 'F-met-leu-phe receptor'),\n",
       " ('GO_PR_EXT', 'GO_PR_EXT:leptin_receptor', 'Lepr'),\n",
       " ('GO', 'GO:0006302', 'repair of DSBs'),\n",
       " ('SO_EXT', 'SO_EXT:0001415', 'deletion breakpoints'),\n",
       " ('UBERON_EXT', 'UBERON_EXT:hindpaw', 'hind paws'),\n",
       " ('PR_EXT', 'PR_EXT:000001168', 'serotonin receptor 2c'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:phenylalanine', 'phe'),\n",
       " ('CHEBI', 'CHEBI:38551', 'cytochrome ... b'),\n",
       " ('UBERON', 'UBERON:0004529', 'Appendages'),\n",
       " ('UBERON', 'UBERON:0004340', 'al'),\n",
       " ('CHEBI_GO_EXT',\n",
       "  'CHEBI_GO_EXT:neomycin_or_neomycin_phosphotransferase',\n",
       "  'neo'),\n",
       " ('CL', 'CL:0000120', 'Granule cell'),\n",
       " ('PR_EXT', 'PR_EXT:CLASP', 'CLASPs'),\n",
       " ('UBERON', 'UBERON:0003946', 'labyrinthine'),\n",
       " ('PR_EXT', 'PR_EXT:000036337', 'T2Rs'),\n",
       " ('CHEBI', 'CHEBI:49575', 'diazepam'),\n",
       " ('PR_EXT', 'PR_EXT:000006847', 'DPPA5'),\n",
       " ('CHEBI', 'CHEBI:24866', 'saline'),\n",
       " ('CL', 'CL:0000084', 'T'),\n",
       " ('CL', 'CL:0010012', 'cortical neurons'),\n",
       " ('PR_EXT', 'PR_EXT:000007295', 'Factors ... XI'),\n",
       " ('GO_PATO_EXT', 'GO_PATO_EXT:biological_adhesion_or_attachedness', 'adhere'),\n",
       " ('UBERON', 'UBERON:0004356', 'apical ectodermal ridge'),\n",
       " ('UBERON', 'UBERON:0001448', 'metatarsals'),\n",
       " ('SO_EXT', 'SO_EXT:0000694', 'SNPs'),\n",
       " ('CHEBI', 'CHEBI:50845', 'Doxycycline'),\n",
       " ('UBERON', 'UBERON:4200215', 'sutures'),\n",
       " ('GO', 'GO:0005622', 'Intracellular'),\n",
       " ('CL', 'CL:0000527', 'output neurons'),\n",
       " ('UBERON', 'UBERON:0004366', 'extraembryonic ectoderm'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_cloned_entity', 'clonal'),\n",
       " ('GO', 'GO:0030154', 'cellular ... differentiation'),\n",
       " ('GO', 'GO:0017145', 'self-renewal of ... cells'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:82824', 'inhibitors of calpains'),\n",
       " ('GO_SO_EXT',\n",
       "  'GO_SO_EXT:chromosomal_part_or_position_or_region_or_site',\n",
       "  'chromosomal segment'),\n",
       " ('CL', 'CL:0002327', 'mammary epithelial cells'),\n",
       " ('UBERON', 'UBERON:0001896', 'Me'),\n",
       " ('PR_EXT', 'PR_EXT:P23940', 'BamHI'),\n",
       " ('CL', 'CL:0002062', 'lung type I AECs'),\n",
       " ('UBERON', 'UBERON:0002186', 'B'),\n",
       " ('GO_EXT', 'GO_EXT:0016301', 'kinases'),\n",
       " ('UBERON', 'UBERON:0002081', 'atrial chamber of ... heart'),\n",
       " ('UBERON', 'UBERON:0010996', 'Articular cartilage'),\n",
       " ('GO', 'GO:0070285', 'pigment-cell development'),\n",
       " ('NCBITaxon_UBERON_EXT', 'NCBITaxon_UBERON_EXT:woman', 'woman'),\n",
       " ('MOP', 'MOP:0000030', 'acetylated'),\n",
       " ('UBERON', 'UBERON:0001789', 'ONLs'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:37958', 'dyes'),\n",
       " ('GO', 'GO:0060215', 'primitive hematopoietic'),\n",
       " ('CHEMINF_GO_EXT',\n",
       "  'CHEMINF_GO_EXT:bearer_of_chemical_binding_or_bond_formation',\n",
       "  'binding'),\n",
       " ('PR_EXT', 'PR_EXT:000006939', 'Egr3'),\n",
       " ('GO', 'GO:0005634', 'Nuclei'),\n",
       " ('SO_EXT', 'SO_EXT:fusion_gene_or_gene_fusion', 'fusion of ... genes'),\n",
       " ('PR_EXT', 'PR_EXT:P23023', 'dsx'),\n",
       " ('PR_EXT', 'PR_EXT:000016653', 'TRIM29'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_upstreamness', \"5' upstream\"),\n",
       " ('UBERON', 'UBERON:0001791', 'inner granular layer'),\n",
       " ('GO', 'GO:0071850', 'mitotic arrest'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:glutamic_acid', 'glutamic acids'),\n",
       " ('UBERON', 'UBERON:0002211', 'roots'),\n",
       " ('PR_EXT', 'PR_EXT:000002005', 'Kcnj5'),\n",
       " ('PR_EXT', 'PR_EXT:000003956', 'Alms1a'),\n",
       " ('CL', 'CL:0000855', 'Hair ... Cell'),\n",
       " ('CHEBI', 'CHEBI:61907', 'medium-chain acyl-CoA'),\n",
       " ('UBERON', 'UBERON:0001890', 'FB'),\n",
       " ('GO_EXT', 'GO_EXT:tetrameric_macromolecular_complex', 'tetramers'),\n",
       " ('UBERON', 'UBERON:0005062', 'nf'),\n",
       " ('PR_EXT', 'PR_EXT:000014774', 'surfactant proteins ... C'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_altered_entity_or_alteration_process', 'mt'),\n",
       " ('CHEBI', 'CHEBI:78021', 'tetrazolium'),\n",
       " ('UBERON', 'UBERON:0003121', '4th ... PAAs'),\n",
       " ('UBERON', 'UBERON:0002346', 'neural ectoderm'),\n",
       " ('CL', 'CL:0000609', 'vestibular hair cell'),\n",
       " ('CL', 'CL:0002222', 'lens cells'),\n",
       " ('PR_EXT', 'PR_EXT:000010686', 'MSX1'),\n",
       " ('PR_EXT', 'PR_EXT:000001178', 'D3Rs'),\n",
       " ('PR_EXT', 'PR_EXT:000006922', 'ephrin-B2'),\n",
       " ('GO_EXT',\n",
       "  'GO_EXT:cell_communication_or_signaling_or_signal_transduction',\n",
       "  'signaling transduction'),\n",
       " ('UBERON', 'UBERON:0005749', 'glomerular tuft'),\n",
       " ('GO', 'GO:0000811', 'GINS'),\n",
       " ('UBERON', 'UBERON:0005253', 'mesenchymal tissues of ... head'),\n",
       " ('PR_EXT', 'PR_EXT:000014390', 'REF2'),\n",
       " ('PR_EXT', 'PR_EXT:000000167', 'BMP6'),\n",
       " ('UBERON', 'UBERON:0001047', 'glomerulus'),\n",
       " ('CHEBI', 'CHEBI:25218', 'methacrylate'),\n",
       " ('PR_EXT', 'PR_EXT:000010473', 'matrix metalloprotease-13'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:33893', 'Reagent'),\n",
       " ('GO', 'GO:0045177', 'apex'),\n",
       " ('GO', 'GO:0005874', 'microtubules'),\n",
       " ('NCBITaxon', 'NCBITaxon:9596', 'chimp'),\n",
       " ('CL', 'CL:0002319', 'neural cell'),\n",
       " ('UBERON', 'UBERON:0006585', 'vestibular endorgan'),\n",
       " ('GO', 'GO:0090009', 'streak formation'),\n",
       " ('PR_EXT', 'PR_EXT:000010687', 'Msx2'),\n",
       " ('PR_EXT', 'PR_EXT:000010246', 'Mcm4'),\n",
       " ('PR_EXT', 'PR_EXT:000003712', 'ADAM15'),\n",
       " ('CL', 'CL:0000057', 'MC'),\n",
       " ('UBERON', 'UBERON:0001979', 'venules'),\n",
       " ('SO_EXT', 'SO_EXT:0000028', 'base pair'),\n",
       " ('SO_EXT', 'SO_EXT:0000363', 'floxed ... genes'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:molecular_probe', 'Probes'),\n",
       " ('CL', 'CL:0002613', 'striatal neurons'),\n",
       " ('PR_EXT', 'PR_EXT:000011546', 'p15'),\n",
       " ('UBERON', 'UBERON:0000966', 'retinas'),\n",
       " ('PR_EXT', 'PR_EXT:000006524', 'Delta-like ... 3'),\n",
       " ('CHEBI', 'CHEBI:15541', 'stearoyl-CoA'),\n",
       " ('CL', 'CL:0011113', 'spiral neuron'),\n",
       " ('SO_EXT', 'SO_EXT:0000167', 'promoter region'),\n",
       " ('CHEBI', 'CHEBI:23995', 'ethyl nitroso urea'),\n",
       " ('CHEBI', 'CHEBI:16066', '11-cis-retinal'),\n",
       " ('GO', 'GO:0035791', 'transmission of PDGFRβ signals'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:biomarker', 'biomarker'),\n",
       " ('UBERON', 'UBERON:0004621', 'fifth lumbar vertebrae'),\n",
       " ('UBERON', 'UBERON:0006049', 'second digits'),\n",
       " ('SO', 'SO:0001030', 'F'),\n",
       " ('UBERON', 'UBERON:0004340', 'allantois'),\n",
       " ('PR_EXT', 'PR_EXT:000012583', 'PFK-M'),\n",
       " ('GO', 'GO:0000380', 'Alternative pre-mRNA splicing'),\n",
       " ('UBERON', 'UBERON:0016920', 'descending part of ... aortic arch'),\n",
       " ('CHEBI', 'CHEBI:60004', 'mixture'),\n",
       " ('UBERON', 'UBERON:0001388', 'g'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:nickel', 'Ni'),\n",
       " ('CHEBI', 'CHEBI:16469', '17β estradiol'),\n",
       " ('GO', 'GO:0030324', 'development of ... lung'),\n",
       " ('CHEBI', 'CHEBI:33694', 'Biopolymer'),\n",
       " ('PR_EXT', 'PR_EXT:000000047', 'Alk5'),\n",
       " ('PR_EXT', 'PR_EXT:000017355', 'Chx10'),\n",
       " ('CL', 'CL:0000115', 'endothelial ... cells'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_nullness_or_absence', '–'),\n",
       " ('GO', 'GO:0019722', 'Ca2+-dependent signaling pathways'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:75599', 'inhibitor of glutamate-cysteine ligase'),\n",
       " ('UBERON', 'UBERON:0000085', 'morula'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_substitution_entity_or_process', 'substitutions'),\n",
       " ('UBERON', 'UBERON:0001803', 'lens epithelial'),\n",
       " ('PR_EXT', 'PR_EXT:000003263', 'Collagen 1'),\n",
       " ('GO', 'GO:0006936', 'contract'),\n",
       " ('GO', 'GO:0005753', 'mitochondrial ATP synthase complex'),\n",
       " ('PR_EXT', 'PR_EXT:000008317', 'p62 subunit of ... TFIIH'),\n",
       " ('CHEBI', 'CHEBI:4883', 'ethidium bromide'),\n",
       " ('GO', 'GO:0007114', 'budding'),\n",
       " ('GO', 'GO:0007283', 'spermatogenesis'),\n",
       " ('PR_EXT',\n",
       "  'PR_EXT:000016672',\n",
       "  'thyroid hormone receptor interacting protein 13'),\n",
       " ('NCBITaxon', 'NCBITaxon:9606', 'man'),\n",
       " ('GO', 'GO:0042088', 'Th ... 1 immune response'),\n",
       " ('PR_EXT', 'PR_EXT:Q9VDZ3', 'Squeeze'),\n",
       " ('GO', 'GO:0042995', 'projections'),\n",
       " ('UBERON', 'UBERON:0007376', 'Epidermal'),\n",
       " ('CL', 'CL:0000233', 'platelet'),\n",
       " ('PR_EXT', 'PR_EXT:000015849', 'SV2'),\n",
       " ('UBERON_EXT', 'UBERON_EXT:childhood', 'childhood'),\n",
       " ('CHEBI', 'CHEBI:35607', 'Na3VO4'),\n",
       " ('GO', 'GO:0006289', 'NER'),\n",
       " ('CHEBI', 'CHEBI:51103', 'Fluo'),\n",
       " ('GO', 'GO:0071736', 'IgG antibody'),\n",
       " ('SO_EXT', 'SO_EXT:0000871', 'polyA+ RNA'),\n",
       " ('CHEBI_SO_EXT',\n",
       "  'CHEBI_SO_EXT:N_terminus_or_N_terminal_region',\n",
       "  'N terminus'),\n",
       " ('GO', 'GO:0060349', 'Bone morphogenetic'),\n",
       " ('CL', 'CL:0000499', 'stromal cells'),\n",
       " ('UBERON', 'UBERON:0002495', 'long bones'),\n",
       " ('GO', 'GO:0007608', 'olfaction'),\n",
       " ('GO', 'GO:0031080', 'Nup107-Nup160 complex'),\n",
       " ('PR_EXT', 'PR_EXT:000015906', 'synaptotagmin ... IV'),\n",
       " ('GO_EXT',\n",
       "  'GO_EXT:neuron_development_or_generation',\n",
       "  'development of ... neuron'),\n",
       " ('UBERON', 'UBERON:0000006', 'pancreatic islet'),\n",
       " ('UBERON', 'UBERON:0001046', 'hind ... gut'),\n",
       " ('GO', 'GO:0007416', 'formation of ... synapses'),\n",
       " ('SO', 'SO:0000359', 'Flox'),\n",
       " ('GO', 'GO:0042613', 'MHC class II'),\n",
       " ('CHEBI', 'CHEBI:50325', 'Side chains'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:N_terminus_or_N_terminal_region', 'Nter'),\n",
       " ('CL', 'CL:0000646', 'basal epithelial cell'),\n",
       " ('GO', 'GO:0000235', 'radial ... microtubules'),\n",
       " ('CL', 'CL:1000497', 'Kidney ... cells'),\n",
       " ('PR_EXT', 'PR_EXT:000003676', 'Actb'),\n",
       " ('PR_EXT', 'PR_EXT:000008373', 'connexin43'),\n",
       " ('GO', 'GO:0044838', 'cellular quiescence'),\n",
       " ('UBERON', 'UBERON:0001004', 'respiratory'),\n",
       " ('GO', 'GO:0007411', 'axon pathfinding'),\n",
       " ('GO_EXT', 'GO_EXT:0004725', 'phosphotyrosine phosphatase'),\n",
       " ('GO', 'GO:0005654', 'p'),\n",
       " ('GO', 'GO:0001966', 'thigmotaxis'),\n",
       " ('MOP', 'MOP:0000780', 'break'),\n",
       " ('CHEBI', 'CHEBI:16919', 'creatine'),\n",
       " ('NCBITaxon', 'NCBITaxon:7955', 'Danio rerio'),\n",
       " ('GO_EXT', 'GO_EXT:negative_regulation', 'negatively regulates'),\n",
       " ('CHEBI_EXT',\n",
       "  'CHEBI_EXT:guanine_nucleobase_or_nucleoside_or_nucleotide_molecular_entity_or_group',\n",
       "  'guanosine'),\n",
       " ('SO_EXT', 'SO_EXT:gene_trapping_process', 'gene-trapped'),\n",
       " ('GO', 'GO:0008282', 'KATP channel'),\n",
       " ('PR_EXT', 'PR_EXT:hedgehog', 'Hedgehog'),\n",
       " ('GO', 'GO:0032508', 'unwinding of duplex DNA'),\n",
       " ('GO', 'GO:0043335', 'unfolding'),\n",
       " ('UBERON', 'UBERON:0001424', 'ulnar'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:biomarker', 'Biomarkers'),\n",
       " ('GO_SO_EXT',\n",
       "  'GO_SO_EXT:chromosomal_part_or_position_or_region_or_site',\n",
       "  'chromosomal region'),\n",
       " ('CHEBI', 'CHEBI:27902', 'tetracycline'),\n",
       " ('GO_EXT', 'GO_EXT:0016248', 'channel blocker'),\n",
       " ('GO_EXT', 'GO_EXT:0008910', 'neomycin phosphotransferase'),\n",
       " ('CL', 'CL:0002592', 'Vascular Smooth Muscle Cells of ... Coronary Arteries'),\n",
       " ('UBERON_EXT',\n",
       "  'UBERON_EXT:skeletal_muscle_organ_or_tissue',\n",
       "  'skeletal-muscle'),\n",
       " ('CHEBI', 'CHEBI:17824', 'isopropanol'),\n",
       " ('UBERON', 'UBERON:0001052', 'Rectal'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:50112', 'sex hormone'),\n",
       " ('CHEBI', 'CHEBI:30411', 'vitamin B12'),\n",
       " ('CHEBI', 'CHEBI:15854', 'Quinine'),\n",
       " ('UBERON', 'UBERON:0003128', 'cranium'),\n",
       " ('PR_EXT', 'PR_EXT:000000134', 'TNFα'),\n",
       " ('MOP', 'MOP:0000780', 'cut'),\n",
       " ('GO_EXT', 'GO_EXT:0004175', 'endoprotease'),\n",
       " ('GO', 'GO:0008306', 'classical ... conditioning'),\n",
       " ('UBERON', 'UBERON:0006022', '3/4 interdigit'),\n",
       " ('GO', 'GO:0005615', 'extracellular space'),\n",
       " ('GO_PATO_EXT',\n",
       "  'GO_PATO_EXT:biological_pigmentation_process_or_quality',\n",
       "  'pigmentation'),\n",
       " ('GO', 'GO:0000239', 'Pachynema'),\n",
       " ('GO_EXT', 'GO_EXT:0005125', 'cytokines'),\n",
       " ('GO', 'GO:0060047', 'beating'),\n",
       " ('UBERON', 'UBERON:0002037', 'cerebella'),\n",
       " ('GO', 'GO:0005856', 'cytoskeleton'),\n",
       " ('PR_EXT', 'PR_EXT:000007861', 'Gatas ... 6'),\n",
       " ('CL', 'CL:0002608', 'Hippocampal neurons'),\n",
       " ('UBERON', 'UBERON:0001684', 'mandibular'),\n",
       " ('SO_EXT', 'SO_EXT:0000028', 'Basepair'),\n",
       " ('UBERON', 'UBERON:0001844', 'cochleae'),\n",
       " ('UBERON', 'UBERON:0003428', 'gonadal fat pads'),\n",
       " ('CHEBI', 'CHEBI:16249', 'protein disulfide'),\n",
       " ('NCBITaxon_UBERON_EXT', 'NCBITaxon_UBERON_EXT:woman', 'women'),\n",
       " ('UBERON', 'UBERON:0002394', 'bile duct'),\n",
       " ('UBERON', 'UBERON:0001766', 'anterior chamber'),\n",
       " ('UBERON', 'UBERON:0002346', 'neuroectoderm'),\n",
       " ('GO', 'GO:0045165', 'commitment of ... cells ... to ... cell fate'),\n",
       " ('PR_EXT', 'PR_EXT:000001044', 'CTRF'),\n",
       " ('UBERON', 'UBERON:0006134', 'Nerve fibers'),\n",
       " ('SO_EXT', 'SO_EXT:0000851', 'sites within ... coding region'),\n",
       " ('GO', 'GO:0007608', 'perception of smell'),\n",
       " ('SO_EXT',\n",
       "  'SO_EXT:alternative_splice_variant',\n",
       "  'alternatively spliced ... isoforms'),\n",
       " ('GO', 'GO:0050817', 'clot formation'),\n",
       " ('PR_EXT', 'PR_EXT:000003266', 'Collagen II'),\n",
       " ('CHEBI', 'CHEBI:28623', 'campesterol'),\n",
       " ('SO_EXT', 'SO_EXT:splice_donor', 'splice donor'),\n",
       " ('CHEBI', 'CHEBI:18070', 'cytochrome c'),\n",
       " ('GO', 'GO:0032940', 'release from ... cells'),\n",
       " ('GO_EXT', 'GO_EXT:biological_movement_or_translocation_process', 'carried'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_rescue_process', 'rescued'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:metal', 'Metal'),\n",
       " ('UBERON', 'UBERON:0004288', 'skeletons'),\n",
       " ('UBERON', 'UBERON:0000935', 'AC'),\n",
       " ('CL', 'CL:0000549', 'early erythroblast'),\n",
       " ('PR_EXT', 'PR_EXT:000015432', 'SOX6'),\n",
       " ('NCBITaxon', 'NCBITaxon:8296', 'Ambystoma mexicanum'),\n",
       " ('PR_EXT', 'PR_EXT:000008609', 'hexokinase 2'),\n",
       " ('SO_EXT', 'SO_EXT:0000954', 'Chromosomal DNA'),\n",
       " ('UBERON', 'UBERON:0002185', 'bronchi'),\n",
       " ('GO', 'GO:0031323', 'control of cellular ... metabolism'),\n",
       " ('PR_EXT', 'PR_EXT:000017438', 'Wnt11'),\n",
       " ('CL', 'CL:0000019', 'Sperm'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:deoxyribonucleotide', 'deoxynucleotidyl'),\n",
       " ('CHEBI', 'CHEBI:18035', 'DAGs'),\n",
       " ('UBERON', 'UBERON:0001461', 'elbow'),\n",
       " ('PR_EXT', 'PR_EXT:000017296', 'Vil'),\n",
       " ('PR_EXT', 'PR_EXT:000022190', 'mitochondrial ATPase subunit c'),\n",
       " ('CL', 'CL:0000300', 'gametes'),\n",
       " ('CHEBI_EXT', 'CHEBI_EXT:dNTP', 'dNTPs'),\n",
       " ('GO', 'GO:1990794', 'basolateral face'),\n",
       " ('CL', 'CL:0000148', 'melanocyte'),\n",
       " ('UBERON', 'UBERON:0004288', 'Skeleton'),\n",
       " ('PR_EXT', 'PR_EXT:000013523', 'Pygo1'),\n",
       " ('GO', 'GO:0006915', 'cellular apoptosis'),\n",
       " ('PR_EXT', 'PR_EXT:000007229', 'TEL'),\n",
       " ('GO', 'GO:0070498', 'cytokine IL-1 signaling pathway'),\n",
       " ('CL', 'CL:0000771', 'eosinophil leukocytes'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:methionine', 'methionine'),\n",
       " ('UBERON', 'UBERON:0000056', 'ureter'),\n",
       " ('GO', 'GO:0006415', 'translational stop'),\n",
       " ('GO', 'GO:0006754', 'ATP production'),\n",
       " ('UBERON', 'UBERON:0002185', 'b'),\n",
       " ('PR_EXT', 'PR_EXT:000030444', 'osteocalcin'),\n",
       " ('SO_EXT', 'SO_EXT:sequence_deletion_process', 'excisions'),\n",
       " ('PR_EXT', 'PR_EXT:000006300', 'E2 subunit of BCKDH'),\n",
       " ('PR_EXT', 'PR_EXT:000016285', 'transforming growth factor alpha'),\n",
       " ('GO', 'GO:0051301', 'Cell ... division'),\n",
       " ('GO', 'GO:1990774', 'TNF-α release'),\n",
       " ('GO', 'GO:0051656', 'trafficking of ... organelles'),\n",
       " ('GO_EXT',\n",
       "  'GO_EXT:cell_communication_or_signaling_or_signal_transduction',\n",
       "  'Signaling'),\n",
       " ('UBERON', 'UBERON:0001113', 'liver lobe'),\n",
       " ('CHEBI_GO_PR_EXT', 'CHEBI_GO_PR_EXT:growth_hormone', 'growth hormone'),\n",
       " ('GO_EXT', 'GO_EXT:0004519', 'endonuclease'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:methionine', 'met'),\n",
       " ('GO', 'GO:0006397', 'mRNA editing'),\n",
       " ('UBERON_EXT', 'UBERON_EXT:bone_element_or_tissue', 'bone'),\n",
       " ('CHEBI_SO_EXT', 'CHEBI_SO_EXT:glutamine', 'glutamine'),\n",
       " ('CL', 'CL:0002062', 'type I ... epithelial cells'),\n",
       " ('PR_EXT',\n",
       "  'PR_EXT:000002087',\n",
       "  'signal transducer and activator of transcription 1'),\n",
       " ('PR_EXT', 'PR_EXT:000001672', 'Sstr5'),\n",
       " ('CL', 'CL:0000127', 'astrocytic cell'),\n",
       " ('GO_EXT', 'GO_EXT:0004129', 'cytochrome c oxidase'),\n",
       " ('CL', 'CL:0002561', 'ORS cells'),\n",
       " ('GO', 'GO:0001917', 'IS'),\n",
       " ('GO', 'GO:0006741', 'NADPH-generating'),\n",
       " ('CL', 'CL:0000353', 'blastomeres'),\n",
       " ('CHEBI_SO_EXT',\n",
       "  'CHEBI_SO_EXT:molecular_indicator_or_label_or_marker_or_tag',\n",
       "  'marker'),\n",
       " ('CL', 'CL:0000120', 'GC'),\n",
       " ('SO_EXT',\n",
       "  'SO_EXT:radiation_hybrid_mapping_process',\n",
       "  'Radiation hybrid mapping'),\n",
       " ('PR_EXT', 'PR_EXT:000016313', 'REF1'),\n",
       " ('GO', 'GO:0015701', 'HCO3 - transport'),\n",
       " ('GO', 'GO:0051866', 'adaptive responses'),\n",
       " ('GO', 'GO:0009888', 'creation of ... tissues'),\n",
       " ('CL', 'CL:0000101', 'afferent sensory neurons'),\n",
       " ('CHEBI', 'CHEBI:14314', 'glucose-6-phosphate'),\n",
       " ('UBERON', 'UBERON:0001833', 'lip'),\n",
       " ('PR_EXT', 'PR_EXT:000010717', 'metal-responsive transcription factor 1'),\n",
       " ('MOP', 'MOP:0000635', 'chain reaction'),\n",
       " ('GO_PR_EXT', 'GO_PR_EXT:choline_O_acetyltransferase', 'Chat'),\n",
       " ('GO', 'GO:0006306', 'DNA methylation'),\n",
       " ('PR_EXT', 'PR_EXT:Q12436', 'zinc-regulated transporter 2'),\n",
       " ('UBERON', 'UBERON:0000323', 'late stage embryos'),\n",
       " ...]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "uni_data_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"unidata.txt\", 'w', encoding='UTF-8') as f:\n",
    "    for i in uni_data_:\n",
    "        data_str = \"__label__\"+i[1]+\" \"+i[0]+\" \"+i[2]+\"\\n\"\n",
    "        f.write(data_str)\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "159137"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(data_)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
